Class ID,Preferred Label,Synonyms,Definitions,Obsolete,CUI,Semantic Types,Parents,has role,http://data.bioontology.org/metadata/prefixIRI,http://purl.org/dc/elements/1.1/contributor,http://purl.org/dc/elements/1.1/creator,http://purl.org/dc/elements/1.1/date,http://purl.org/dc/elements/1.1/format,http://purl.org/dc/elements/1.1/identifier,http://purl.org/dc/elements/1.1/language,http://purl.org/dc/elements/1.1/publisher,http://purl.org/dc/elements/1.1/rights,http://purl.org/dc/elements/1.1/source,http://purl.org/dc/elements/1.1/title,http://scai.fraunhofer.de/NDDUO#adjacent_to,http://scai.fraunhofer.de/NDDUO#bearer_of,http://scai.fraunhofer.de/NDDUO#derives_from,http://scai.fraunhofer.de/NDDUO#has_agent,http://scai.fraunhofer.de/NDDUO#has_participant,http://scai.fraunhofer.de/NDDUO#inheres_in,http://scai.fraunhofer.de/NDDUO#is_entity_used_in,http://scai.fraunhofer.de/NDDUO#located_in,http://scai.fraunhofer.de/NDDUO#mapping,http://scai.fraunhofer.de/NDDUO#part_of,http://scai.fraunhofer.de/NDDUO#preceded_by,http://scai.fraunhofer.de/NDDUO#Reference,http://scai.fraunhofer.de/NDDUO#Synonym,http://scai.fraunhofer.de/NDDUO#transformation_of,http://www.pepathway.org/peo/1.1#is_entity_used_in,http://www.pepathway.org/peo/1.1#Synonym,http://www.pepathway.org/peo/1.2#Definitions,http://www.w3.org/2000/01/rdf-schema#comment,http://www.w3.org/2000/01/rdf-schema#label,http://www.w3.org/2002/07/owl#versionInfo
http://www.pepathway.org/peo/1.2#Endothelial_lining,Endothelial lining,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Endothelial_lining,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Endothelial lining,
http://www.pepathway.org/peo/1.1#ENV,ENV,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:ENV,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/155971,,,,,,,,,,,,,,,,,,,,ENV,
http://www.pepathway.org/peo/1.2#outcome_assessor,outcome assessor,,shouldn't this be a role?,false,,,http://www.ifomis.org/bfo/1.1/snap#Object,,peo2:outcome_assessor,,,,,,,,,,,,,,,,,,,,,,,outcome assessors,,,,,shouldn't this be a role?,outcome assessor,
http://www.pepathway.org/peo/1.2#Disorder_of_cardiovascular_system,Disorder of cardiovascular system,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Disorder_of_cardiovascular_system,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/49601007,,,,Cardiovascular system disease|Disorder of the circulatory system|Disorder of circulatory system|Disorder of cardiovascular system (disorder)|Cardiovascular disease|CVD - cardiovascular disease|Cardiovascular disorder|CVS disease - cardiovascular system disease,,,,,,Disorder of cardiovascular system,
http://www.pepathway.org/peo/1.2#Dengue,Dengue,,,false,,,http://www.pepathway.org/peo/1.2#Infection,,peo2:Dengue,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/38362002,,,,Breakbone fever|Dengue fever|Dengue (disorder),,,,,,Dengue,
http://www.pepathway.org/peo/1.2#Malaria,Malaria,,,false,,,http://www.pepathway.org/peo/1.2#Infection,,peo2:Malaria,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/61462000,,,,,,,,,,Malaria (disorder)|Plasmodiosis|Malaria|Paludism,
http://www.pepathway.org/peo/1.2#Vasodepressor_activity,Vasodepressor activity,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Vasodepressor_activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Vasodepressor activity,
http://www.pepathway.org/peo/1.1#ANKS1B,ANKS1B,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:ANKS1B,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/56899,,,,,,,,,,,,,,,,,,,,ANKS1B,
http://www.pepathway.org/peo/1.2#Platelet_count,Platelet count,,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:Platelet_count,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/61928009,,,,Platelet count - observation|Platelet count (procedure)|Plt - Platelet count,,,,,,Platelet count,
http://www.pepathway.org/peo/1.2#Myometrial_structure,Myometrial structure,,,false,,,http://www.pepathway.org/peo/1.2#Entire_uterus,,peo2:Myometrial_structure,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/27232003,,,,Myometrial structure (body structure)|Myometrium,,,,,,Myometrial structure,
http://www.pepathway.org/peo/1.2#Sumoylation,Sumoylation,,AD598,false,,,http://www.pepathway.org/peo/1.2#Epigenetics,,peo2:Sumoylation,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/GO#GO_0016925,,,,small ubiquitin-related protein 1 conjugation|SUMO-protein conjugation|protein sumolation|sumoylation,,,,,AD598,Sumoylation,
http://www.pepathway.org/peo/1.2#Magnesium_sulfate,Magnesium sulfate,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:Magnesium_sulfate,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/37400007,,,,Magnesium sulfate (product)|Magnesium sulphate|Epsom salt,,,,,,Magnesium sulfate,
http://www.pepathway.org/peo/1.2#Neonatal_disorder,Neonatal disorder,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:Neonatal_disorder,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/22925008,,,,Neonatal disorder (disorder)|Neonatal disease,,,,,,Neonatal disorder,
http://www.pepathway.org/peo/1.2#immunotherapy,immunotherapy,,from manual annotation of text corpus,false,,,http://www.ifomis.org/bfo/1.1/span#Process,,peo2:immunotherapy,,,,,,,,,http://en.wikipedia.org/wiki/Immunotherapy,,,,,,,,,,,,,,immunotherapies|AD-directed immunotherapy,,,,,from manual annotation of text corpus,immunotherapy,
http://www.pepathway.org/peo/1.2#lateral_E_wave_velocity,lateral E' wave velocity,,,false,,,http://www.pepathway.org/peo/1.2#Echocardiography,,peo2:lateral_E_wave_velocity,,,,,,,,,,,,,,,,,,,,,,,lateral E' wave velocity,,,,,,lateral E' wave velocity,
http://www.pepathway.org/peo/1.2#E_E_ratio,E/E' ratio,,,false,,,http://www.pepathway.org/peo/1.2#Echocardiography,,peo2:E_E_ratio,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E/E' ratio,
http://www.pepathway.org/peo/1.2#syncytiotrophoblast_cell,syncytiotrophoblast cell,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:syncytiotrophoblast_cell,,,,,,,,,,,,,,,,,,,,,,,syncytial trophoblast|syntrophoblast|plasmidotrophoblast,,,,,,syncytiotrophoblast cell,
http://www.ifomis.org/bfo/1.1/snap#ObjectBoundary,object_boundary,,"Examples: the surface of the skin, the surface of the earth, the surface of the interior of the stomach, the outer surface of a cell or cell wall|Definition: An independent continuant [snap:IndependentContinuant] that is a lower dimensional part of a spatial entity, normally a closed two-dimensional surface. Boundaries are those privileged parts of object [snap:Object] entities that exist at exactly the point where the object [snap:Object] is separated off from the rest of the existing entities in the world.|Comment: Boundaries are theoretically difficult entities to account for, however the intuitive notion of a physical boundary as a surface of some sort (whether inside or outside of a thing) will generally serve as a good guide for the use of this universal.|Synonyms: substance boundary",false,,,http://www.ifomis.org/bfo/1.1/snap#IndependentContinuant,,snap:ObjectBoundary,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Examples: the surface of the skin, the surface of the earth, the surface of the interior of the stomach, the outer surface of a cell or cell wall|Definition: An independent continuant [snap:IndependentContinuant] that is a lower dimensional part of a spatial entity, normally a closed two-dimensional surface. Boundaries are those privileged parts of object [snap:Object] entities that exist at exactly the point where the object [snap:Object] is separated off from the rest of the existing entities in the world.|Comment: Boundaries are theoretically difficult entities to account for, however the intuitive notion of a physical boundary as a surface of some sort (whether inside or outside of a thing) will generally serve as a good guide for the use of this universal.|Synonyms: substance boundary",object_boundary,
http://www.pepathway.org/peo/1.1#ADIPOQ,ADIPOQ,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:ADIPOQ,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/9370,,,,,,,,,,,,,,,,,,,,ADIPOQ,
http://www.pepathway.org/peo/1.2#Cholestrol_reducing_drugs,Cholesterol reducing drug,,AD021,false,,,http://scai.fraunhofer.de/NDDUO#drug_role,,peo2:Cholestrol_reducing_drugs,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_35821,,,http://www.omnimedicalsearch.com/conditions-diseases/alzheimers-disease-treatment-prevention.html,anticholesteremic drug|anticholesteremic drugs|Cholesterol reducing drugs,,,,,AD021,Cholesterol reducing drug,
http://www.pepathway.org/peo/1.2#thing_related_to_biological_functions,thing related to biological functions,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_functional_phenotypes,,peo2:thing_related_to_biological_functions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to biological functions,
http://www.pepathway.org/peo/1.1#CST3,CST3,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:CST3,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/1471,,,,,,,,,,,,,,,,,,,,CST3,
http://www.pepathway.org/peo/1.2#Subdural,Subdural,,,false,,,http://www.pepathway.org/peo/1.2#Dura_Mater,,peo2:Subdural,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://www.pepathway.org/peo/1.2#Pre-eclampsia,Pre-eclampsia,,,false,,,http://www.pepathway.org/peo/1.2#Hypertension_associated_disorders_of_pregnancy,,peo2:Pre-eclampsia,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/398254007,,,,"PE - Pre-eclampsia|Preeclampsia|PET - Pre-eclamptic toxaemia|Pre-eclampsia (disorder)|Proteinuric hypertension of pregnancy|EPH - Oedema, proteinuria and hypertension of pregnancy|EPH - Edema, proteinuria and hypertension of pregnancy|Pre-eclamptic toxaemia|Pre-eclamptic toxemia|PET - Pre-eclamptic toxemia",,,,,,Pre-eclampsia,
http://www.pepathway.org/peo/1.2#Cardiac_ventricular_structure,Cardiac ventricular structure,,,false,,,http://www.pepathway.org/peo/1.2#Entire_heart,,peo2:Cardiac_ventricular_structure,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/21814001,,,,Cardiac ventricular structure (body structure)|Cardiac ventricle|Ventricle,,,,,,Cardiac ventricular structure,
http://www.pepathway.org/peo/1.2#insulin_signalling,insulin signalling,,from manual annotation of text corpus,false,,,http://scai.fraunhofer.de/NDDUO#Cell_cell_interaction,,peo2:insulin_signalling,,,,,,,,,,,,,,,,,,,,,,,insulin resistance,,,,,from manual annotation of text corpus,insulin signalling,
http://www.pepathway.org/peo/1.2#Adrenal_disease,Adrenal disease,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Adrenal_disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Adrenal disease,
http://www.pepathway.org/peo/1.2#C10AA_HMG_CoA_reductase_inhibitor,C10AA:HMG CoA reductase inhibitor,,,false,,,http://www.pepathway.org/peo/1.2#Cholestrol_reducing_drugs,,peo2:C10AA_HMG_CoA_reductase_inhibitor,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_35664,,,,C10AA:HMG CoA reductase inhibitors,,,,,,C10AA:HMG CoA reductase inhibitor,
http://www.pepathway.org/peo/1.1#SYT6,SYT6,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:SYT6,,,,,,,,,,,,,,,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/148281,,,,,,SYT6,
http://scai.fraunhofer.de/NDDUO#pathology_context,pathology context,,,false,,,http://www.pepathway.org/peo/1.2#clinical_phenotypic_context,,NDDUO:pathology_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pathology context,
http://scai.fraunhofer.de/NDDUO#Measure_of_central_location,Measure of central location,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,NDDUO:Measure_of_central_location,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/PATO#PATO_0002268,,,,Measures of central location,,,,,,Measure of central location,
http://www.pepathway.org/peo/1.2#plumbum,plumbum,,from manual annotation of text corpus,false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,peo2:plumbum,,,,,,,,,,,,,,,,,,,,,,,Pb,,,,,from manual annotation of text corpus,plumbum,
http://www.pepathway.org/peo/1.2#wnt_signalling,wnt signalling,,from manual annotation of text corpus,false,,,http://scai.fraunhofer.de/NDDUO#Cell_cell_interaction,,peo2:wnt_signalling,,,,,,,,,,,,,,,,,,,,,,,wingless signalling|wnt-signalling,,,,,from manual annotation of text corpus,wnt signalling,
http://www.pepathway.org/peo/1.2#High_physical_activity,High physical activity,,,false,,,http://www.pepathway.org/peo/1.2#Physically_active,,peo2:High_physical_activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,High physical activity,
http://www.pepathway.org/peo/1.2#Academic_progress,Academic progress,,,false,,,http://www.pepathway.org/peo/1.2#Education_and_schooling_detail,,peo2:Academic_progress,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/370973005,,,,Academic progress (observable entity),,,,,,Academic progress,
http://www.pepathway.org/peo/1.1#EDN1,EDN1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:EDN1,,,,,,,,,,,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/1906,,,,,,,,,,EDN1,
http://www.pepathway.org/peo/1.2#Amnion_nodosum,Amnion nodosum,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Amnion_nodosum,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/71473008,,,,Amnion nodosum (disorder),,,,,,Amnion nodosum,
http://www.pepathway.org/peo/1.1#LTBR,LTBR,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:LTBR,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/4055,,,,,,,,,,,,,,,,,,,,LTBR,
http://www.pepathway.org/peo/1.2#Economic_status,Economic status,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Economic_status,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/73831000,,,,Economic status (social concept),,,,,,Economic status,
http://www.pepathway.org/peo/1.2#Malignant_tumor_of_lung,Malignant tumor of lung,,,false,,,http://www.pepathway.org/peo/1.2#Neoplasm_by_body_site,,peo2:Malignant_tumor_of_lung,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/363358000,,,,CA - Lung cancer|Malignant tumor of lung (disorder)|Malignant tumour of lung,,,,,,Malignant tumor of lung,
http://www.pepathway.org/peo/1.2#Single_pregnancy,Single pregnancy,,,false,,,http://www.pepathway.org/peo/1.2#Current_pregnancy,,peo2:Single_pregnancy,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/237244005,,,,Single pregnancy (finding),,,,,,Single pregnancy,
http://www.pepathway.org/peo/1.2#Cardiac_preload,Cardiac preload,,,false,,,http://www.pepathway.org/peo/1.2#Echocardiography,,peo2:Cardiac_preload,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Cardiac preload,
http://scai.fraunhofer.de/NDDUO#Exposure,Exposure,,,false,,,http://scai.fraunhofer.de/NDDUO#Cohort_study,,NDDUO:Exposure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Exposure,
http://www.pepathway.org/peo/1.2#metal_chelation,metal chelation,,from manual annotation of text corpus,false,,,http://www.pepathway.org/peo/1.2#processes_all_cells,,peo2:metal_chelation,,,,,,,,,,,,,,,,,,,,,,,chelate metals,,,,,from manual annotation of text corpus,metal chelation,
http://scai.fraunhofer.de/NDDUO#statistical_context,statistical context,,,false,,,http://scai.fraunhofer.de/NDDUO#descriptive_epidemiology_context,,NDDUO:statistical_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,statistical context,
http://www.pepathway.org/peo/1.2#Postpartum_state,Postpartum state,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Postpartum_state,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/86569001,,,,Postpartum state (finding)|Postpartum period|Puerperium,,,,,,Postpartum state,
http://scai.fraunhofer.de/NDDUO#measure_of_disease_occurrence_context,measure of disease occurrence context,,,false,,,http://scai.fraunhofer.de/NDDUO#statistical_context,,NDDUO:measure_of_disease_occurrence_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,measure of disease occurrence context,
http://www.pepathway.org/peo/1.1#HSPA5,HSPA5,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:HSPA5,,,,,,,,,,,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/1910,,,,,,,,,,HSPA5,
http://www.ifomis.org/bfo/1.1/span#ConnectedTemporalRegion,connected_temporal_region,,"Examples: the 1970s years, the time from the beginning to the end of a heart attack, the time taken up by cellular meiosis|Definition: A temporal region [span:TemporalRegion] every point of which is mediately or immediately connected with every other point of which.",false,,,http://www.ifomis.org/bfo/1.1/span#TemporalRegion,,span:ConnectedTemporalRegion,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Examples: the 1970s years, the time from the beginning to the end of a heart attack, the time taken up by cellular meiosis|Definition: A temporal region [span:TemporalRegion] every point of which is mediately or immediately connected with every other point of which.",connected_temporal_region,
http://www.pepathway.org/peo/1.2#Nulliparous,Nulliparous,,,false,,,http://www.pepathway.org/peo/1.2#Parity,,peo2:Nulliparous,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/102877006,,,,Nulliparous (finding),,,,,,Nulliparous,
http://scai.fraunhofer.de/NDDUO#Study_phase,Study phase,,,false,,,http://www.ifomis.org/bfo/1.1/span#TemporalInterval,,NDDUO:Study_phase,,,,,,,,,,,,,,,,,,,,,,,Study phases,,,,,,Study phase,
http://www.pepathway.org/peo/1.1#RNASE11,RNASE11,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:RNASE11,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/122651,,,,,,,,,,,,,,,,,,,,RNASE11,
http://www.pepathway.org/peo/1.2#Congestive_heart_failure,Congestive heart failure,,,false,,,http://www.pepathway.org/peo/1.2#Heart_disease,,peo2:Congestive_heart_failure,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/42343007,,,,Congestive heart failure (disorder)|CCF - Congestive cardiac failure|CHF - Congestive heart failure|Congestive heart disease|Congestive cardiac failure,,,,,,Congestive heart failure,
http://www.pepathway.org/peo/1.1#IL4,IL4,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:IL4,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/3565,,,,,,,,,,,,,,,,,,,,IL4,
http://scai.fraunhofer.de/NDDUO#Person,Person,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Object,,NDDUO:Person,,,,,,,,,,,,,,,,,,,,,,,Alzheimer's patient|Alzheimer's patients|Alzheimer patients|Alzheimer patient|Persons,,,,,,Person,
http://www.pepathway.org/peo/1.2#Spontaneous_labor,Spontaneous labor,,,false,,,http://www.pepathway.org/peo/1.2#Therapeutics,,peo2:Spontaneous_labor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Spontaneous labor,
http://www.pepathway.org/peo/1.2#anti-HVEM,anti-HVEM,,,false,,,http://www.pepathway.org/peo/1.2#Antibody,,peo2:anti-HVEM,,,,,,,,,,,,,,,,,,,,,,,HVEM antibody,,,,,,anti-HVEM,
http://www.pepathway.org/peo/1.2#Live_Birth,Live Birth,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:Live_Birth,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D050498,,,,Live Births,,,,"The event that a FETUS is born alive with heartbeats or RESPIRATION regardless of GESTATIONAL AGE. Such liveborn is called a newborn infant (INFANT, NEWBORN).",,Live Birth,
http://www.pepathway.org/peo/1.2#Decidual_cell,Decidual cell,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:Decidual_cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Decidual cell,
http://www.pepathway.org/peo/1.1#VEGFR,VEGFR,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:VEGFR,,,,,,,,,http://purl.bioontology.org/ontology/OMIM/191306,,,,,,,,,,,,,,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR|TYROSINE KINASE GROWTH FACTOR RECEPTOR|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|KINASE INSERT DOMAIN RECEPTOR|FLK1|KDR|VEGFR2,,,,,,VEGFR,
http://www.pepathway.org/peo/1.2#Multiple_pregnancy,Multiple pregnancy,,,false,,,http://www.pepathway.org/peo/1.2#Current_pregnancy,,peo2:Multiple_pregnancy,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/16356006,,,,Multiple pregnancy (disorder),,,,,,Multiple pregnancy,
http://www.pepathway.org/peo/1.2#Vascular_disorders,Vascular disorders,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_cardiovascular_system,,peo2:Vascular_disorders,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10047065,,,,,,,,,,Vascular disorders,
http://scai.fraunhofer.de/NDDUO#Diagnosis,thing related to diagnosis,,AD105,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_observations,,NDDUO:Diagnosis,,,,,,,,,,,,,,,,,,,,,,,Diagnosis,,,,,AD105,thing related to diagnosis,
http://www.ifomis.org/bfo/1.1/snap#SpatialRegion,spatial_region,,"Comment: Space and spatial region [snap:SpatialRegion] entities are entities in their own rights which exist independently of any entities which can be located at them. This view of space is sometimes called ""absolutist"" or ""the container view"". In BFO, the class site [snap:Site] allows for a so-called relational view of space, that is to say, a view according to which spatiality is a matter of relative location between entities and not a matter of being tied to space. The bridge between these two views is secured through the fact that while instances of site [snap:Site] are not spatial region [snap:SpatialRegion] entities, they are nevertheless spatial entities.|Definition: A continuant [snap:Continuant] that is neither bearer of quality [snap:Quality] entities nor inheres in any other entities.|Examples: the sum total of all space in the universe, parts of the sum total of all space in the universe|Comment: An instance of spatial region [snap:SpatialRegion] is a part of space. All parts of space are spatial region [snap:SpatialRegion] entities and only spatial region [snap:SpatialRegion] entities are parts of space. Space is the entire extent of the spatial universe, a designated individual, which is thus itself a spatial region [snap:SpatialRegion].|Comment: All instances of continuant [snap:Continuant] are spatial entities, that is, they enter in the relation of (spatial) location with spatial region [snap:SpatialRegion] entities. As a particular case, the exact spatial location of a spatial region [snap:SpatialRegion] is this region itself.",false,,,http://www.ifomis.org/bfo/1.1/snap#Continuant,,snap:SpatialRegion,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Comment: Space and spatial region [snap:SpatialRegion] entities are entities in their own rights which exist independently of any entities which can be located at them. This view of space is sometimes called ""absolutist"" or ""the container view"". In BFO, the class site [snap:Site] allows for a so-called relational view of space, that is to say, a view according to which spatiality is a matter of relative location between entities and not a matter of being tied to space. The bridge between these two views is secured through the fact that while instances of site [snap:Site] are not spatial region [snap:SpatialRegion] entities, they are nevertheless spatial entities.|Definition: A continuant [snap:Continuant] that is neither bearer of quality [snap:Quality] entities nor inheres in any other entities.|Examples: the sum total of all space in the universe, parts of the sum total of all space in the universe|Comment: An instance of spatial region [snap:SpatialRegion] is a part of space. All parts of space are spatial region [snap:SpatialRegion] entities and only spatial region [snap:SpatialRegion] entities are parts of space. Space is the entire extent of the spatial universe, a designated individual, which is thus itself a spatial region [snap:SpatialRegion].|Comment: All instances of continuant [snap:Continuant] are spatial entities, that is, they enter in the relation of (spatial) location with spatial region [snap:SpatialRegion] entities. As a particular case, the exact spatial location of a spatial region [snap:SpatialRegion] is this region itself.",spatial_region,
http://www.pepathway.org/peo/1.2#Cardiotocography,Cardiotocography,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_observable,,peo2:Cardiotocography,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D015148,,,,"Monitoring, External Fetal|CTG, Antepartum|Cardiotocograms|Fetal Monitoring, Internal|External Cardiotocography|External Fetal Monitoring|Fetal Monitoring, Electronic|Cardiotocography, External|Antepartum CTG|Internal Fetal Monitoring|Monitoring, Internal Fetal|Electronic Fetal Monitoring|Cardiotocography, Internal|Internal Cardiotocography|Monitoring, Electronic Fetal|Fetal Monitoring, External",,,,Monitoring of FETAL HEART frequency before birth in order to assess impending prematurity in relation to the pattern or intensity of antepartum UTERINE CONTRACTION.,,Cardiotocography,
http://scai.fraunhofer.de/NDDUO#Study_design,Study design,,,false,,,http://www.ifomis.org/bfo/1.1/snap#GenericallyDependentContinuant,,NDDUO:Study_design,,,,,,,,,,,,,,,,,,,http://www.ebi.ac.uk/efo/EFO_0001426,,,,Study designs,,,,,,Study design,
http://www.pepathway.org/peo/1.2#Unsafe_living_conditions,Unsafe living conditions,,,false,,,http://www.pepathway.org/peo/1.2#Social_context,,peo2:Unsafe_living_conditions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Unsafe living conditions,
http://scai.fraunhofer.de/NDDUO#Age_standardized_mortality_rate,Age standardized mortality rate,,,false,,,http://scai.fraunhofer.de/NDDUO#Standardized_mortality_rate,,NDDUO:Age_standardized_mortality_rate,,,,,,,,,,,,,,,,,,,,,,,Age standardized mortality rates,,,,,,Age standardized mortality rate,
http://www.pepathway.org/peo/1.2#very-low-density_lipoprotein_cholesterol,very-low-density lipoprotein cholesterol,,,false,,,http://www.pepathway.org/peo/1.2#cholesterol,,peo2:very-low-density_lipoprotein_cholesterol,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_47773,,,,VLDL cholesterol|pre-beta-lipoprotein cholesterol|VLDL-C,,,,Cholesterol esters and free cholesterol which are contained in or bound to very low density lipoproteins (VLDL).,,very-low-density lipoprotein cholesterol,
http://www.pepathway.org/peo/1.2#Hemostatic_function,Hemostatic function,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Hemostatic_function,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/74848003,,,,Blood clotting|Hemostatic function (observable entity)|Haemostasis|Haemostatic function|Blood coagulation|Hemostasis,,,,,,Hemostatic function,
http://www.pepathway.org/peo/1.1#REN,REN,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:REN,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/5972,,,,,,,,,,,,,,,,,,,,REN,
http://www.pepathway.org/peo/1.2#Puerperal_endometritis,Puerperal endometritis,,,false,,,http://www.pepathway.org/peo/1.2#Inflammatory_disorder,,peo2:Puerperal_endometritis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/22399000,,,,Puerperal endometritis (disorder),,,,,,Puerperal endometritis,
http://www.ifomis.org/bfo/1.1/span#TemporalInterval,temporal_interval,,Examples: any continuous temporal duration during which a process occurs|Definition: A connected temporal region [span:ConnectedTemporalRegion] lasting for more than a single moment of time.,false,,,http://www.ifomis.org/bfo/1.1/span#ConnectedTemporalRegion,,span:TemporalInterval,,,,,,,,,,,,,,,,,,,,,,,,,,,,Examples: any continuous temporal duration during which a process occurs|Definition: A connected temporal region [span:ConnectedTemporalRegion] lasting for more than a single moment of time.,temporal_interval,
http://www.pepathway.org/peo/1.2#Atherosclerosis,Atherosclerosis,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_cardiovascular_system,,peo2:Atherosclerosis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/38716007,,,,Atheromatosis|Atherosclerosis (morphologic abnormality),,,,,,Atherosclerosis,
http://www.pepathway.org/peo/1.1#ACE,ACE,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:ACE,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/1636,,,,,,,,,,,,,,,,,,,,ACE,
http://www.pepathway.org/peo/1.1#ACE2,ACE2,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:ACE2,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/59272,,,,,,,,,,,,,,,,,,,,ACE2,
http://scai.fraunhofer.de/NDDUO#Period_Prevalence,Period Prevalence,,,false,,,http://scai.fraunhofer.de/NDDUO#prevalence,,NDDUO:Period_Prevalence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Period Prevalence,
http://scai.fraunhofer.de/NDDUO#Measure_of_dispersion,Measure of dispersion,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,NDDUO:Measure_of_dispersion,,,,,,,,,,,,,,,,,,,,,,,Measures of dispersion,,,,,,Measure of dispersion,
http://www.pepathway.org/peo/1.2#Odds_ratio,Odds ratio,,AD316,false,,,http://www.pepathway.org/peo/1.2#Analysis_of_cohort_studies,,peo2:Odds_ratio,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD316,Odds ratio,
http://www.pepathway.org/peo/1.1#IL2,IL2,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:IL2,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/3558,,,,,,,,,,,,,,,,,,,,IL2,
http://www.pepathway.org/peo/1.2#Current_pregnancy,Current pregnancy,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy,,peo2:Current_pregnancy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Current pregnancy,
http://scai.fraunhofer.de/NDDUO#Cell_cell_interaction,Cell cell interaction,,,false,,,http://www.pepathway.org/peo/1.2#processes_all_cells,,NDDUO:Cell_cell_interaction,,,,,,,,,,,,,,,,,,,,,,,Cell cell interactions,,,,,,Cell cell interaction,
http://www.pepathway.org/peo/1.1#DHX34,DHX34,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:DHX34,,,,,,,,,,,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/9704,,,,,,,,,,DHX34,
http://scai.fraunhofer.de/NDDUO#Analytical_study,Analytical study,,,false,,,http://scai.fraunhofer.de/NDDUO#Epidemiological_study_type,,NDDUO:Analytical_study,,,,,,,,,,,,,,,,,,,,,,,Analytical studies,,,,,,Analytical study,
http://www.pepathway.org/peo/1.2#prepregnancy_body_weight,Prepregnancy body weight,,,false,,,http://www.pepathway.org/peo/1.2#Body_weight_measure,,peo2:prepregnancy_body_weight,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Prepregnancy body weight,
http://www.pepathway.org/peo/1.2#Segmentation,Segmentation,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Segmentation,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/257928003,,,,Segmentation (qualifier value),,,,,,Segmentation,
http://www.pepathway.org/peo/1.2#glucose,glucose,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:glucose,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_17234,,,,gluco-hexose|C6H12O6|Glc|Glucose|Glukose|glucose,,,,An aldohexose used as a source of energy and metabolic intermediate.,,glucose,
http://scai.fraunhofer.de/NDDUO#outcome_context,outcome context,,,false,,,http://scai.fraunhofer.de/NDDUO#clinical_trial_context,,NDDUO:outcome_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,outcome context,
http://scai.fraunhofer.de/NDDUO#Annual_prevalence,Annual prevalence,,,false,,,http://scai.fraunhofer.de/NDDUO#prevalence,,NDDUO:Annual_prevalence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Annual prevalence,
http://www.pepathway.org/peo/1.2#Poor_uteroplacental_perfusion,Poor uteroplacental perfusion,,,false,,,http://www.pepathway.org/peo/1.2#Placental_finding,,peo2:Poor_uteroplacental_perfusion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Poor uteroplacental perfusion,
http://www.pepathway.org/peo/1.2#Renin_inhibitor,Renin inhibitor,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:Renin_inhibitor,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/426228001,,,,Renin inhibitor (substance),,,,,,Renin inhibitor,
http://www.pepathway.org/peo/1.2#AT1R_antagonists,AT1R antagonists,,,false,,,http://scai.fraunhofer.de/NDDUO#drug_role,,peo2:AT1R_antagonists,,,,,,,,,,,,,,,,,,,,,,,,,,,,,AT1R antagonists,
http://www.pepathway.org/peo/1.1#IGF1R,IGF1R,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:IGF1R,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/3480,,,,,,,,,,,,,,,,,,,,IGF1R,
http://www.pepathway.org/peo/1.2#Epidural_hemorrhage,Epidural hemorrhage,,,false,,,http://www.pepathway.org/peo/1.2#Finding_of_brain,,peo2:Epidural_hemorrhage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Epidural hemorrhage,
http://www.pepathway.org/peo/1.2#Vascular_wall_hypertrophy,Vascular wall hypertrophy,,,false,,,http://www.pepathway.org/peo/1.2#Vascular_disorders,,peo2:Vascular_wall_hypertrophy,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10072810,,,,,,,,,,Vascular wall hypertrophy,
http://www.pepathway.org/peo/1.2#Late-preterm,Late-preterm,,,false,,,http://www.pepathway.org/peo/1.2#Premature_Birth,,peo2:Late-preterm,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Late-preterm,
http://www.pepathway.org/peo/1.2#Clinical_situation,Clinical situation,,,false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,peo2:Clinical_situation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical situation,
http://www.pepathway.org/peo/1.1#Endogenous_ligands,Endogenous ligands,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:Endogenous_ligands,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Endogenous ligands,
http://scai.fraunhofer.de/NDDUO#drug_side_effect,drug side effect,,,false,,,http://scai.fraunhofer.de/NDDUO#Pharmacotherapy,,NDDUO:drug_side_effect,,,,,,,,,http://www.thefreedictionary.com/side+effect,,,,,,,,,,,,,,drug side effects,,,,,,drug side effect,
http://www.pepathway.org/peo/1.2#Cardioprotection,Cardioprotection,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Cardioprotection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Cardioprotection,
http://www.pepathway.org/peo/1.2#Hyperglycemia,Hyperglycemia,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Hyperglycemia,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/80394007,,,,Hyperglycaemia|Hyperglycemia (disorder),,,,,,Hyperglycemia,
http://www.ifomis.org/bfo/1.1/span#ProcessualContext,processual_context,,"Definition: An occurrent [span:Occurrent] consisting of a characteristic spatial shape inhering in some arrangement of other occurrent [span:Occurrent] entities. Processual context [span:ProcessualContext] entities are characteristically entities at or in which other occurrent [span:Occurrent] entities can be located or occur.|Comment: An instance of a processual context [span:ProcessualContext] is a mixture of processual entity [span:ProcessualEntity] which stand as surrounding environments for other processual entity [span:ProcessualEntity] entities. The class processual context [span:ProcessualContext] is the analogous among occurrent [span:Occurrent] entities to the class site [snap:Site] among continuant [snap:Continuant] entities.|Examples: The processual context for a given manipulation occurring as part of an experiment is made of processual entities which occur in parallel, are not necessarily all parts of the experiment themselves and may involve continuant [snap:Continuant] entities which are in the spatial vicinity of the participants in the experiment.",false,,,http://www.ifomis.org/bfo/1.1/span#ProcessualEntity,,span:ProcessualContext,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Definition: An occurrent [span:Occurrent] consisting of a characteristic spatial shape inhering in some arrangement of other occurrent [span:Occurrent] entities. Processual context [span:ProcessualContext] entities are characteristically entities at or in which other occurrent [span:Occurrent] entities can be located or occur.|Comment: An instance of a processual context [span:ProcessualContext] is a mixture of processual entity [span:ProcessualEntity] which stand as surrounding environments for other processual entity [span:ProcessualEntity] entities. The class processual context [span:ProcessualContext] is the analogous among occurrent [span:Occurrent] entities to the class site [snap:Site] among continuant [snap:Continuant] entities.|Examples: The processual context for a given manipulation occurring as part of an experiment is made of processual entities which occur in parallel, are not necessarily all parts of the experiment themselves and may involve continuant [snap:Continuant] entities which are in the spatial vicinity of the participants in the experiment.",processual_context,
http://www.pepathway.org/peo/1.2#Postmenopausal_state,Postmenopausal state,,,false,,,http://www.ifomis.org/bfo/1.1/span#TemporalInterval,,peo2:Postmenopausal_state,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Postmenopausal state,
http://www.ifomis.org/bfo/1.1/span#FiatProcessPart,fiat_process_part,,"Examples: chewing during a meal, the middle part of a rainstorm, the worst part of a heart-attack, the most interesting part of Van Gogh's life|Definition: A processual entity [span:ProcessualEntity] that is part of a process but that does not have bona fide beginnings and endings corresponding to real discontinuities.",false,,,http://www.ifomis.org/bfo/1.1/span#ProcessualEntity,,span:FiatProcessPart,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Examples: chewing during a meal, the middle part of a rainstorm, the worst part of a heart-attack, the most interesting part of Van Gogh's life|Definition: A processual entity [span:ProcessualEntity] that is part of a process but that does not have bona fide beginnings and endings corresponding to real discontinuities.",fiat_process_part,
http://www.pepathway.org/peo/1.1#PRIMA1,PRIMA1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:PRIMA1,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/145270,,,,,,,,,,,,,,,,,,,,PRIMA1,
http://www.pepathway.org/peo/1.1#ADTRP,ADTRP,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:ADTRP,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/84830,,,,,,,,,,,,,,,,,,,,ADTRP,
http://www.pepathway.org/peo/1.2#Pregnancy_observable,Pregnancy observable,,,false,,,http://www.pepathway.org/peo/1.2#Physiological_test,,peo2:Pregnancy_observable,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/364320009,,,,Pregnancy observable (observable entity),,,,,,Pregnancy observable,
http://www.pepathway.org/peo/1.2#clinical_phenotypic_context,clinical phenotypic context,,,false,,,http://scai.fraunhofer.de/NDDUO#clinical_context,,peo2:clinical_phenotypic_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,clinical phenotypic context,
http://www.pepathway.org/peo/1.2#Polycystic_ovaries,Polycystic ovaries,,,false,,,http://www.pepathway.org/peo/1.2#Ovarian_Diseases,,peo2:Polycystic_ovaries,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/69878008,,,,PCOS - Polycystic ovarian syndrome|Polycystic ovarian syndrome|Polycystic ovary syndrome|PCO - Polycystic ovaries|PCOD - Polycystic ovarian disease|Polycystic ovaries (disorder)|Polycystic ovarian disease|Sclerocystic ovary syndrome|Cystic disease of ovaries|Multicystic ovaries|Stein-Leventhal syndrome,,,,,,Polycystic ovaries,
http://www.pepathway.org/peo/1.2#Before_full_dilatation_of_cervix,Before full dilatation of cervix,,,false,,,http://www.pepathway.org/peo/1.2#Intrapartum,,peo2:Before_full_dilatation_of_cervix,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/255616008,,,,Before full dilatation of cervix (qualifier value),,,,,,Before full dilatation of cervix,
http://www.pepathway.org/peo/1.2#Vascular_constriction,Vascular constriction,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Vascular_constriction,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/32318003,,,,"Vascular constriction, function (observable entity)|Vasoconstriction|Vascular constriction, function",,,,,,Vascular constriction,
http://www.pepathway.org/peo/1.2#Hypercoiled_umbilical_cord,Hypercoiled umbilical cord,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_fetus_or_newborn,,peo2:Hypercoiled_umbilical_cord,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Hypercoiled umbilical cord,
http://www.pepathway.org/peo/1.2#hCG-PlGF_ratio,hCG-PlGF ratio,,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:hCG-PlGF_ratio,,,,,,,,,,,,,,,,,,,,,,,,,,,,,hCG-PlGF ratio,
http://www.pepathway.org/peo/1.2#Middle_class_economic_status,Middle class economic status,,,false,,,http://www.pepathway.org/peo/1.2#Economic_status,,peo2:Middle_class_economic_status,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/22575004,,,,Middle class economic status (social concept),,,,,,Middle class economic status,
http://www.pepathway.org/peo/1.2#Hematopoietic_stem_cell,Hematopoietic stem cell,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:Hematopoietic_stem_cell,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/418318001,,,,Hematopoietic stem cell (cell)|Haematopoietic stem cell,,,,,,Hematopoietic stem cell,
http://www.pepathway.org/peo/1.1#Oxidase,Oxidase,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:Oxidase,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/129921004,,,,Oxidase (substance),,,,,,Oxidase,
http://www.pepathway.org/peo/1.2#regulation_of_immune_system_process,regulation of immune system process,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:regulation_of_immune_system_process,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/GO_0002682,,,,,,,,"Any process that modulates the frequency, rate, or extent of an immune system process.",,regulation of immune system process,
http://www.pepathway.org/peo/1.2#thing_related_to_mild_stage,thing related to mild stage,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_stage,,peo2:thing_related_to_mild_stage,,,,,,,,,mild,,,,,,,,,,,,,,,,,,,,thing related to mild stage,
http://scai.fraunhofer.de/NDDUO#disorder,disorder,,,false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,NDDUO:disorder,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/OGMS_0000045,,,,neurodegenerative disorder|disorders,,,,,,disorder,
http://www.pepathway.org/peo/1.2#Gave_up_before_pregnancy,Gave up before pregnancy,,,false,,,http://www.pepathway.org/peo/1.2#Maternal_tobacco_use,,peo2:Gave_up_before_pregnancy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Gave up before pregnancy,
http://scai.fraunhofer.de/NDDUO#Molecular_processes,Molecular process,,,false,,,http://www.ifomis.org/bfo/1.1/span#Process,,NDDUO:Molecular_processes,,,,,,,,,,,,,,,,,,,,,,,Molecular processes,,,,,,Molecular process,
http://www.pepathway.org/peo/1.2#Never_intake_alcohol,Never intake alcohol,,,false,,,http://www.pepathway.org/peo/1.2#Alcohol_intake,,peo2:Never_intake_alcohol,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Never intake alcohol,
http://www.pepathway.org/peo/1.2#thing_related_to_late_onset,thing related to late onset,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_stage,,peo2:thing_related_to_late_onset,,,,,,,,,,,,,,,,,,,,,,,LO|Late onset|Late-onset,,,,,,thing related to late onset,
http://www.pepathway.org/peo/1.2#Cerebral_blood_flow,Cerebral blood flow,,,false,,,http://www.pepathway.org/peo/1.2#Finding_of_brain,,peo2:Cerebral_blood_flow,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/250847003,,,,CBF - Cerebral blood flow|Cerebral blood flow (observable entity),,,,,,Cerebral blood flow,
http://scai.fraunhofer.de/NDDUO#Cellular_and_sub_cellular_processes,Cellular and sub cellular process,,,false,,,http://www.ifomis.org/bfo/1.1/span#Process,,NDDUO:Cellular_and_sub_cellular_processes,,,,,,,,,,,,,,,,,,,,,,,cellular physiological processes|cell physiology|Cellular and sub cellular processes|cellular physiological process,,,,,,Cellular and sub cellular process,
http://www.pepathway.org/peo/1.1#EGF_family,EGF family,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:EGF_family,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D004815,,,,"Epidermal growth factor|Urogastrone|beta-Urogastrone|Growth Factor-Urogastrone, Epidermal|beta Urogastrone|Human Urinary Gastric Inhibitor|Growth Factor, Epidermal|Epidermal Growth Factor-Urogastrone|EGF",,,,A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form.,,EGF family,
http://www.pepathway.org/peo/1.2#Duration_of_formal_education,Duration of formal education,,,false,,,http://www.pepathway.org/peo/1.2#Education_and_schooling_detail,,peo2:Duration_of_formal_education,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/224288002,,,,Duration of formal education (observable entity),,,,,,Duration of formal education,
http://www.pepathway.org/peo/1.2#Obstructed_labor,Obstructed labor,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Obstructed_labor,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/199746004,,,,Obstructed labor (finding)|Obstructed labour,,,,,,Obstructed labor,
http://www.pepathway.org/peo/1.2#processes_all_cells,processes all cells,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_sub_cellular_processes,,peo2:processes_all_cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,processes all cells,
http://www.pepathway.org/peo/1.2#Microvillus_plasma_membrane,Microvillus plasma membrane,,,false,,,http://www.pepathway.org/peo/1.2#Chorionic_villi_structure,,peo2:Microvillus_plasma_membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Microvillus plasma membrane,
http://www.ifomis.org/bfo/1.1/snap#DependentContinuant,dependent_continuant,,Definition: A continuant [snap:Continuant] that is either dependent on one or other independent continuant [snap:IndependentContinuant] bearers or inheres in or is borne by other entities.,false,,,http://www.ifomis.org/bfo/1.1/snap#Continuant,,snap:DependentContinuant,,,,,,,,,,,,,,,,,,,,,,,,,,,,Definition: A continuant [snap:Continuant] that is either dependent on one or other independent continuant [snap:IndependentContinuant] bearers or inheres in or is borne by other entities.,dependent_continuant,
http://scai.fraunhofer.de/NDDUO#Prevalence_rate,Prevalence rate,,,false,,,http://scai.fraunhofer.de/NDDUO#prevalence,,NDDUO:Prevalence_rate,,,,,,,,,,,,,,,,,,,,,,,Prevalence rates,,,,,,Prevalence rate,
http://www.pepathway.org/peo/1.2#Entire_uterus,Entire uterus,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Entire_uterus,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/181452004,,,,Entire uterus (body structure)|UT - Uterus|Uterus|Womb,,,,,,Entire uterus,
http://www.pepathway.org/peo/1.2#A-type_natriuretic_peptide,A-type natriuretic peptide,,,false,,,http://www.pepathway.org/peo/1.2#Peptide,,peo2:A-type_natriuretic_peptide,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/30326004,,,,Atriopeptin|Atrial natriuretic hormone|ANH - Atrial natriuretic hormone|Atrial natriuretic factor (substance)|ANP - Atrial natriuretic peptide|Atrial natriuretic factor|Atrial natriuretic peptide,,,,,,A-type natriuretic peptide,
http://www.pepathway.org/peo/1.2#wk36,wk36,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_time_period,,peo2:wk36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://www.pepathway.org/peo/1.2#antiinflammatory_drugs,anti-inflammatory drug,,,false,,,http://scai.fraunhofer.de/NDDUO#drug_role,,peo2:antiinflammatory_drugs,,,,,,,,,"Drugs with analgesic and antipyretic (fever-reducing) effects and which have, in higher doses, anti-inflammatory effects.",,,,,,,,,,,,,,anti-inflammatory drugs,,,,,,anti-inflammatory drug,
http://www.pepathway.org/peo/1.2#Serum_lipid_levels_-_finding,Serum lipid levels - finding,,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:Serum_lipid_levels_-_finding,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/365798004,,,,Finding of serum lipid levels (finding)|Finding of serum lipid levels|Serum lipid levels,,,,,,Serum lipid levels - finding,
http://www.pepathway.org/peo/1.2#Availability_of_medical_resources,Availability of medical resources,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Availability_of_medical_resources,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Availability of medical resources,
http://www.pepathway.org/peo/1.1#ENG,ENG,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:ENG,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/2022,,,,,,,,,,,,,,,,,,,,ENG,
http://scai.fraunhofer.de/NDDUO#antidepressant,antidepressant,,,false,,,http://scai.fraunhofer.de/NDDUO#drug_role,,NDDUO:antidepressant,,,,,,,,,http://en.wikipedia.org/wiki/Antidepressant,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_35469,,,,antidepressants,,,,,,antidepressant,
http://www.pepathway.org/peo/1.2#Spiral_artery_remodeling,Spiral artery remodeling,,,false,,,http://www.pepathway.org/peo/1.2#Placentation,,peo2:Spiral_artery_remodeling,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Spiral artery remodeling,
http://www.pepathway.org/peo/1.2#Ischemia_placental,Ischemia placental,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_placenta,,peo2:Ischemia_placental,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10023035,,,,,,,,,,Ischemia placental,
http://www.pepathway.org/peo/1.2#Peripheral_vascular_disease,Peripheral vascular disease,,,false,,,http://www.pepathway.org/peo/1.2#Vascular_disorders,,peo2:Peripheral_vascular_disease,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/400047006,,,,Peripheral vascular disease (disorder)|PVD-peripheral vascular disease,,,,,,Peripheral vascular disease,
http://www.pepathway.org/peo/1.2#Enoxaparin,Enoxaparin,,,false,,,http://www.pepathway.org/peo/1.2#drug,,peo2:Enoxaparin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Enoxaparin,
http://www.pepathway.org/peo/1.2#Normal_functions_of_organs,Normal functions of organs,,,false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,peo2:Normal_functions_of_organs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Normal functions of organs,
http://www.pepathway.org/peo/1.2#Neurodevelopment,Neurodevelopment,,,false,,,http://www.pepathway.org/peo/1.2#Developmental,,peo2:Neurodevelopment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Neurodevelopment,
http://scai.fraunhofer.de/NDDUO#Disease_rate_at_autopsy,Disease rate at autopsy,,,false,,,http://scai.fraunhofer.de/NDDUO#prevalence,,NDDUO:Disease_rate_at_autopsy,,,,,,,,,,,,,,,,,,,,,,,Disease rates at autopsy,,,,,,Disease rate at autopsy,
http://www.pepathway.org/peo/1.2#Entire_blood_vessel,Entire blood vessel,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Entire_blood_vessel,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/361097006,,,,Blood vessel|Entire blood vessel (body structure),,,,,,Entire blood vessel,
http://scai.fraunhofer.de/NDDUO#molecular_and_cellular_mechanism_context,molecular and cellular mechanism context,,,false,,,http://scai.fraunhofer.de/NDDUO#context,,NDDUO:molecular_and_cellular_mechanism_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,molecular and cellular mechanism context,
http://www.pepathway.org/peo/1.2#Age_at_onset,Age at onset,,,false,,,http://scai.fraunhofer.de/NDDUO#Age,,peo2:Age_at_onset,,,,,,,,,,,,,,,,,,,,,,,age-at-onset|age at onset|maternal age,,,,,,Age at onset,
http://www.pepathway.org/peo/1.2#Placental_abruption,Placental abruption,,,false,,,http://www.pepathway.org/peo/1.2#Placental_finding,,peo2:Placental_abruption,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/415105001,,,,Abruptio placentae|Premature detachment of normally implanted placenta|Ablatio placentae|Placental abruption (disorder)|Premature separation of placenta|Premature detachment of placenta,,,,,,Placental abruption,
http://www.pepathway.org/peo/1.2#Tuberculosis,Tuberculosis,,,false,,,http://www.pepathway.org/peo/1.2#Infection,,peo2:Tuberculosis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/56717001,,,,Tuberculosis (disorder)|TB - Tuberculosis,,,,,,Tuberculosis,
http://www.pepathway.org/peo/1.2#Embryonic_Development,Embryonic Development,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Embryonic_Development,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D047108,,,,,,,"Embryo Development, Postimplantation|Postimplantation Embryo Development|Postnidation Embryo Development, Animal|Embryo Development, Preimplantation|Embryo Development, Post-implantation|Prenidation Embryo Development, Animal|Embryonic Programming|Development, Postnidation Embryo|Embryonic Programmings|Post implantation Embryo Development|Postnidation Embryo Development|Development, Embryonic|Embryogenesis|Embryonic Developments|Preimplantation Embryo Development|Pre implantation Embryo Development|Development, Embryo|Embryo Development, Pre-implantation|Pre-implantation Embryo Development|Post-implantation Embryo Development|Embryo Development|Embryo Development, Postnidation","Morphological and physiological development of EMBRYOS. Permanent alteration of tissue structures and functions in the EMBRYO as a result of its environment, either positive or negative. The cellular development between the time of mammalian gamete FERTILIZATION and EMBRYO IMPLANTATION. This represents the development in the FALLOPIAN TUBES.",,Embryonic Development,
http://scai.fraunhofer.de/NDDUO#Molecular_and_cellular_mechanism,Molecular and cellular mechanism thing,,AD460,false,,,http://www.w3.org/2002/07/owl#Thing,,NDDUO:Molecular_and_cellular_mechanism,,,,,,,,,,,,,,,,,,,,,,,Molecular and cellular mechanism|Molecular and cellular mechanisms,,,,,AD460,Molecular and cellular mechanism thing,
http://www.pepathway.org/peo/1.2#Entire_lymph_node,Entire lymph node,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Entire_lymph_node,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/181756000,,,,LN - Lymph node|Entire lymph node (body structure)|Lymph node,,,,,,Entire lymph node,
http://www.pepathway.org/peo/1.2#Loan_foreclosure_status,Loan foreclosure status,,,false,,,http://www.pepathway.org/peo/1.2#Economic_status,,peo2:Loan_foreclosure_status,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/105578003,,,,Foreclosure on loan|Loan foreclosure status (social concept),,,,,,Loan foreclosure status,
http://www.pepathway.org/peo/1.2#Hydatidiform_mole_benign,"Hydatidiform mole, benign",,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Hydatidiform_mole_benign,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/417044008,,,,"Hydatid mole|Molar pregnancy with vesicular mole|Hydatidiform mole, benign (disorder)|Hydatidiform mole|Molar pregnancy with hydatid mole",,,,,,"Hydatidiform mole, benign",
http://www.pepathway.org/peo/1.2#Small_for_gestational_age_fetus,Small for gestational age fetus,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:Small_for_gestational_age_fetus,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/267258002,,,,,,,Infant underweight for gestational age|Light for dates|Fetus small-for-dates|SGA - Small for gestational age fetus|Subnormal birth weight|Small for gestational age fetus (disorder)|Light for gestational dates|SFD - Fetus small-for-dates|Small for gestational age|Light for gestational age,,,Small for gestational age fetus,
http://www.pepathway.org/peo/1.2#Pre-gestational_period,Pre-gestational period,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_time_period,,peo2:Pre-gestational_period,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pre-gestational period,
http://www.pepathway.org/peo/1.2#marriageable_age,marriageable age,,,false,,,http://www.pepathway.org/peo/1.2#Age_at_onset,,peo2:marriageable_age,,,,,,,,,,,,,,,,,,,,,,,adolescents|adolescent|adult|adults,,,,,,marriageable age,
http://scai.fraunhofer.de/NDDUO#morbidity_context,morbidity context,,,false,,,http://scai.fraunhofer.de/NDDUO#descriptive_statistical_context,,NDDUO:morbidity_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,morbidity context,
http://www.pepathway.org/peo/1.2#Platelet_count_below_reference_range,Platelet count below reference range,,,false,,,http://www.pepathway.org/peo/1.2#Red_blood_cell_disorder,,peo2:Platelet_count_below_reference_range,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/415116008,,,,Thrombocytopenia|Platelet count below reference range (finding),,,,,,Platelet count below reference range,
http://www.pepathway.org/peo/1.2#C_H_-_Chronic_disease,C / H - Chronic disease,,,false,,,http://www.pepathway.org/peo/1.2#Medical_history,,peo2:C_H_-_Chronic_disease,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/27624003,,,,Chronic disease (disorder),,,,,,C / H - Chronic disease,
http://www.pepathway.org/peo/1.2#Smoking_during_pregnancy,Smoking during pregnancy,,,false,,,http://www.pepathway.org/peo/1.2#Maternal_tobacco_use,,peo2:Smoking_during_pregnancy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Smoking during pregnancy,
http://www.pepathway.org/peo/1.2#LIGHT_Signaling,LIGHT Signaling,,,false,,,http://www.pepathway.org/peo/1.2#Pathway,,peo2:LIGHT_Signaling,,,,,,,,,,,,,,,,,,,,,,,,,,,,,LIGHT Signaling,
http://www.pepathway.org/peo/1.2#Xiusanzhen,Xiusanzhen,,,false,,,http://scai.fraunhofer.de/NDDUO#non_pharmacotherapy_procedure,,peo2:Xiusanzhen,,,,,,,,,,,,,,,,,,,,,,from manual annotation of text corpus,electroacupuncture,,,,,,Xiusanzhen,
http://www.pepathway.org/peo/1.2#metabolic_change,metabolic change,,from manual annotation of text corpus,false,,,http://www.ifomis.org/bfo/1.1/span#Process,,peo2:metabolic_change,,,,,,,,,,,,,,,,,,,,,,,metabolic changes,,,,,from manual annotation of text corpus,metabolic change,
http://www.pepathway.org/peo/1.2#Indian,Indian,,,false,,,http://scai.fraunhofer.de/NDDUO#Race,,peo2:Indian,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/414481008,,,,Indian (racial group),,,,,,Indian,
http://www.pepathway.org/peo/1.2#thing_related_to_past_treatment,thing related to past treatment,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_medical_history,,peo2:thing_related_to_past_treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to past treatment,
http://www.pepathway.org/peo/1.2#Phenotypic_functions,Phenotypic functions,,,false,,,http://www.pepathway.org/peo/1.2#Cytodiagnosis,,peo2:Phenotypic_functions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phenotypic functions,
http://www.pepathway.org/peo/1.2#Age_at_menarche,Age at menarche,,,false,,,http://scai.fraunhofer.de/NDDUO#Age,,peo2:Age_at_menarche,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/398700009,,,,Age at menarche (observable entity),,,,,,Age at menarche,
http://www.pepathway.org/peo/1.2#Estrogen_level,Estrogen level,,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:Estrogen_level,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Estrogen level,
http://scai.fraunhofer.de/NDDUO#infectious_cause_context,infectious cause context,,,false,,,http://scai.fraunhofer.de/NDDUO#etiological_context,,NDDUO:infectious_cause_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,infectious cause context,
http://scai.fraunhofer.de/NDDUO#Point_prevalence,Point prevalence,,,false,,,http://scai.fraunhofer.de/NDDUO#prevalence,,NDDUO:Point_prevalence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Point prevalence,
http://www.pepathway.org/peo/1.2#Black_-_ethnic_group,Black - ethnic group,,,false,,,http://scai.fraunhofer.de/NDDUO#Race,,peo2:Black_-_ethnic_group,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/315240009,,,,Black - ethnic group (ethnic group)|Black,,,,,,Black - ethnic group,
http://www.pepathway.org/peo/1.2#Microvascular_Markers,Microvascular Marker,,AD135,false,,,http://scai.fraunhofer.de/NDDUO#biomarker,,peo2:Microvascular_Markers,,,,,,,,,,,,,,,,,,,,,,http://www.benthamscience.com/open/tonmedj/article/V002/SI0010TONMEDJ/12TONMEDJ.pdf,Microvascular Markers|microvascular biomarker|microvascular biomarkers,,,,,AD135,Microvascular Marker,
http://www.pepathway.org/peo/1.2#Supplements,Supplements,,,false,,,http://scai.fraunhofer.de/NDDUO#drug_role,,peo2:Supplements,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Supplements,
http://www.pepathway.org/peo/1.2#low-density_lipoprotein_cholesterol,low-density lipoprotein cholesterol,,,false,,,http://www.pepathway.org/peo/1.2#cholesterol,,peo2:low-density_lipoprotein_cholesterol,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_47774,,,,beta-lipoprotein cholesterol|LDL cholesterol|LDL-C,,,,Cholesterol esters and free cholesterol which are contained in or bound to low-density lipoproteins (LDL).,,low-density lipoprotein cholesterol,
http://www.pepathway.org/peo/1.2#Cerebral_palsy,Cerebral palsy,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Cerebral_palsy,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/128188000,,,,CP - Cerebral palsy|Congenital cerebral palsy|Cerebral palsy (disorder)|Cerebral palsy (CP)|Infantile cerebral palsy,,,,"A permanent disorder of the development of movement, posture and motor function, causing activity limitation, caused by non-progressive disturbances in the developing fetal or infant brain.",,Cerebral palsy,
http://scai.fraunhofer.de/NDDUO#disease_cause,disease cause,,,false,,,http://www.ifomis.org/bfo/1.1#Entity,,NDDUO:disease_cause,,,,,,,,,,,,,,,,,,,,,,,disease causes,,,,,,disease cause,
http://www.pepathway.org/peo/1.2#Systemic_lupus_erythematosus-related_syndrome,Systemic lupus erythematosus-related syndrome,,,false,,,http://www.pepathway.org/peo/1.2#Mixed_collagen_vascular_disease,,peo2:Systemic_lupus_erythematosus-related_syndrome,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/397856003,,,,Systemic lupus erythematosus-related syndrome (disorder)|SLE - Systemic lupus erythematosus-related syndrome,,,,,,Systemic lupus erythematosus-related syndrome,
http://www.pepathway.org/peo/1.2#Blood_pressure_finding,Blood pressure finding,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_observable,,peo2:Blood_pressure_finding,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/392570002,,,,Blood pressure finding (finding),,,,,,Blood pressure finding,
http://www.pepathway.org/peo/1.2#Pituitary_apoplexy,Pituitary apoplexy,,,false,,,http://www.pepathway.org/peo/1.2#Brain_Diseases,,peo2:Pituitary_apoplexy,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/237701005,,,,Pituitary apoplexy (disorder),,,,,,Pituitary apoplexy,
http://www.pepathway.org/peo/1.2#Compression_of_umbilical_cord,Compression of umbilical cord,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_fetus_or_newborn,,peo2:Compression_of_umbilical_cord,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/79222000,,,,Compression of umbilical cord (disorder),,,,,,Compression of umbilical cord,
http://www.pepathway.org/peo/1.2#Early_neonatal_death,Early neonatal death,,,false,,,http://www.pepathway.org/peo/1.2#Newborn_death,,peo2:Early_neonatal_death,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/391181005,,,,Early neonatal death (event),,,,,,Early neonatal death,
http://www.ifomis.org/bfo/1.1/span#ProcessualEntity,processual_entity,,"Examples: the life of an organism, the process of meiosis, the course of a disease, the flight of a bird|Definition: An occurrent [span:Occurrent] that exists in time by occurring or happening, has temporal parts and always involves and depends on some entity.",false,,,http://www.ifomis.org/bfo/1.1/span#Occurrent,,span:ProcessualEntity,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Examples: the life of an organism, the process of meiosis, the course of a disease, the flight of a bird|Definition: An occurrent [span:Occurrent] that exists in time by occurring or happening, has temporal parts and always involves and depends on some entity.",processual_entity,
http://www.pepathway.org/peo/1.2#Basic_attribute_on_pregnancy,Basic attribute on pregnancy,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Basic_attribute_on_pregnancy,,,,,,,,,,,,,,,,,,,,,,,Basic attrubute,,,,,,Basic attribute on pregnancy,
http://scai.fraunhofer.de/NDDUO#Race_specific_mortality_rate,Race specific mortality rate,,,false,,,http://scai.fraunhofer.de/NDDUO#Mortility_rate,,NDDUO:Race_specific_mortality_rate,,,,,,,,,,,,,,,,,,,,,,,Race specific mortality rates,,,,,,Race specific mortality rate,
http://www.pepathway.org/peo/1.2#Family_history_of_diabetes_mellitus,Family history of diabetes mellitus,,,false,,,http://www.pepathway.org/peo/1.2#Family_History,,peo2:Family_history_of_diabetes_mellitus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Family history of diabetes mellitus,
http://scai.fraunhofer.de/NDDUO#First_generation_migrant,First generation migrant,,,false,,,http://scai.fraunhofer.de/NDDUO#Migrant_study,,NDDUO:First_generation_migrant,,,,,,,,,,,,,,,,,,,,,,,,,,,,,First generation migrant,
http://www.pepathway.org/peo/1.2#Fibrosis_of_Chorionic_Villi,Fibrosis of Chorionic Villi,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_placenta,,peo2:Fibrosis_of_Chorionic_Villi,,,,,,,,,,,,,,,,,,,,,,,Villous Fibrosis,,,,,,Fibrosis of Chorionic Villi,
http://www.pepathway.org/peo/1.2#cell_cycle_process,cell-cycle process,,from manual annotation of text corpus,false,,,http://www.pepathway.org/peo/1.2#processes_all_cells,,peo2:cell_cycle_process,,,,,,,,,,,,,,,,,,,,,,,cell-cycle processes,,,,,from manual annotation of text corpus,cell-cycle process,
http://www.pepathway.org/peo/1.2#Heart_rate,Heart rate,,,false,,,http://www.pepathway.org/peo/1.2#Echocardiography,,peo2:Heart_rate,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/364075005,,,,Cardiac rate|Heart rate (observable entity),,,,,,Heart rate,
http://www.pepathway.org/peo/1.2#late_onset_context,late onset context,,,false,,,http://scai.fraunhofer.de/NDDUO#stage_context,,peo2:late_onset_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,late onset context,
http://www.pepathway.org/peo/1.2#perfluorooctanoic_acid,perfluorooctanoic acid,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:perfluorooctanoic_acid,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/C023036,,,,"perfluorooctanoyl chloride|perfluorinated octanoic acid|ammonium perfluorooctanoate|perfluorooctanoic acid, chromium (3+) salt|sodium perfluorooctanoate|perfluorooctanoic acid, monoammonium salt|perfluorooctanoic acid, monosilver (1+) salt|perfluorooctanoate|perfluorooctanoic acid, monopotassium salt|perfluorooctanoic acid, monosodium salt|perfluorooctanoic acid, anhydride|perfluorooctanoic acid, cesium salt|perfluorooctanoic acid, cobalt (2+) salt|pentadecafluorooctanoic acid|perfluorooctanoic acid, lithium salt|APFO|PFOA cpd",,,,,,perfluorooctanoic acid,
http://www.pepathway.org/peo/1.2#Neonate_observable,Neonate observable,,,false,,,http://www.pepathway.org/peo/1.2#Physiological_test,,peo2:Neonate_observable,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/364585000,,,,Neonate observable (observable entity),,,,,,Neonate observable,
http://www.ifomis.org/bfo/1.1/snap#ZeroDimensionalRegion,zero_dimensional_region,,Definition: A spatial region [snap:SpatialRegion] with no dimensions.|Examples: a point,false,,,http://www.ifomis.org/bfo/1.1/snap#SpatialRegion,,snap:ZeroDimensionalRegion,,,,,,,,,,,,,,,,,,,,,,,,,,,,Definition: A spatial region [snap:SpatialRegion] with no dimensions.|Examples: a point,zero_dimensional_region,
http://www.pepathway.org/peo/1.2#Endothelium,Endothelium,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Endothelium,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/27168002,,,,Endothelial tissue|Endothelium (body structure),,,,,,Endothelium,
http://www.pepathway.org/peo/1.2#Trimesters,Trimesters,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_time_period,,peo2:Trimesters,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/272107002,,,,Trimesters (qualifier value),,,,,,Trimesters,
http://www.pepathway.org/peo/1.2#Abdominal_pain,Abdominal pain,,,false,,,http://www.pepathway.org/peo/1.2#Pain,,peo2:Abdominal_pain,,,,,,,,,,,,,,,,,,,,,,,acute abdominal pain,,,,,,Abdominal pain,
http://www.pepathway.org/peo/1.2#comparative_study,comparative study,,from NP chunking,false,,,http://scai.fraunhofer.de/NDDUO#Study_type,,peo2:comparative_study,,,,,,,,,,,,,,,,,,,,,,,comparative studies,,,,,from NP chunking,comparative study,
http://www.pepathway.org/peo/1.2#De_phosphorylation,De-phosphorylation,,AD603,false,,,http://www.pepathway.org/peo/1.2#Post_translational_modification,,peo2:De_phosphorylation,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD603,De-phosphorylation,
http://www.pepathway.org/peo/1.2#Previous_HELLP_syndrom,Previous HELLP syndrome,,,false,,,http://www.pepathway.org/peo/1.2#Medical_history,,peo2:Previous_HELLP_syndrom,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Previous HELLP syndrome,
http://www.pepathway.org/peo/1.2#cell_growth,cell growth,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:cell_growth,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/GO_0016049,,,,cellular growth; growth of cell|cell expansion; non-developmental growth of a unicellular organism; metabolic process resulting in cell growth; metabolism resulting in cell growth; non-developmental cell growth,,,,,,cell growth,
http://www.pepathway.org/peo/1.2#Episiotomy,Episiotomy,,,false,,,http://www.pepathway.org/peo/1.2#Therapeutics,,peo2:Episiotomy,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/85548006,,,,Episiotomy (procedure),,,,,,Episiotomy,
http://www.pepathway.org/peo/1.2#Neurological_dysfunction,Neurological dysfunction,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Neurological_dysfunction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Neurological dysfunction,
http://www.pepathway.org/peo/1.2#Pulmonary_embolism,Pulmonary embolism,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Pulmonary_embolism,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/59282003,,,,PE - Pulmonary embolism|Pulmonary embolism (disorder),,,,,,Pulmonary embolism,
http://scai.fraunhofer.de/NDDUO#Diagnostic_tests,Diagnostic test,,,false,,,http://scai.fraunhofer.de/NDDUO#Diagnostic_Procedures|http://scai.fraunhofer.de/NDDUO#Evaluation,,NDDUO:Diagnostic_tests,,,,,,,,,,,,,,,,,,,,,,,Diagnostic tests,,,,,,Diagnostic test,
http://www.pepathway.org/peo/1.1#LYZ,LYZ,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:LYZ,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/4069,,,,,,,,,,,,,,,,,,,,LYZ,
http://www.pepathway.org/peo/1.2#Aspirin,Aspirin,,,false,,,http://www.pepathway.org/peo/1.2#drug,,peo2:Aspirin,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/7947003,,,,Acetylsalicylic acid|Aspirin (product),,,,,,Aspirin,
http://www.pepathway.org/peo/1.2#Type_1_diabetes_mellitus,Type 1 diabetes mellitus,,,false,,,http://www.pepathway.org/peo/1.2#Diabetes,,peo2:Type_1_diabetes_mellitus,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/46635009,,,,Diabetes mellitus type 1 (disorder)|Type I diabetes mellitus|Diabetes mellitus type I|Diabetes mellitus type 1,,,,,,Type 1 diabetes mellitus,
http://www.pepathway.org/peo/1.2#Previous_pregnancies,Previous pregnancies,,,false,,,http://www.ifomis.org/bfo/1.1/span#TemporalInterval,,peo2:Previous_pregnancies,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/127362006,,,,Previous pregnancies (finding),,,,,,Previous pregnancies,
http://scai.fraunhofer.de/NDDUO#In_vitro,In vitro thing,,,false,,,http://scai.fraunhofer.de/NDDUO#Non_clinical,,NDDUO:In_vitro,,,,,,,,,,,,,,,,,,,,,,,In vitro,,,,,,In vitro thing,
http://www.pepathway.org/peo/1.2#stroke,stroke,,from NP chunking,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:stroke,,,,,,,,,,,,,,,,,,,,,,,strokes,,,,,from NP chunking,stroke,
http://www.pepathway.org/peo/1.2#thing_related_to_lifestyle,thing related to lifestyle,,,false,,,http://www.pepathway.org/peo/1.2#Environmental_features,,peo2:thing_related_to_lifestyle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to lifestyle,
http://www.pepathway.org/peo/1.2#Chemical_exposure,Chemical exposure,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Chemical_exposure,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10068154,,,,,,,,,,Chemical exposure,
http://www.pepathway.org/peo/1.2#Fetal_intrapartum_death,Fetal intrapartum death,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:Fetal_intrapartum_death,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/237362003,,,,Intrapartum fetal death (event)|Intrapartum fetal death|Intrapartum foetal death|Foetal intrapartum death,,,,,,Fetal intrapartum death,
http://www.pepathway.org/peo/1.2#Twin_pregnancy,Twin pregnancy,,,false,,,http://www.pepathway.org/peo/1.2#Multiple_pregnancy,,peo2:Twin_pregnancy,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/65147003,,,,Twin pregnancy (disorder),,,,,,Twin pregnancy,
http://www.pepathway.org/peo/1.1#CXCL2,CXCL2,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:CXCL2,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/2920,,,,,,,,,,,,,,,,,,,,CXCL2,
http://www.pepathway.org/peo/1.2#Fibrin,Fibrin,,,false,,,http://www.pepathway.org/peo/1.2#Peptide,,peo2:Fibrin,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/113361004,,,,Fibrin (substance),,,,,,Fibrin,
http://www.pepathway.org/peo/1.2#Previous_neonatal_death,Previous neonatal death,,,false,,,http://www.pepathway.org/peo/1.2#Medical_history,,peo2:Previous_neonatal_death,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Previous neonatal death,
http://www.ifomis.org/bfo/1.1/snap#SpecificallyDependentContinuant,specifically_dependent_continuant,,"Definition: A continuant [snap:Continuant] that inheres in or is borne by other entities. Every instance of A requires some specific instance of B which must always be the same.|Synonyms: property, trope, mode|Examples: the mass of a cloud, the smell of mozzarella, the liquidity of blood, the color of a tomato, the disposition of fish to decay, the role of being a doctor, the function of the heart in the body: to pump blood, to receive de-oxygenated and oxygenated blood, etc.",false,,,http://www.ifomis.org/bfo/1.1/snap#DependentContinuant,,snap:SpecificallyDependentContinuant,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Definition: A continuant [snap:Continuant] that inheres in or is borne by other entities. Every instance of A requires some specific instance of B which must always be the same.|Synonyms: property, trope, mode|Examples: the mass of a cloud, the smell of mozzarella, the liquidity of blood, the color of a tomato, the disposition of fish to decay, the role of being a doctor, the function of the heart in the body: to pump blood, to receive de-oxygenated and oxygenated blood, etc.",specifically_dependent_continuant,
http://scai.fraunhofer.de/NDDUO#Genetic_causes,Entity relating to genetic cause,,AD447,false,,,http://scai.fraunhofer.de/NDDUO#disease_cause,,NDDUO:Genetic_causes,,,,,,,,,,,,,,,,,,,,,,,Genetic cause,,,,,AD447,Entity relating to genetic cause,
http://www.pepathway.org/peo/1.2#procedures_using_biomarkers,thing related to procedure using biomarkers,,,false,,,http://scai.fraunhofer.de/NDDUO#Diagnosis,,peo2:procedures_using_biomarkers,,,,,,,,,,,,,,,,,,,,,,,biological marker|biomarker,,,,,,thing related to procedure using biomarkers,
http://scai.fraunhofer.de/NDDUO#descriptive_epidemiology_context,descriptive epidemiology context,,,false,,,http://scai.fraunhofer.de/NDDUO#epidemiology_context,,NDDUO:descriptive_epidemiology_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,descriptive epidemiology context,
http://www.ifomis.org/bfo/1.1/span#ConnectedSpatiotemporalRegion,connected_spatiotemporal_region,,"Examples: the spatial and temporal location of an individual organism's life, the spatial and temporal location of the development of a fetus|Definition: A spatiotemporal region [span:SpatiotemporalRegion] that has temporal and spatial dimensions such that all points within the spatiotemporal region are mediately or immediately connected to all other points within the same spatiotemporal region [span:SpatiotemporalRegion].",false,,,http://www.ifomis.org/bfo/1.1/span#SpatiotemporalRegion,,span:ConnectedSpatiotemporalRegion,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Examples: the spatial and temporal location of an individual organism's life, the spatial and temporal location of the development of a fetus|Definition: A spatiotemporal region [span:SpatiotemporalRegion] that has temporal and spatial dimensions such that all points within the spatiotemporal region are mediately or immediately connected to all other points within the same spatiotemporal region [span:SpatiotemporalRegion].",connected_spatiotemporal_region,
http://scai.fraunhofer.de/NDDUO#In_vivo,In vivo thing,,,false,,,http://scai.fraunhofer.de/NDDUO#Non_clinical,,NDDUO:In_vivo,,,,,,,,,,,,,,,,,,,,,,,In vivo,,,,,,In vivo thing,
http://www.pepathway.org/peo/1.2#thing_related_to_transcript,thing related to transcript,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_gene,,peo2:thing_related_to_transcript,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to transcript,
http://www.pepathway.org/peo/1.2#Birth_weight,Birth weight,,,false,,,http://www.pepathway.org/peo/1.2#Neonate_observable,,peo2:Birth_weight,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/364589006,,,,Birth weight (observable entity),,,,,,Birth weight,
http://www.pepathway.org/peo/1.2#Blood_Transfusion_in_present_pregnancy,Blood transfusion in present pregnancy,,,false,,,http://www.pepathway.org/peo/1.2#Blood_Transfusion,,peo2:Blood_Transfusion_in_present_pregnancy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Blood transfusion in present pregnancy,
http://www.pepathway.org/peo/1.2#Poor_placental_development,Poor placental development,,,false,,,http://www.pepathway.org/peo/1.2#Placental_finding,,peo2:Poor_placental_development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Poor placental development,
http://www.pepathway.org/peo/1.2#Image_based_biomarkers,Image based biomarker,,AD118,false,,,http://scai.fraunhofer.de/NDDUO#biomarker,,peo2:Image_based_biomarkers,,,,,,,,,,,,,,,,,,,,,,"R. J. Killiany, T. Gomez-Isla, and T. Gomez-Isla, “Use of structural magnetic resonance imaging to predict who will get Alzheimers disease,” Annals of Neurology, vol. 47, no. 4, pp. 430–439, 2000.

C. J. A. Moulin, M. Laine, J. O. Rinne, V. Kaasinen, H. Sipilä, J. Hiltunen, and A. Kangasmäki, “Brain function during multi-trial learning in mild cognitive impairment: a PET activation study,” Brain Research, vol. 1136, no. 1, pp. 132–141, 2007.

C. A. Mathis, Y. Wang, D. P. Holt, G.-F. Huang, M. L. Debnath, and W. E. Klunk, “Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents,” Journal of Medicinal Chemistry, vol. 46, no. 13, pp. 2740–2754, 2003.


http://www.sage-hindawi.com/journals/ijad/2010/606802/#B18",imaging biomarkers|imaging biomarker|molecular imaging biomarker|neuroimaging biomarkers|neuroimaging biomarker|Image based biomarkers|molecular imaging biomarkers,,,,,AD118,Image based biomarker,
http://www.pepathway.org/peo/1.2#Human_chorionic_gonadotropin,Human chorionic gonadotropin,,,false,,,http://www.pepathway.org/peo/1.2#hormone,,peo2:Human_chorionic_gonadotropin,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/59433001,,,,Chorionic gonadotrophin human|Chorionic gonadotrophin|HCG - Human chorionic gonadotrophin|Human chorionic gonadotropin (substance)|Chorionic gonadotropin human|HCG - Human chorionic gonadotropin|Human chorionic gonadotrophin|HCG,,,,,,Human chorionic gonadotropin,
http://www.pepathway.org/peo/1.2#Spermatogenesis,Spermatogenesis,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Spermatogenesis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/20412003,,,,"Spermatogenesis, function|Spermatogenesis, function (observable entity)|Spermatocytogenesis",,,,,,Spermatogenesis,
http://www.pepathway.org/peo/1.2#Red_blood_cell_disorder,Red blood cell disorder,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Red_blood_cell_disorder,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/38292009,,,,Red blood cell disorder (disorder),,,,,,Red blood cell disorder,
http://www.pepathway.org/peo/1.2#AGT_precursor,AGT precursor,,,false,,,http://www.pepathway.org/peo/1.2#Precursors,,peo2:AGT_precursor,,,,,,,,,,,,,,,,,,,http://www.uniprot.org/uniprot/P01019,,,,,,,,,,AGT precursor,
http://www.pepathway.org/peo/1.2#study_nurse,study nurse,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Object,,peo2:study_nurse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,study nurse,
http://www.pepathway.org/peo/1.2#UtAD_velocimetry,UtAD velocimetry,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_uterine_artery_Doppler,,peo2:UtAD_velocimetry,,,,,,,,,,,,,,,,,,,,,,,uterine artery Doppler velocimetry,,,,,,UtAD velocimetry,
http://www.pepathway.org/peo/1.2#Hypertensive_disorder,Hypertensive disorder,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Hypertensive_disorder,,,,,,,,,,,,,,,,,,,,,,,"High blood pressure|BP+ - Hypertension|Hypertensive vascular degeneration|HTN - Hypertension|Raised blood pressure|Hypertensive disorder, systemic arterial|Systemic arterial hypertension|Hypertensive disorder, systemic arterial (disorder)|HT - Hypertension|HBP - High blood pressure|BP - High blood pressure|Hypertensive vascular disease|Hypertension|High blood pressure disorder|Elevated blood pressure|Hyperpiesis|Hyperpiesia",,,,,,Hypertensive disorder,
http://www.pepathway.org/peo/1.2#Intravillous_hemorrhage,Intravillous hemorrhage,,,false,,,http://www.pepathway.org/peo/1.2#Haemorrhage_finding,,peo2:Intravillous_hemorrhage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Intravillous hemorrhage,
http://www.ifomis.org/bfo/1.1#Entity,entity,,,false,,,http://www.w3.org/2002/07/owl#Thing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,entity,
http://www.pepathway.org/peo/1.2#Previous_gestational_hypertension,Previous gestational hypertension,,,false,,,http://www.pepathway.org/peo/1.2#Medical_history,,peo2:Previous_gestational_hypertension,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Previous gestational hypertension,
http://www.pepathway.org/peo/1.2#Infection,Infection,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Infection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Infection,
http://www.pepathway.org/peo/1.2#Fetal_growth_restriction,Fetal growth restriction,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_fetus_or_newborn,,peo2:Fetal_growth_restriction,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/22033007,,,,FGR - Fetal growth retardation|Intrauterine growth retardation|Microsomic baby|Poor fetal growth state|Poor fetal growth|IUGR - Intrauterine growth retardation|Fetal growth retardation|Fetal growth retardation (disorder)|Microsomia,,,,,,Fetal growth restriction,
http://scai.fraunhofer.de/NDDUO#prevalence,prevalence,,,false,,,http://scai.fraunhofer.de/NDDUO#rate,,NDDUO:prevalence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,prevalence,
http://scai.fraunhofer.de/NDDUO#biomarker,biomarker,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Role,,NDDUO:biomarker,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_59163,,,,biomarkers|marker|markers,,,,,,biomarker,
http://www.pepathway.org/peo/1.1#MDA,MDA,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:MDA,,,,,,,,,,,,,,,,,,,,,,,Melanoma Differentiation-Associated protein,,,,,,MDA,
http://www.pepathway.org/peo/1.2#UtA-RI,UtA-RI,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_uterine_artery_Doppler,,peo2:UtA-RI,,,,,,,,,,,,,,,,,,,,,,,uterine artery resistance index,,,,,,UtA-RI,
http://www.pepathway.org/peo/1.2#Chorioamnionitis,Chorioamnionitis,,,false,,,http://www.pepathway.org/peo/1.2#Inflammatory_disorder,,peo2:Chorioamnionitis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/11612004,,,,Membranitis|Chorioamnionitis (disorder),,,,,,Chorioamnionitis,
http://www.pepathway.org/peo/1.2#Placenta_previa,Placenta previa,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_placenta,,peo2:Placenta_previa,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/36813001,,,,Placenta praevia|PP - Placenta previa|PP - Placenta praevia|Placenta previa (disorder),,,,,,Placenta previa,
http://www.pepathway.org/peo/1.2#Amnion,Amnion,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Amnion,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D000650,,,,"Amniotic Membranes|Amniotic Membrane|Membrane, Amniotic|Membranes, Amniotic|Amnions",,,,The innermost membranous sac that surrounds and protects the developing embryo which is bathed in the AMNIOTIC FLUID. Amnion cells are secretory EPITHELIAL CELLS and contribute to the amniotic fluid.,,Amnion,
http://www.pepathway.org/peo/1.1#BAX,BAX,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:BAX,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/581,,,,,,,,,,,,,,,,,,,,BAX,
http://www.pepathway.org/peo/1.1#TGFB1,TGFB1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:TGFB1,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/7040,,,,,,,,,,,,,,,,,,,,TGFB1,
http://www.pepathway.org/peo/1.2#B_lymphocyte,B lymphocyte,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:B_lymphocyte,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/112130006,,,,B lymphocyte (cell)|B cell|B-cell,,,,,,B lymphocyte,
http://scai.fraunhofer.de/NDDUO#surgery_context,surgery context,,,false,,,http://scai.fraunhofer.de/NDDUO#non_pharmacotherapy_treatment_context,,NDDUO:surgery_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,surgery context,
http://www.pepathway.org/peo/1.1#PROS1,PROS1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:PROS1,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/5627,,,,,,,,,,,,,,,,,,,,PROS1,
http://www.pepathway.org/peo/1.2#Resveratrol,Resveratrol,,,false,,,http://www.pepathway.org/peo/1.2#drug,,peo2:Resveratrol,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/96383001,,,,Resveratrol (substance),,,,,,Resveratrol,
http://scai.fraunhofer.de/NDDUO#Rat,Rat,,,false,,,http://scai.fraunhofer.de/NDDUO#Rodents,,NDDUO:Rat,,,,,,,,,,,,,,,,,,,http://semanticscience.org/resource/SIO_000487,,,,Rats,,,,,,Rat,
http://www.pepathway.org/peo/1.2#Passive_smoker,Passive smoker,,,false,,,http://www.pepathway.org/peo/1.2#Maternal_tobacco_use,,peo2:Passive_smoker,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/43381005,,,,Passive smoker (finding)|Exposed to second hand tobacco smoke|Involuntary smoker|Exposed to environmental tobacco smoke|ETS - Exposed to tobacco smoke|Exposed to tobacco smoke,,,,,,Passive smoker,
http://www.pepathway.org/peo/1.2#Antepartum,Antepartum,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_time_period,,peo2:Antepartum,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/276986009,,,,Antepartum (qualifier value),,,,,,Antepartum,
http://www.pepathway.org/peo/1.2#NFKB,NFKB,,,false,,,http://www.pepathway.org/peo/1.2#Dimers,,peo2:NFKB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NFKB,
http://www.pepathway.org/peo/1.2#Heart_disease,Heart disease,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Heart_disease,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/56265001,,,,Disorder of heart|Heart disease (disorder)|Morbus cordis|Cardiac disorder|Cardiopathy,,,,,,Heart disease,
http://www.pepathway.org/peo/1.2#thing_related_to_observations,thing related to observations,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_phenotypic_features,,peo2:thing_related_to_observations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to observations,
http://www.pepathway.org/peo/1.1#RIPPLY1,RIPPLY1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:RIPPLY1,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/92129,,,,,,,,,,,,,,,,,,,,RIPPLY1,
http://www.pepathway.org/peo/1.2#Aminopterin,Aminopterin,,,false,,,http://www.pepathway.org/peo/1.2#drug,,peo2:Aminopterin,,,,,,,,,CHEMBL274619,,,,,,,,,,,,,,,,,,,,Aminopterin,
http://www.pepathway.org/peo/1.2#Coagulation_factor_I,Coagulation factor I,,,false,,,http://www.pepathway.org/peo/1.2#Peptide,,peo2:Coagulation_factor_I,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/23295004,,,,Coagulation factor I (substance)|Fibrinogen,,,,,,Coagulation factor I,
http://www.pepathway.org/peo/1.2#Thrombosis,Thrombosis,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Thrombosis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/439127006,,,,Thrombosis (disorder),,,,,,Thrombosis,
http://www.pepathway.org/peo/1.1#TPSAB1,TPSAB1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:TPSAB1,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/7177,,,,,,,,,,,,,,,,,,,,TPSAB1,
http://www.pepathway.org/peo/1.2#Cohort_effect,Cohort effect,,AD259,false,,,http://www.ifomis.org/bfo/1.1/snap#DependentContinuant,,peo2:Cohort_effect,,,,,,,,,,,,,,,,,,,,,,,cohort,,,,,AD259,Cohort effect,
http://www.pepathway.org/peo/1.2#Placental_Hematoma,Placental Hematoma,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_placenta,,peo2:Placental_Hematoma,,,,,,,,,,,,,,,,,,,,,,,Subchorionic Hemorrhage|Subchorionic Hematoma,,,,,,Placental Hematoma,
http://www.pepathway.org/peo/1.2#After_full_dilatation_of_cervix,After full dilatation of cervix,,,false,,,http://www.pepathway.org/peo/1.2#Intrapartum,,peo2:After_full_dilatation_of_cervix,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/255617004,,,,After full dilatation of cervix (qualifier value),,,,,,After full dilatation of cervix,
http://www.pepathway.org/peo/1.2#anti-TNFRSF14,anti-TNFRSF14,,,false,,,http://www.pepathway.org/peo/1.2#Antibody,,peo2:anti-TNFRSF14,,,,,,,,,,,,,,,,,,,,,,,TNFRSF14 antibody,,,,,,anti-TNFRSF14,
http://www.pepathway.org/peo/1.2#Educational_level_of_guardian_of_subject,Educational level of guardian of subject,,,false,,,http://www.pepathway.org/peo/1.2#Education_and_schooling_detail,,peo2:Educational_level_of_guardian_of_subject,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/444028004,,,,Educational level of guardian of subject (observable entity),,,,,,Educational level of guardian of subject,
http://www.pepathway.org/peo/1.2#White_-_ethnic_group,White - ethnic group,,,false,,,http://scai.fraunhofer.de/NDDUO#Race,,peo2:White_-_ethnic_group,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/185984009,,,,White - ethnic group (ethnic group)|White,,,,,,White - ethnic group,
http://www.pepathway.org/peo/1.2#oxytocin,oxytocin,,,false,,,http://www.pepathway.org/peo/1.2#hormone,,peo2:oxytocin,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_7872,,,,"(1-Hemicystine)oxytocin|[H][C@]1(NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)[C@|3-Isoleucine-8-leucine vasopressin|L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic(1-6)-disulfide|InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1|1-({(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide|Endopituitrina|C43H66N12O12S2|A cyclic nonapeptide hormone with amino acid sequence CYIQNCPLG that also acts as a neurotransmitter in the brain; the principal uterine-contracting and milk-ejecting hormone of the posterior pituitary. Together with the neuropeptide vasopressin, it is believed to influence social cognition and behaviour.|InChIKey=XNOPRXBHLZRZKH-DSZYJQQASA-N|OT|OXT|Ocytocin|Orasthin|Oxytocin|Pitocin|Piton S|Syntocinon|oxitocina|oxytocin|oxytocine|oxytocinum",,,,,,oxytocin,
http://www.pepathway.org/peo/1.2#AT2R_antagonists,AT2R antagonists,,,false,,,http://scai.fraunhofer.de/NDDUO#drug_role,,peo2:AT2R_antagonists,,,,,,,,,,,,,,,,,,,,,,,,,,,,,AT2R antagonists,
http://www.pepathway.org/peo/1.2#single_masked_study,single masked study,,,false,,,http://scai.fraunhofer.de/NDDUO#Study_type,,peo2:single_masked_study,,,,,,,,,,,,,,,,,,,,,,,single masked studies,,,,,,single masked study,
http://www.pepathway.org/peo/1.2#Postnatal,Postnatal,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_time_period,,peo2:Postnatal,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/263844007,,,,Postnatal (qualifier value),,,,,,Postnatal,
http://www.pepathway.org/peo/1.2#thing_related_to_gene,thing related to gene,,,false,,,http://www.pepathway.org/peo/1.2#Genomic_features,,peo2:thing_related_to_gene,,,,,,,,,,,,,,,,,,,,,,,gene|genes,,,,,,thing related to gene,
http://www.pepathway.org/peo/1.2#Entity_relating_to_environmental_cause,Entity relating to environmental cause,,,false,,,http://scai.fraunhofer.de/NDDUO#disease_cause,,peo2:Entity_relating_to_environmental_cause,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Entity relating to environmental cause,
http://www.pepathway.org/peo/1.1#Bradykinin_receptors,Bradykinin receptors,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:Bradykinin_receptors,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D018002,,,,,,,,,,,,,,BDKR family,,,,,,Bradykinin receptors,
http://www.pepathway.org/peo/1.2#Age_at_leaving_school,Age at leaving school,,,false,,,http://www.pepathway.org/peo/1.2#Education_and_schooling_detail,,peo2:Age_at_leaving_school,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/224287007,,,,Age at leaving school (observable entity),,,,,,Age at leaving school,
http://www.pepathway.org/peo/1.2#Phosphorylation,Phosphorylation,,AD607,false,,,http://www.pepathway.org/peo/1.2#Post_translational_modification,,peo2:Phosphorylation,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/GO#GO_0016310,,,,,,,,,AD607,Phosphorylation,
http://www.ifomis.org/bfo/1.1/snap#Object,object,,"Definition: A material entity [snap:MaterialEntity] that is spatially extended, maximally self-connected and self-contained (the parts of a substance are not separated from each other by spatial gaps) and possesses an internal unity. The identity of substantial object [snap:Object] entities is independent of that of other entities and can be maintained through time.|Synonyms: substance|Examples: an organism, a heart, a chair, a lung, an apple",false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,snap:Object,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Definition: A material entity [snap:MaterialEntity] that is spatially extended, maximally self-connected and self-contained (the parts of a substance are not separated from each other by spatial gaps) and possesses an internal unity. The identity of substantial object [snap:Object] entities is independent of that of other entities and can be maintained through time.|Synonyms: substance|Examples: an organism, a heart, a chair, a lung, an apple",object,
http://scai.fraunhofer.de/NDDUO#Epidemiological_study_type,Epidemiological study,,,false,,,http://www.ifomis.org/bfo/1.1/span#Process,,NDDUO:Epidemiological_study_type,,,,,,,,,,,,,,,,,,,,,,,Epidemiological studies,,,,,,Epidemiological study,
http://scai.fraunhofer.de/NDDUO#Monkey,Monkey,,,false,,,http://scai.fraunhofer.de/NDDUO#Vertebrate,,NDDUO:Monkey,,,,,,,,,,,,,,,,,,,,,,,Monkeys,,,,,,Monkey,
http://www.pepathway.org/peo/1.2#T_lymphocyte,T lymphocyte,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:T_lymphocyte,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/57184004,,,,T lymphocyte (cell)|T cell|T-cell,,,,,,T lymphocyte,
http://www.pepathway.org/peo/1.2#thing_related_to_outcome_of_mother,thing related to outcome of mother,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_outcomes,,peo2:thing_related_to_outcome_of_mother,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to outcome of mother,
http://www.pepathway.org/peo/1.2#Open_populations,Open populations,,AD314,false,,,http://www.pepathway.org/peo/1.2#Populations,,peo2:Open_populations,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD314,Open populations,
http://www.pepathway.org/peo/1.2#Therapeutics,Therapeutics,,,false,,,http://www.ifomis.org/bfo/1.1/span#Process,,peo2:Therapeutics,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D013812,,,,Therapeutic|Therapies|Therapy|Treatment|Treatments,,,,,,Therapeutics,
http://www.pepathway.org/peo/1.2#Dimers,Dimers,,,false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,peo2:Dimers,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Dimers,
http://www.pepathway.org/peo/1.2#High_birth_weight,High birth weight,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:High_birth_weight,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/276613009,,,,High birth weight (disorder)|High birth weight baby,,,,,,High birth weight,
http://www.pepathway.org/peo/1.2#eicosanoids,eicosanoids,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:eicosanoids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,eicosanoids,
http://www.pepathway.org/peo/1.2#Marital_status,Marital status,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Marital_status,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/125680007,,,,Marital status (observable entity),,,,,,Marital status,
http://scai.fraunhofer.de/NDDUO#pre_clinical_context,pre clinical context,,,false,,,http://scai.fraunhofer.de/NDDUO#context,,NDDUO:pre_clinical_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pre clinical context,
http://www.pepathway.org/peo/1.2#open_label_study,open label study,,,false,,,http://scai.fraunhofer.de/NDDUO#Study_type,,peo2:open_label_study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,open label study,
http://www.pepathway.org/peo/1.2#steroid_hormone,steroid hormone,,,false,,,http://www.pepathway.org/peo/1.2#hormone,,peo2:steroid_hormone,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_26764,,,,hormonas esteroideas|Steroidhormone|hormones steroides|steroid hormones|hormone steroide|Steroidhormon|hormona esteroide,,,,Any steroid that acts as hormone.,,steroid hormone,
http://www.pepathway.org/peo/1.2#delivery_mode,delivery mode,,,false,,,http://www.pepathway.org/peo/1.2#Therapeutics,,peo2:delivery_mode,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/HL7/C1555567,,,,,,,,"Indicates the type of service offered, method of delivery. For example: post office box, rural route, general delivery, etc.",,delivery mode,
http://www.pepathway.org/peo/1.2#Lower_middle_class_economic_status,Lower middle class economic status,,,false,,,http://www.pepathway.org/peo/1.2#Economic_status,,peo2:Lower_middle_class_economic_status,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/80123004,,,,Lower middle class economic status (social concept),,,,,,Lower middle class economic status,
http://www.pepathway.org/peo/1.2#thing_related_to_history_of_obestric_complications,thing related to history of obestric complications,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_medical_history,,peo2:thing_related_to_history_of_obestric_complications,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to history of obestric complications,
http://www.pepathway.org/peo/1.2#mo_6_24_postportum,6-24 month postportum,,,false,,,http://www.pepathway.org/peo/1.2#Postpartum,,peo2:mo_6_24_postportum,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6-24 month postportum,
http://www.pepathway.org/peo/1.2#Delivery_by_vacuum_extraction,Delivery by vacuum extraction,,,false,,,http://www.pepathway.org/peo/1.2#delivery_mode,,peo2:Delivery_by_vacuum_extraction,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/61586001,,,,Ventouse extraction|Vacuum extraction|Delivery by vacuum extraction (procedure)|Vacuum extraction of fetus,,,,,,Delivery by vacuum extraction,
http://scai.fraunhofer.de/NDDUO#Cumulative_death_rate,Cumulative death rate,,,false,,,http://scai.fraunhofer.de/NDDUO#Mortility_rate,,NDDUO:Cumulative_death_rate,,,,,,,,,,,,,,,,,,,,,,,Cumulative death rates,,,,,,Cumulative death rate,
http://www.pepathway.org/peo/1.2#haematoxylin,haematoxylin,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:haematoxylin,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_51686,,,,"7,11b-dihydrobenz[b]indeno[1,2-d]pyran-3,4,6a,9,10(6H)-pentol|hematoxyline|hematoxylin|InChI=1S/C16H14O6/c17-10-2-1-8-13-9-4-12(19)11(18)3-7(9)5-16(13,21)6-22-15(8)14(10)20/h1-4,13,17-21H,5-6H2|hematoxilina|Oc1cc2CC3(O)COc4c(O)c(O)ccc4C3c2cc1O|Haematoxylin|7,11b-dihydroindeno[2,1-c]chromene-3,4,6a,9,10(6H)-pentol|InChIKey=WZUVPPKBWHMQCE-UHFFFAOYSA-N|C16H14O6",,,,An organic heterotetracyclic compound that has formula C16H14O6.,,haematoxylin,
http://www.pepathway.org/peo/1.2#wk28,28 wk,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_time_period,,peo2:wk28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,28 wk,
http://www.pepathway.org/peo/1.2#Medical_history,Medical history,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Medical_history,,,,,,,,,,,,,,,,,,,http://www.ebi.ac.uk/efo/EFO_0000352,,,,Clinical history,,,,,,Medical history,
http://www.pepathway.org/peo/1.2#Doppler_studies,Doppler studies,,,false,,,http://www.pepathway.org/peo/1.2#Ultrasonography,,peo2:Doppler_studies,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/268447006,,,,Doppler studies (procedure)|Doppler,,,,,,Doppler studies,
http://www.pepathway.org/peo/1.1#FURIN,FURIN,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:FURIN,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/5045,,,,,,,,,,,,,,,,,,,,FURIN,
http://scai.fraunhofer.de/NDDUO#Pathogenesis,thing related to pathogenesis,,AD343,false,,,http://scai.fraunhofer.de/NDDUO#Etiology,,NDDUO:Pathogenesis,,,,,,,,,,,,,,,,,,,,,,,Alzheimer's disease (AD) pathogenesis|pathogenesis,,,,,AD343,thing related to pathogenesis,
http://www.pepathway.org/peo/1.2#THROMBOPHILIA_DUE_TO_THROMBIN_DEFECT,THROMBOPHILIA DUE TO THROMBIN DEFECT,,,false,,,http://www.pepathway.org/peo/1.2#Thrombosis,,peo2:THROMBOPHILIA_DUE_TO_THROMBIN_DEFECT,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/OMIM/188050,,,,"THROMBOSIS, PROTECTION AGAINST|VENOUS THROMBOSIS|VENOUS THROMBOEMBOLISM|THROMBOPHILIA DUE TO FACTOR 2 DEFECT|THPH1",,,,,,THROMBOPHILIA DUE TO THROMBIN DEFECT,
http://scai.fraunhofer.de/NDDUO#Frequency_measure,Frequency measure,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,NDDUO:Frequency_measure,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/PATO#PATO_0000044,,,,Frequency measures,,,,,,Frequency measure,
http://www.pepathway.org/peo/1.2#Birth,Birth,,,false,,,http://www.pepathway.org/peo/1.2#Basic_attribute_on_pregnancy,,peo2:Birth,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/3950001,,,,Birth (finding),,,,,,Birth,
http://www.pepathway.org/peo/1.2#Age_at_birth,Age at birth,,,false,,,http://scai.fraunhofer.de/NDDUO#Age,,peo2:Age_at_birth,,,,,,,,,,,,,,,,,,,,,,,age at birth|age-at-birth|maternal age,,,,,,Age at birth,
http://www.pepathway.org/peo/1.2#Pregnancy,Pregnancy,,,false,,,http://www.pepathway.org/peo/1.2#Basic_attribute_on_pregnancy,,peo2:Pregnancy,,,,,,,,,,,,,,,,,,,,,,,Gravidity,,,,,,Pregnancy,
http://scai.fraunhofer.de/NDDUO#Symptoms,Symptom or sign,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,NDDUO:Symptoms,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/OGMS_0000020,,,,sign|signs|symptom|symptoms,,,,,,Symptom or sign,
http://www.pepathway.org/peo/1.2#Serum_total_HCG_measurement,Serum total HCG measurement,,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:Serum_total_HCG_measurement,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/167037004,,,,Serum total HCG level|Serum total human chorionic gonadotropin measurement|Measurement of serum total human chorionic gonadotrophin|Measurement of serum total human chorionic gonadotropin|Serum total human chorionic gonadotrophin measurement|Measurement of serum total human chorionic gonadotropin (procedure),,,,,,Serum total HCG measurement,
http://www.pepathway.org/peo/1.2#vitamin,vitamin,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Role,,peo2:vitamin,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_33229,,,,vitamins,,,,,,vitamin,
http://www.pepathway.org/peo/1.1#HCG26,HCG26,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:HCG26,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/352961,,,,,,,,,,,,,,,,,,,,HCG26,
http://scai.fraunhofer.de/NDDUO#Pathology,thing related to pathology,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_phenotypic_features,,NDDUO:Pathology,,,,,,,,,,,,,,,,,,,,,,,Preeclampsia-related pathological changes|Preeclampsia-related pathology,,,,,,thing related to pathology,
http://scai.fraunhofer.de/NDDUO#Clinical_trial,thing related to clinical trial,,,false,,,http://scai.fraunhofer.de/NDDUO#Clinical,,NDDUO:Clinical_trial,,,,,,,,,,,,,,,,,,,,,,,Community bases clinical trials|Clinical trial|CBCT,,,,,,thing related to clinical trial,
http://www.pepathway.org/peo/1.2#Pregnancy_Ectopic,"Pregnancy, Ectopic",,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Pregnancy_Ectopic,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D011271,,,,"Pregnancies, Extrauterine|Pregnancy, Extrauterine|Ectopic Pregnancies|Extrauterine Pregnancies|Extrauterine Pregnancy|Ectopic Pregnancy|Pregnancies, Ectopic",,,,"A potentially life-threatening condition in which EMBRYO IMPLANTATION occurs outside the cavity of the UTERUS. Most ectopic pregnancies (>96%) occur in the FALLOPIAN TUBES, known as TUBAL PREGNANCY. They can be in other locations, such as UTERINE CERVIX; OVARY; and abdominal cavity (PREGNANCY, ABDOMINAL).",,"Pregnancy, Ectopic",
http://scai.fraunhofer.de/NDDUO#Second_generation_migrant,Second generation migrant,,,false,,,http://scai.fraunhofer.de/NDDUO#Migrant_study,,NDDUO:Second_generation_migrant,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Second generation migrant,
http://www.pepathway.org/peo/1.2#Bariatric_Surgery,Bariatric Surgery,,,false,,,http://www.pepathway.org/peo/1.2#Therapeutics,,peo2:Bariatric_Surgery,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D050110,,,,"Bariatric Surgical Procedure|Bariatric Surgical Procedures|Surgery, Bariatric|Surgeries, Metabolic|Surgical Procedures, Bariatric|Bariatric Surgeries|Procedures, Bariatric Surgical|Stapling, Stomach|Surgical Procedure, Bariatric|Metabolic Surgeries|Stomach Stapling|Procedure, Bariatric Surgical|Metabolic Surgery|Surgery, Metabolic|Surgeries, Bariatric",,,,Surgical procedures aimed at affecting metabolism and producing major WEIGHT REDUCTION in patients with MORBID OBESITY.,,Bariatric Surgery,
http://www.pepathway.org/peo/1.2#Basement_membrane,Basement membrane,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Basement_membrane,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/68989006,,,,Basement membrane (body structure)|Membrana basalis|Basal lamina|External lamina,,,,,,Basement membrane,
http://scai.fraunhofer.de/NDDUO#Age_period_cohort_analysis,Age period cohort analysis,,,false,,,http://scai.fraunhofer.de/NDDUO#Cohort_study,,NDDUO:Age_period_cohort_analysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Age period cohort analysis,
http://scai.fraunhofer.de/NDDUO#Rodents,Rodent,,,false,,,http://scai.fraunhofer.de/NDDUO#Vertebrate,,NDDUO:Rodents,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9989,,,,Rodents,,,,,,Rodent,
http://www.ifomis.org/bfo/1.1/span#Process,process,,"Definition: A processual entity [span:ProcessualEntity] that is a maximally connected spatiotemporal whole and has bona fide beginnings and endings corresponding to real discontinuities.|Examples: the life of an organism, the process of sleeping, the process of cell-division",false,,,http://www.ifomis.org/bfo/1.1/span#ProcessualEntity,,span:Process,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Definition: A processual entity [span:ProcessualEntity] that is a maximally connected spatiotemporal whole and has bona fide beginnings and endings corresponding to real discontinuities.|Examples: the life of an organism, the process of sleeping, the process of cell-division",process,
http://www.pepathway.org/peo/1.2#phase_2B,phase 2B,,,false,,,http://scai.fraunhofer.de/NDDUO#phase_2,,peo2:phase_2B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,phase 2B,
http://www.pepathway.org/peo/1.2#phase_2A,phase 2A,,,false,,,http://scai.fraunhofer.de/NDDUO#phase_2,,peo2:phase_2A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,phase 2A,
http://www.pepathway.org/peo/1.2#Sepsis,Sepsis,,,false,,,http://www.pepathway.org/peo/1.2#Infection,,peo2:Sepsis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/91302008,,,,Sepsis (disorder)|Systemic infection,,,,,,Sepsis,
http://www.pepathway.org/peo/1.2#Entire_heart,Entire heart,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Entire_heart,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/302509004,,,,Entire heart (body structure)|Heart,,,,,,Entire heart,
http://www.pepathway.org/peo/1.2#metformin,metformin,,,false,,,http://www.pepathway.org/peo/1.2#drug,,peo2:metformin,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_6801,,,,"CN(C)C(=N)NC(N)=N|1,1-Dimethylbiguanide|InChI=1S/C4H11N5/c1-9(2)4(7)8-3(5)6/h1-2H3,(H5,5,6,7,8)|InChIKey=XZWYZXLIPXDOLR-UHFFFAOYSA-N|N,N-dimethylimidodicarbonimidic diamide|C4H11N5|Metformin",,,,"A member of the class of guanidines that is the 1,1-dimethyl derivative of biguanide.",,metformin,
http://www.pepathway.org/peo/1.2#study_subject,study subject,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Object,,peo2:study_subject,,,,,,,,,,,,,,,,,,,,,,,study subjects,,,,,,study subject,
http://www.pepathway.org/peo/1.2#Lipid_overload,Lipid overload,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Lipid_overload,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Lipid overload,
http://www.pepathway.org/peo/1.2#Dementia,Dementia,,,false,,,http://www.pepathway.org/peo/1.2#Brain_Diseases,,peo2:Dementia,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/52448006,,,,Organic dementia|Dementia (disorder),,,,,,Dementia,
http://www.pepathway.org/peo/1.2#Gave_up_during_pregnancy_(Alcohol_intake),Gave up during pregnancy (Alcohol intake),,,false,,,http://www.pepathway.org/peo/1.2#Alcohol_intake,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Gave up during pregnancy (Alcohol intake),
http://scai.fraunhofer.de/NDDUO#outcome_measure,outcome measure,,,false,,,http://scai.fraunhofer.de/NDDUO#Outcome|http://www.ifomis.org/bfo/1.1/snap#Quality,,NDDUO:outcome_measure,,,,,,,,,,,,,,,,,,,,,,,outcome measures,,,,,,outcome measure,
http://scai.fraunhofer.de/NDDUO#Epidemiology,thing related to epidemiology,,AD249,false,,,http://scai.fraunhofer.de/NDDUO#Clinical,,NDDUO:Epidemiology,,,,,,,,,,,,,,,,,,,,,,,Epidemiology,,,,,AD249,thing related to epidemiology,
http://www.pepathway.org/peo/1.1#LAIR2,LAIR2,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:LAIR2,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/3904,,,,,,,,,,,,,,,,,,,,LAIR2,
http://www.pepathway.org/peo/1.2#Platelet,Platelet,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:Platelet,,,,,,,,,,,,,,,,,,,,,,,Platelet (cell structure)|PLT - Platelet|PLT - Platelets|http://purl.bioontology.org/ontology/SNOMEDCT/16378004|Thrombocyte|Platelets,,,,,,Platelet,
http://www.pepathway.org/peo/1.2#eosin_YS_dye,eosin YS dye,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:eosin_YS_dye,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_52053,,,,"Eosine Yellowish|C20H6Br4Na2O5|[Na+].[Na+].[O-]C(=O)c1ccccc1-c1c2cc(Br)c([O-])c(Br)c2oc2c(Br)c(=O)c(Br)cc12|InChI=1S/C20H8Br4O5.2Na/c21-11-5-9-13(7-3-1-2-4-8(7)20(27)28)10-6-12(22)17(26)15(24)19(10)29-18(9)14(23)16(11)25;;/h1-6,25H,(H,27,28);;/q;2*+1/p-2|Acid red 87|InChIKey=SEACYXSIPDVVMV-UHFFFAOYSA-L|disodium 2-(2,4,5,7-tetrabromo-6-oxido-3-oxo-3H-xanthen-9-yl)benzoate|2',4',5',7'-Tetrabromo-3',6'-dihydroxyspiro(isobenzofuran-1(3H),9-'-(9H)xanthen)-3-one, disodium salt|Eosin Y|Eosine G",,,,An organobromine compound that has formula C20H6Br4Na2O5.,,eosin YS dye,
http://www.pepathway.org/peo/1.1#OR51G1,OR51G1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:OR51G1,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/79324,,,,,,,,,,,,,,,,,,,,OR51G1,
http://www.pepathway.org/peo/1.2#triglyceride,triglyceride,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:triglyceride,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_17855,,,,Triglyzerid|Triglycerid|Triglyceride|Triacylglycerol|triglycerides|[*]C(=O)OCC(COC([*])=O)OC([*])=O|triacylglycerols|a triacylglycerol|C6H5O6R3,,,,,,triglyceride,
http://www.pepathway.org/peo/1.2#Crude_incidence,Crude incidence,,AD303,false,,,http://www.pepathway.org/peo/1.2#Incidence,,peo2:Crude_incidence,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD303,Crude incidence,
http://www.pepathway.org/peo/1.2#Poor_education,Poor education,,,false,,,http://www.pepathway.org/peo/1.2#Education_and_schooling_detail,,peo2:Poor_education,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/105422001,,,,Poor education (finding),,,,,,Poor education,
http://scai.fraunhofer.de/NDDUO#Age_adjusted_mortality_rate,Age adjusted mortality rate,,,false,,,http://scai.fraunhofer.de/NDDUO#Mortility_rate,,NDDUO:Age_adjusted_mortality_rate,,,,,,,,,,,,,,,,,,,,,,,Age adjusted mortality rates,,,,,,Age adjusted mortality rate,
http://www.pepathway.org/peo/1.2#Haematological_disorders,Haematological disorders,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Haematological_disorders,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10018847,,,,Hematological disorders,,,,,,Haematological disorders,
http://www.pepathway.org/peo/1.2#Physiological_stress,Physiological stress,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Physiological_stress,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/260759008,,,,Physiological stress (attribute),,,,,,Physiological stress,
http://scai.fraunhofer.de/NDDUO#Case_study,Case study,,,false,,,http://scai.fraunhofer.de/NDDUO#Descriptive_study,,NDDUO:Case_study,,,,,,,,,,,,,,,,,,,,,,,Case studies,,,,,,Case study,
http://www.pepathway.org/peo/1.2#Toxic_causes,Toxic cause,,AD457,false,,,http://scai.fraunhofer.de/NDDUO#disease_cause,,peo2:Toxic_causes,,,,,,,,,,,,,,,,,,,,,,,Toxic causes,,,,,AD457,Toxic cause,
http://www.pepathway.org/peo/1.2#high-density_lipoprotein_cholesterol,high-density lipoprotein cholesterol,,,false,,,http://www.pepathway.org/peo/1.2#cholesterol,,peo2:high-density_lipoprotein_cholesterol,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_47775,,,,alpha-lipoprotein cholesterol|HDL cholesterol|HDL-C,,,,Cholesterol esters and free cholesterol which are contained in or bound to high-density lipoproteins (HDL).,,high-density lipoprotein cholesterol,
http://www.pepathway.org/peo/1.2#Capillary_lumens,Capillary lumens,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Capillary_lumens,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Capillary lumens,
http://www.pepathway.org/peo/1.2#Mid_pregnancy,Mid pregnancy,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_time_period,,peo2:Mid_pregnancy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mid pregnancy,
http://www.pepathway.org/peo/1.2#Crohns_disease,Crohn's disease,,,false,,,http://www.pepathway.org/peo/1.2#Inflammatory_disorder,,peo2:Crohns_disease,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/34000006,,,,Crohns disease|Crohn's disease (disorder)|CD - Crohn's disease|Granulomatous enteritis|Crohn's regional enteritis|Crohn disease|Regional enteritis|RE - Regional enteritis,,,,,,Crohn's disease,
http://www.pepathway.org/peo/1.2#Drug_abuse,Drug abuse,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Drug_abuse,,,,,,,,,,,,,,,,,,,,,,,,,,Drug abuse (disorder),,,Drug abuse,
http://www.pepathway.org/peo/1.2#Stage_2_systolic_hypertension,Stage 2 systolic hypertension,,,false,,,http://www.pepathway.org/peo/1.2#Hypertensive_disorder,,peo2:Stage_2_systolic_hypertension,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Stage 2 systolic hypertension,
http://www.pepathway.org/peo/1.2#Arteriosclerosis,Arteriosclerosis,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Arteriosclerosis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/28960008,,,,Arteriosclerosis (morphologic abnormality),,,,,,Arteriosclerosis,
http://www.pepathway.org/peo/1.1#LEMD1,LEMD1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:LEMD1,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/93273,,,,,,,,,,,,,,,,,,,,LEMD1,
http://www.pepathway.org/peo/1.2#Pro-inflammatory_mediators,Pro-inflammatory mediators,,,false,,,http://www.pepathway.org/peo/1.2#Molecular_rolls,,peo2:Pro-inflammatory_mediators,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pro-inflammatory mediators,
http://www.pepathway.org/peo/1.2#Body_measure,Body measure,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Body_measure,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/248326004,,,,Body measure (observable entity)|Body measurements,,,,,,Body measure,
http://www.pepathway.org/peo/1.1#LDLR,LDLR,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:LDLR,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/3949,,,,,,,,,,,,,,,,,,,,LDLR,
http://www.pepathway.org/peo/1.2#protein_synthesis,protein synthesis,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:protein_synthesis,,,,,,,,,,,,,,,,,,,,,,,cerebral protein synthesis|CPS|rCPS,,,,,,protein synthesis,
http://www.pepathway.org/peo/1.1#TIMPs,TIMPs,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:TIMPs,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D019714,,,,,,,,,,,,,,Tissue Inhibitor of Metalloproteinases|Metalloproteinases Tissue Inhibitor,,,,"A family of secreted protease inhibitory proteins that regulates the activity of SECRETED MATRIX METALLOENDOPEPTIDASES. They play an important role in modulating the proteolysis of EXTRACELLULAR MATRIX, most notably during tissue remodeling and inflammatory processes.",,TIMPs,
http://scai.fraunhofer.de/NDDUO#Recruitment_crieteria,Recruitment criterion,,check classifications of all subtypes and subtypes themselves!!!,false,,,http://www.ifomis.org/bfo/1.1/snap#GenericallyDependentContinuant,,NDDUO:Recruitment_crieteria,,,,,,,,,,,,,,,,,,,,,,,Recruitment criteria,,,,,check classifications of all subtypes and subtypes themselves!!!,Recruitment criterion,
http://www.pepathway.org/peo/1.1#SLAMF1,SLAMF1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:SLAMF1,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/6504,,,,,,,,,,,,,,,,,,,,SLAMF1,
http://www.pepathway.org/peo/1.2#Uterine_Artery,Uterine Artery,,,false,,,http://www.pepathway.org/peo/1.2#Entire_uterus,,peo2:Uterine_Artery,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D055988,,,,"Uterine Arteries|Arteries, Uterine|Artery, Uterine",,,,"A branch arising from the internal iliac artery in females, that supplies blood to the uterus.",,Uterine Artery,
http://www.pepathway.org/peo/1.2#perfluorooctane_sulfonic_acid,perfluorooctane sulfonic acid,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:perfluorooctane_sulfonic_acid,,,,,,,,,,,,,,,,,,,,,,,"perfluorooctane sulphonic acid|http://purl.bioontology.org/ontology/MESH/C076994|1-Octanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-|perfluorooctanyl sulfonate|Perfluorooctanesulfonate|PFOS compound|heptadecafluorooctane sulfonic acid|perfluorooctanesulfonic acid|perfluorooctane sulfonate|heptadecafluoro-1-octane sulfonic acid|PFOSA",,,,,,perfluorooctane sulfonic acid,
http://www.pepathway.org/peo/1.1#CAT,CAT,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:CAT,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/847,,,,,,,,,,,,,,,,,,,,CAT,
http://www.pepathway.org/peo/1.2#Diastolic_blood_pressure,Diastolic blood pressure,,,false,,,http://www.pepathway.org/peo/1.2#Blood_pressure_finding,,peo2:Diastolic_blood_pressure,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/271650006,,,,Diastolic blood pressure (observable entity)|Diastolic arterial pressure|DAP - Diastolic arterial pressure|DBP - Diastolic blood pressure,,,,,,Diastolic blood pressure,
http://www.pepathway.org/peo/1.2#Omental_Vessels,Omental Vessels,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Omental_Vessels,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Omental Vessels,
http://www.pepathway.org/peo/1.2#Macerated_stillbirth,Macerated stillbirth,,,false,,,http://www.pepathway.org/peo/1.2#Newborn_death,,peo2:Macerated_stillbirth,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/237366000,,,,Macerated stillbirth (finding),,,,,,Macerated stillbirth,
http://www.pepathway.org/peo/1.2#Education_currently_received,Education currently received,,,false,,,http://www.pepathway.org/peo/1.2#Education_and_schooling_detail,,peo2:Education_currently_received,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/224303005,,,,Education currently received (observable entity),,,,,,Education currently received,
http://www.pepathway.org/peo/1.2#Late_fetal_death,Late fetal death,,,false,,,http://www.pepathway.org/peo/1.2#Newborn_death,,peo2:Late_fetal_death,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Late fetal death,
http://scai.fraunhofer.de/NDDUO#cellular_context,cellular context,,,false,,,http://scai.fraunhofer.de/NDDUO#context,,NDDUO:cellular_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular context,
http://www.pepathway.org/peo/1.1#HMOX1,HMOX1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:HMOX1,,,,,,,,,,,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/3162,,,,,,,,,,HMOX1,
http://www.pepathway.org/peo/1.2#sleep_disorder,sleep disorder,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:sleep_disorder,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/39898005,,,,Sleep disorder (disorder),,,,,,sleep disorder,
http://www.pepathway.org/peo/1.2#antioxidant,antioxidant,,from NP chunking,false,,,http://scai.fraunhofer.de/NDDUO#drug_role,,peo2:antioxidant,,,,,,,,,http://en.wikipedia.org/wiki/Antioxidant,,,,,,,,,,,,,,antioxidants,,,,,from NP chunking,antioxidant,
http://www.pepathway.org/peo/1.2#Vesicular_transport,Vesicular transport,,AD508,false,,,http://www.pepathway.org/peo/1.2#processes_all_cells,,peo2:Vesicular_transport,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/GO#GO_0016192,,,,vesicular transport|vesicle transport,,,,,AD508,Vesicular transport,
http://www.pepathway.org/peo/1.1#CHI3L1,CHI3L1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:CHI3L1,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/1116,,,,,,,,,,,,,,,,,,,,CHI3L1,
http://www.pepathway.org/peo/1.2#Protein_misfolding,Protein misfolding,,AD611,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:Protein_misfolding,,,,,,,,,,,,,,,,,,,,,,,Protein misfoldings,,,,,AD611,Protein misfolding,
http://scai.fraunhofer.de/NDDUO#female,female,,,false,,,http://scai.fraunhofer.de/NDDUO#Gender,,NDDUO:female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,female,
http://www.pepathway.org/peo/1.2#hypertension,hypertension,,from NP chunking,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:hypertension,,,,,,,,,,,,,,,,,,,,,,,,,,,,from NP chunking,hypertension,
http://www.pepathway.org/peo/1.2#Heart_failure,Heart failure,,,false,,,http://www.pepathway.org/peo/1.2#Heart_disease,,peo2:Heart_failure,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/84114007,,,,Cardiac failure|Myocardial failure|HF - Heart failure|Cardiac insufficiency|Heart failure (disorder)|Weak heart,,,,,,Heart failure,
http://www.pepathway.org/peo/1.2#Cerebrovascular_Disorders,Cerebrovascular Disorders,,,false,,,http://www.pepathway.org/peo/1.2#Brain_Diseases,,peo2:Cerebrovascular_Disorders,,,,,,,,,,,,,,,,,,,,,,,"Cerebrovascular Occlusions|Intracranial Vascular Diseases|Vascular Disease, Intracranial|Cerebrovascular Insufficiency|Cerebrovascular Disorder|Vascular Disorder, Brain|Vascular Disorders, Intracranial|Vascular Diseases, Intracranial|Brain Vascular Disorders|Insufficiencies, Cerebrovascular|Cerebrovascular Occlusion|Brain Vascular Disorder|Occlusions, Cerebrovascular|Insufficiency, Cerebrovascular|Vascular Disorder, Intracranial|Intracranial Vascular Disease|Cerebrovascular Insufficiencies|Vascular Disorders, Brain|Occlusion, Cerebrovascular|Intracranial Vascular Disorder|Intracranial Vascular Disorders",,,,,,Cerebrovascular Disorders,
http://www.pepathway.org/peo/1.2#Maternal_near_miss,Maternal near miss,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Maternal_near_miss,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maternal near miss,
http://www.pepathway.org/peo/1.2#Born_from_pre-eclamptic_mother,Born from pre-eclamptic mother,,,false,,,http://www.pepathway.org/peo/1.2#Basic_attribute_on_pregnancy,,peo2:Born_from_pre-eclamptic_mother,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Born from pre-eclamptic mother,
http://www.pepathway.org/peo/1.2#Oxidative_stress,Oxidative stress,,AD601,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:Oxidative_stress,,,,,,,,,,,,,,,,,,,,,,,oxidative damage,,,,,AD601,Oxidative stress,
http://www.pepathway.org/peo/1.2#Family_history_of_cardiovascular_disease,Family history of cardiovascular disease,,,false,,,http://www.pepathway.org/peo/1.2#Family_History,,peo2:Family_history_of_cardiovascular_disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Family history of cardiovascular disease,
http://www.pepathway.org/peo/1.2#Gave_up_during_pregnancy,Gave up during pregnancy,,,false,,,http://www.pepathway.org/peo/1.2#Maternal_tobacco_use,,peo2:Gave_up_during_pregnancy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Gave up during pregnancy,
http://www.pepathway.org/peo/1.2#Regularly_used,Regularly used,,,false,,,http://www.pepathway.org/peo/1.2#Maternal_tobacco_use,,peo2:Regularly_used,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Regularly used,
http://www.pepathway.org/peo/1.2#Angioedema,Angioedema,,,false,,,http://www.pepathway.org/peo/1.2#Edema,,peo2:Angioedema,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/41291007,,,,Quincke's disease|Quincke's edema|Angioneurotic edema|Angio-oedema|Urticaria-angio-oedema|Angioneurotic oedema|Angioedema (disorder)|Giant urticaria|Quincke's oedema|Angio-oedema-urticaria|Angioedema-urticaria|Urticaria-angioedema,,,,,,Angioedema,
http://www.pepathway.org/peo/1.2#thing_related_to_social_factors,thing related to social factors,,,false,,,http://www.pepathway.org/peo/1.2#Environmental_features,,peo2:thing_related_to_social_factors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to social factors,
http://www.pepathway.org/peo/1.2#Cannabis_abuse,Cannabis abuse,,,false,,,http://www.pepathway.org/peo/1.2#Drug_abuse,,peo2:Cannabis_abuse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Cannabis abuse,
http://www.pepathway.org/peo/1.2#mixed,Mixed racial group,,,false,,,http://scai.fraunhofer.de/NDDUO#Race,,peo2:mixed,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/414752008,,,,Mixed racial group (racial group),,,,,,Mixed racial group,
http://www.pepathway.org/peo/1.1#KLRK1,KLRK1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:KLRK1,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/22914,,,,,,,,,,,,,,,,,,,,KLRK1,
http://scai.fraunhofer.de/NDDUO#stage_context,stage context,,,false,,,http://scai.fraunhofer.de/NDDUO#pathogenesis_context|http://scai.fraunhofer.de/NDDUO#etiological_context,,NDDUO:stage_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,stage context,
http://www.pepathway.org/peo/1.2#Proteinuria,Proteinuria,,,false,,,http://scai.fraunhofer.de/NDDUO#Symptoms,,peo2:Proteinuria,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/29738008,,,,Proteinuria (finding)|Abnormal presence of protein in urine,,,,,,Proteinuria,
http://www.pepathway.org/peo/1.2#Asthma,Asthma,,,false,,,http://www.pepathway.org/peo/1.2#Inflammatory_disorder,,peo2:Asthma,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/195967001,,,,Bronchial asthma|Bronchial hyperreactivity|Hyperreactive airway disease|Asthma (disorder)|Airway hyperreactivity|Bronchial hyperresponsiveness|Bronchial hypersensitivity|BHR - Bronchial hyperreactivity|Asthmatic,,,,,,Asthma,
http://scai.fraunhofer.de/NDDUO#in_silico_context,in silico context,,,false,,,http://scai.fraunhofer.de/NDDUO#context,,NDDUO:in_silico_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,in silico context,
http://www.pepathway.org/peo/1.2#perfluoroundecanoic_acid,perfluoroundecanoic acid,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:perfluoroundecanoic_acid,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/C586085,,,,PFUA compound,,,,,,perfluoroundecanoic acid,
http://www.pepathway.org/peo/1.2#Hydatidiform_mole,Hydatidiform mole,,,false,,,http://www.pepathway.org/peo/1.2#Gestational_trophoblastic_disease,,peo2:Hydatidiform_mole,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/48430004,,,,"Hydatid mole|Complete hydatidiform mole|Hydatidiform mole, no ICD-O subtype|Hydatidiform mole, no International Classification of Diseases for Oncology subtype|Hydatidiform mole, no International Classification of Diseases for Oncology subtype (morphologic abnormality)",,,,,,Hydatidiform mole,
http://scai.fraunhofer.de/NDDUO#Outcome,Thing related to outcome,,,false,,,http://scai.fraunhofer.de/NDDUO#Clinical_trial,,NDDUO:Outcome,,,,,,,,,,,,,,,,,,,,,,,outcome,,,,,,Thing related to outcome,
http://www.pepathway.org/peo/1.2#Hyperemesis,Hyperemesis,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Hyperemesis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/444673007,,,,Hyperemesis (disorder),,,,,,Hyperemesis,
http://www.pepathway.org/peo/1.1#ESR1,ESR1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:ESR1,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/2099,,,,,,,,,,,,,,,,,,,,ESR1,
http://www.pepathway.org/peo/1.1#ESR2,ESR2,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:ESR2,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/2100,,,,,,,,,,,,,,,,,,,,ESR2,
http://www.pepathway.org/peo/1.2#Previous_miscarriage,Previous miscarriage,,,false,,,http://www.pepathway.org/peo/1.2#Medical_history,,peo2:Previous_miscarriage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Previous miscarriage,
http://www.pepathway.org/peo/1.2#Newborn_death,Newborn death,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:Newborn_death,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/276506001,,,,Neonatal death|Newborn death (event),,,,,,Newborn death,
http://www.pepathway.org/peo/1.2#Transfection_cells,Transfection cells model,,AD645,false,,,http://scai.fraunhofer.de/NDDUO#In_vitro_models,,peo2:Transfection_cells,,,,,,,,,,,,,,,,,,,,,,,Transfection cells models,,,,,AD645,Transfection cells model,
http://www.pepathway.org/peo/1.1#HSP90B1,HSP90B1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:HSP90B1,,,,,,,,,,,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/7184,,,,,,,,,,HSP90B1,
http://www.pepathway.org/peo/1.2#Uterotonic,Uterotonic,,,false,,,http://www.pepathway.org/peo/1.2#Therapeutics,,peo2:Uterotonic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Uterotonic,
http://www.ifomis.org/bfo/1.1/span#TemporalRegion,temporal_region,,"Comment: An instance of temporal region [span:TemporalRegion] is a part of time. All parts of time are temporal region [span:TemporalRegion] entities and only temporal region [span:TemporalRegion] entities are parts of time. Time is the entire extent of the temporal universe, a designated individual, which is thus a temporal region itself.|Comment: All instances of occurrent [span:Occurrent] are temporal entities, that is, they enter in the relation of (temporal) location with temporal region [span:TemporalRegion] entities. As a particular case, the exact spatiotemporal location of a temporal region [span:TemporalRegion] is this region itself. Continuant [snap:Continuant] entities are not temporal entities in the technical sense just explained; they are related to time in a different way, not through temporal location but through a relation of existence at a time or during a period of time (see continuant [snap:Continuant].|Examples: the time it takes to run a marathon, the duration of a surgical procedure, the moment of death|Comment: Time and temporal region [span:TemporalRegion] entities are entities in their own rights which exist independently of any entities which can be located at them. This view of time can be called ""absolutist"" or ""the container view"" in analogy to what is traditionally the case with space (see spatial region [snap:SpatialRegion].|Definition: An occurrent [span:Occurrent] that is part of time.",false,,,http://www.ifomis.org/bfo/1.1/span#Occurrent,,span:TemporalRegion,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Comment: An instance of temporal region [span:TemporalRegion] is a part of time. All parts of time are temporal region [span:TemporalRegion] entities and only temporal region [span:TemporalRegion] entities are parts of time. Time is the entire extent of the temporal universe, a designated individual, which is thus a temporal region itself.|Comment: All instances of occurrent [span:Occurrent] are temporal entities, that is, they enter in the relation of (temporal) location with temporal region [span:TemporalRegion] entities. As a particular case, the exact spatiotemporal location of a temporal region [span:TemporalRegion] is this region itself. Continuant [snap:Continuant] entities are not temporal entities in the technical sense just explained; they are related to time in a different way, not through temporal location but through a relation of existence at a time or during a period of time (see continuant [snap:Continuant].|Examples: the time it takes to run a marathon, the duration of a surgical procedure, the moment of death|Comment: Time and temporal region [span:TemporalRegion] entities are entities in their own rights which exist independently of any entities which can be located at them. This view of time can be called ""absolutist"" or ""the container view"" in analogy to what is traditionally the case with space (see spatial region [snap:SpatialRegion].|Definition: An occurrent [span:Occurrent] that is part of time.",temporal_region,
http://www.pepathway.org/peo/1.2#Potassium_transport,Potassium transport,,AD608,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:Potassium_transport,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/GO#GO_0006813,,,,K+ conductance|potassium transport,,,,,AD608,Potassium transport,
http://www.pepathway.org/peo/1.2#LVEDP,LVEDP,,,false,,,http://www.pepathway.org/peo/1.2#Echocardiography,,peo2:LVEDP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,LVEDP,
http://scai.fraunhofer.de/NDDUO#thing_related_to_surgery,thing related to surgery,,,false,,,http://www.ifomis.org/bfo/1.1#Entity|http://scai.fraunhofer.de/NDDUO#Non_pharmacotherapy,,NDDUO:thing_related_to_surgery,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to surgery,
http://www.pepathway.org/peo/1.2#Brain_Diseases,Brain Diseases,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Brain_Diseases,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D001927,,,,"Brain Disorder|Brain Disorders|Central Nervous System Disorders, Intracranial|Central Nervous System Intracranial Disorders|CNS Disorders, Intracranial|Intracranial CNS Disorder|Encephalon Disease|Encephalon Diseases|Intracranial Central Nervous System Disorders|CNS Disorder, Intracranial|Brain Disease|Intracranial CNS Disorders",,,,,,Brain Diseases,
http://www.pepathway.org/peo/1.2#Partial_Thromboplastin_Time,Partial Thromboplastin Time,,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:Partial_Thromboplastin_Time,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D010314,,,,"Coagulation Time, Cephalin Kaolin|Coagulation Time, Cephalin-Kaolin|Cephalin Kaolin Coagulation Time|Kaolin Cephalin Coagulation Time|Activated Partial Thromboplastin Time|Coagulation Time, Kaolin-Cephalin|Kaolin-Cephalin Coagulation Time|Thromboplastin Time, Partial|Cephalin-Kaolin Coagulation Time",,,,"The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy.",,Partial Thromboplastin Time,
http://www.w3.org/2002/07/owl#Thing,Thing,,,false,,,,,owl:Thing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://www.pepathway.org/peo/1.2#Induced_labour,Induced labour,,,false,,,http://www.pepathway.org/peo/1.2#Therapeutics,,peo2:Induced_labour,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10021718,,,,,,,,,,Induced labour,
http://www.pepathway.org/peo/1.2#Middle_cerebral_artery,Middle cerebral artery,,,false,,,http://www.pepathway.org/peo/1.2#Echocardiography,,peo2:Middle_cerebral_artery,,,,,,,,,,,,,,,,,,,,,,,MCA,,,,,,Middle cerebral artery,
http://www.pepathway.org/peo/1.2#Labyrinth_zone,Labyrinth zone,,,false,,,http://www.pepathway.org/peo/1.2#Entire_placenta,,peo2:Labyrinth_zone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Labyrinth zone,
http://www.pepathway.org/peo/1.2#apoptotic_signalling,apoptotic signalling,,from manual annotation of text corpus,false,,,http://scai.fraunhofer.de/NDDUO#Cell_cell_interaction,,peo2:apoptotic_signalling,,,,,,,,,,,,,,,,,,,,,,,,,,,,from manual annotation of text corpus,apoptotic signalling,
http://www.pepathway.org/peo/1.2#Large_for_gestational_age,Large for gestational age,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:Large_for_gestational_age,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/OMIM/MTHU005715,,,,,,,,,,Large for gestational age,
http://www.pepathway.org/peo/1.1#SOD,SOD,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:SOD,,,,,,,,,,,,,,,,,,,,,,,Superoxide Dismutase,,,,,,SOD,
http://www.pepathway.org/peo/1.2#Recurrent_miscarriage,Recurrent miscarriage,,,false,,,http://www.pepathway.org/peo/1.2#Miscarriage,,peo2:Recurrent_miscarriage,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/102878001,,,,Recurrent miscarriage (disorder)|Recurrent aborter|Habitual aborter|Recurrent abortion|Habitual abortion,,,,,,Recurrent miscarriage,
http://www.pepathway.org/peo/1.1#SLC1A5,SLC1A5,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:SLC1A5,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/6510,,,,,,,,,,,,,,,,,ASCT2,,,SLC1A5,
http://www.pepathway.org/peo/1.1#SLC1A4,SLC1A4,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:SLC1A4,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/6509,,,,,,,,,,,,,,,,,ASCT1,,,SLC1A4,
http://scai.fraunhofer.de/NDDUO#inhibitor,inhibitor,,,false,,,http://scai.fraunhofer.de/NDDUO#drug_role,,NDDUO:inhibitor,,,,,,,,,,,,,,,,,,,,,,,inhibitors,,,,,,inhibitor,
http://www.pepathway.org/peo/1.2#Later_in_life,Later in life,,,false,,,http://www.ifomis.org/bfo/1.1/span#ConnectedTemporalRegion,,peo2:Later_in_life,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Later in life,
http://scai.fraunhofer.de/NDDUO#Molecular_entities,Molecular entity,,,false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,NDDUO:Molecular_entities,,,,,,,,,,,,,,,,,,,,,,,molecular entity|molecular entities,,,,,,Molecular entity,
http://www.ifomis.org/bfo/1.1/span#SpatiotemporalInstant,spatiotemporal_instant,,Examples: the spatiotemporal region occupied by a single instantaneous temporal slice (part) of a process|Definition: A connected spatiotemporal region [span:ConnectedSpatiotemporalRegion] at a specific moment.,false,,,http://www.ifomis.org/bfo/1.1/span#ConnectedSpatiotemporalRegion,,span:SpatiotemporalInstant,,,,,,,,,,,,,,,,,,,,,,,,,,,,Examples: the spatiotemporal region occupied by a single instantaneous temporal slice (part) of a process|Definition: A connected spatiotemporal region [span:ConnectedSpatiotemporalRegion] at a specific moment.,spatiotemporal_instant,
http://www.pepathway.org/peo/1.2#thing_related_to_precursor,thing related to precursor,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_transcript,,peo2:thing_related_to_precursor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to precursor,
http://www.pepathway.org/peo/1.2#Obstetric_uterine_artery_Doppler,Obstetric uterine artery Doppler,,,false,,,http://www.pepathway.org/peo/1.2#Doppler_studies,,peo2:Obstetric_uterine_artery_Doppler,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/426295007,,,,Obstetric uterine artery Doppler (procedure)|Doppler ultrasound scan of uterine artery,,,,,,Obstetric uterine artery Doppler,
http://www.pepathway.org/peo/1.2#Methadone_abuse,Methadone abuse,,,false,,,http://www.pepathway.org/peo/1.2#Drug_abuse,,peo2:Methadone_abuse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Methadone abuse,
http://www.pepathway.org/peo/1.2#anti-LTBR,anti-LTBR,,,false,,,http://www.pepathway.org/peo/1.2#Antibody,,peo2:anti-LTBR,,,,,,,,,,,,,,,,,,,,,,,LTBR antibody,,,,,,anti-LTBR,
http://www.pepathway.org/peo/1.2#Placental_uterine_interface,Placental uterine interface,,,false,,,http://www.pepathway.org/peo/1.2#Entire_placenta,,peo2:Placental_uterine_interface,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Placental uterine interface,
http://www.pepathway.org/peo/1.2#Stopped_smoking,Stopped smoking,,,false,,,http://www.pepathway.org/peo/1.2#Maternal_tobacco_use,,peo2:Stopped_smoking,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/160617001,,,,Stopped smoking (finding),,,,,,Stopped smoking,
http://www.pepathway.org/peo/1.1#EDNRB,EDNRB,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:EDNRB,,,,,,,,,,,,,,,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/1910,,,,,,EDNRB,
http://www.ifomis.org/bfo/1.1/span#Occurrent,occurrent,,"Definition: An entity [bfo:Entity] that has temporal parts and that happens, unfolds or develops through time. Sometimes also called perdurants.|Synonyms: perdurant|Examples: the life of an organism, a surgical operation as processual context for a nosocomical infection, the spatiotemporal context occupied by a process of cellular meiosis, the most interesting part of Van Gogh's life, the spatiotemporal region occupied by the development of a cancer tumor",false,,,http://www.ifomis.org/bfo/1.1#Entity,,span:Occurrent,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Definition: An entity [bfo:Entity] that has temporal parts and that happens, unfolds or develops through time. Sometimes also called perdurants.|Synonyms: perdurant|Examples: the life of an organism, a surgical operation as processual context for a nosocomical infection, the spatiotemporal context occupied by a process of cellular meiosis, the most interesting part of Van Gogh's life, the spatiotemporal region occupied by the development of a cancer tumor",occurrent,
http://www.pepathway.org/peo/1.2#Fetal_lung_maturation,Fetal lung maturation,,,false,,,http://www.pepathway.org/peo/1.2#Developmental,,peo2:Fetal_lung_maturation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Fetal lung maturation,
http://www.pepathway.org/peo/1.2#Enviornmental_causes,Environmental cause,,AD459,false,,,http://www.pepathway.org/peo/1.2#Toxic_causes,,peo2:Enviornmental_causes,,,,,,,,,,,,,,,,,,,http://www.ebi.ac.uk/efo/EFO_0000469,,,,Environmental causes|environmental factor|environmental factors,,,,,AD459,Environmental cause,
http://www.pepathway.org/peo/1.2#Plasma_cell,Plasma cell,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:Plasma_cell,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/113335003,,,,Plasma cell (cell)|Plasmacyte|Plasmocyte,,,,,,Plasma cell,
http://www.pepathway.org/peo/1.2#thing_related_to_protein,thing related to protein,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_transcript,,peo2:thing_related_to_protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to protein,
http://www.pepathway.org/peo/1.2#wk16_20,16-20 wk,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_time_period,,peo2:wk16_20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16-20 wk,
http://www.pepathway.org/peo/1.2#Postpartum_hemorrhage,Postpartum hemorrhage,,,false,,,http://www.pepathway.org/peo/1.2#Haemorrhage_finding,,peo2:Postpartum_hemorrhage,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/47821001,,,,Postpartum hemorrhage (disorder)|PPH - Postpartum hemorrhage|Postpartum haemorrhage|Haemorrhage after delivery of foetus|PPH - Postpartum haemorrhage|Bleeding postpartum|Hemorrhage after delivery of fetus,,,,,,Postpartum hemorrhage,
http://www.pepathway.org/peo/1.2#Splicing_variants,regulation via splicing variants,,AD615,false,,,http://www.pepathway.org/peo/1.2#Regulation_of_transcription,,peo2:Splicing_variants,,,,,,,,,,,,,,,,,,,,,,,Splicing variant,,,,,AD615,regulation via splicing variants,
http://www.pepathway.org/peo/1.2#Pregnancy-induced_hypertension,Pregnancy-induced hypertension,,,false,,,http://www.pepathway.org/peo/1.2#Hypertension_associated_disorders_of_pregnancy,,peo2:Pregnancy-induced_hypertension,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/48194001,,,,"Hypertension complicating childbirth|Pregnancy-induced hypertension (disorder)|PIH - Pregnancy-induced hypertension|Hypertension complicating pregnancy|GH - Gestational hypertension|Gestational hypertension|Hypertension induced by pregnancy|Hypertension complicating pregnancy, childbirth AND/OR puerperium|Hypertension in the obstetric context|Unspecified hypertension complicating pregnancy, childbirth or puerperium",,,,,,Pregnancy-induced hypertension,
http://www.pepathway.org/peo/1.2#Glomerular_dysfunction,Glomerular dysfunction (variable),,,false,,,http://www.pepathway.org/peo/1.2#Kidney_disease,,peo2:Glomerular_dysfunction,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/OMIM/MTHU031506,,,,,,,,,,Glomerular dysfunction (variable),
http://www.pepathway.org/peo/1.2#Upper_class_economic_status,Upper class economic status,,,false,,,http://www.pepathway.org/peo/1.2#Economic_status,,peo2:Upper_class_economic_status,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/85483007,,,,high regional economic status|high socio economic status|high socioeconomic status|Upper class economic status (social concept),,,,,,Upper class economic status,
http://www.pepathway.org/peo/1.2#Blood_Transfusion,Blood Transfusion,,,false,,,http://www.pepathway.org/peo/1.2#Therapeutics,,peo2:Blood_Transfusion,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D001803,,,,"Transfusion, Blood|Transfusions, Blood|Blood Transfusions",,,,"The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed)",,Blood Transfusion,
http://www.pepathway.org/peo/1.2#Capillary_space,Capillary space,,,false,,,http://www.pepathway.org/peo/1.2#Entire_kidney,,peo2:Capillary_space,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Capillary space,
http://www.pepathway.org/peo/1.2#Endocrine_disorder,Endocrine disorder,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Endocrine_disorder,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10014695,,,,,,,,,,Endocrine disorder,
http://www.pepathway.org/peo/1.2#At_discharge_from_hospital,At discharge from hospital,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_time_period,,peo2:At_discharge_from_hospital,,,,,,,,,,,,,,,,,,,,,,,,,,,,,At discharge from hospital,
http://www.pepathway.org/peo/1.1#ACHE,ACHE,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:ACHE,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/43,,,,,,,,,,,,,,,,,,,,ACHE,
http://scai.fraunhofer.de/NDDUO#prevalence_context,prevalence context,,,false,,,http://scai.fraunhofer.de/NDDUO#descriptive_statistical_context,,NDDUO:prevalence_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,prevalence context,
http://www.pepathway.org/peo/1.2#Polyhydramnios,Polyhydramnios,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Polyhydramnios,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/86203003,,,,Excessive liquor|Polyhydramnios (disorder)|Hydramnios,,,,,,Polyhydramnios,
http://www.pepathway.org/peo/1.2#Previous_SGA,Previous SGA,,,false,,,http://www.pepathway.org/peo/1.2#Medical_history,,peo2:Previous_SGA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Previous SGA,
http://www.pepathway.org/peo/1.2#older_than_marriageable_age,older than marriageable age,,,false,,,http://www.pepathway.org/peo/1.2#Age_at_onset,,peo2:older_than_marriageable_age,,,,,,,,,,,,,,,,,,,,,,,high maternal age|increased maternal age|older than 35 years old,,,,,,older than marriageable age,
http://www.pepathway.org/peo/1.2#Antibody,Antibody,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:Antibody,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/68498002,,,,Antibody (substance),,,,,,Antibody,
http://scai.fraunhofer.de/NDDUO#non_pharma_therapy,non-pharma therapy,,,false,,,http://www.ifomis.org/bfo/1.1/span#Process|http://scai.fraunhofer.de/NDDUO#Non_pharmacotherapy,,NDDUO:non_pharma_therapy,,,,,,,,,,,,,,,,,,,,,,,non-pharma therapies,,,,,,non-pharma therapy,
http://www.pepathway.org/peo/1.1#IL10,IL10,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:IL10,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/3586,,,,,,,,,,,,,,,,,,,,IL10,
http://www.pepathway.org/peo/1.1#IL1A,IL1A,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:IL1A,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/3552,,,,,,,,,,,,,,,,,,,,IL1A,
http://www.pepathway.org/peo/1.2#Cumulative_incidence_rate,Cumulative incidence rate,,AD305,false,,,http://www.pepathway.org/peo/1.2#Cumulative_incidence,,peo2:Cumulative_incidence_rate,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD305,Cumulative incidence rate,
http://www.pepathway.org/peo/1.2#Prenatal_Nutritional_Physiological_Phenomena,Prenatal Nutritional Physiological Phenomena,,,false,,,http://www.pepathway.org/peo/1.2#Nutritional_condition,,peo2:Prenatal_Nutritional_Physiological_Phenomena,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D039401,,,,"Prenatal Nutritional Physiology|Nutrition Physiology, Prenatal|Prenatal Nutritional Physiological Phenomenon|Physiology, Prenatal Nutritional|Nutrition During Pregnancy|Pregnancy Nutrition|Nutrition, Pregnancy|Physiology, Prenatal Nutrition|Prenatal Nutrition Physiology|Nutritional Physiology, Prenatal",,,,Nutrition of FEMALE during PREGNANCY.,,Prenatal Nutritional Physiological Phenomena,
http://scai.fraunhofer.de/NDDUO#Anatomical,Anatomical entity,,,false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,NDDUO:Anatomical,,,,,,,,,,,,,,,,,,,,,,,Anatomical entities|Anatomical,,,,,,Anatomical entity,
http://www.pepathway.org/peo/1.2#Lipid_metabolism,Lipid metabolism,,AD600,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:Lipid_metabolism,,,,,,,,,,,,,,,,,,,,,,,lipid metabolism,,,,,AD600,Lipid metabolism,
http://www.pepathway.org/peo/1.2#ischemic_lesion,ischemic lesion,,from manual annotation of text corpus,false,,,http://www.pepathway.org/peo/1.2#Morphologically_abnormal_structure,,peo2:ischemic_lesion,,,,,,,,,,,,,,,,,,,,,,,ischemic lesions,,,,,from manual annotation of text corpus,ischemic lesion,
http://www.pepathway.org/peo/1.2#thing_related_to_outcome_of_child,thing related to outcome of child,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_outcomes,,peo2:thing_related_to_outcome_of_child,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to outcome of child,
http://www.pepathway.org/peo/1.2#Endoplasmic_Reticulum_Stress,Endoplasmic Reticulum Stress,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:Endoplasmic_Reticulum_Stress,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D059865,,,,"Reticulum Stress, Endoplasmic|Endoplasmic Reticulum Stresses|Stress, Endoplasmic Reticulum|Stresses, Endoplasmic Reticulum|Reticulum Stresses, Endoplasmic",,,,"Various physiological or molecular disturbances that impair ENDOPLASMIC RETICULUM function. It triggers many responses, including UNFOLDED PROTEIN RESPONSE, which may lead to APOPTOSIS; and AUTOPHAGY.",,Endoplasmic Reticulum Stress,
http://www.pepathway.org/peo/1.2#Parity,Parity,,,false,,,http://www.pepathway.org/peo/1.2#Basic_attribute_on_pregnancy,,peo2:Parity,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/364325004,,,,Parity (observable entity),,,,,,Parity,
http://www.pepathway.org/peo/1.2#Employment_detail,Employment detail,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Employment_detail,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/364703007,,,,Employment detail (observable entity),,,,,,Employment detail,
http://www.pepathway.org/peo/1.2#Reproductive_Techniques_Assisted,"Reproductive Techniques, Assisted",,,false,,,http://www.pepathway.org/peo/1.2#Therapeutics,,peo2:Reproductive_Techniques_Assisted,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D027724,,,,Assisted Reproductive Techniques|ART,,,,,,"Reproductive Techniques, Assisted",
http://www.pepathway.org/peo/1.2#Protein_aggregation,Protein aggregation,,AD609,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:Protein_aggregation,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD609,Protein aggregation,
http://www.pepathway.org/peo/1.1#CORIN,CORIN,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:CORIN,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/10699,,,,,,,,,,,,,,,,,,,,CORIN,
http://www.pepathway.org/peo/1.2#Blood_cell,Blood cell,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:Blood_cell,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/63370004,,,,Blood cell (cell),,,,,,Blood cell,
http://www.pepathway.org/peo/1.2#Cardiac_output,Cardiac output,,,false,,,http://www.pepathway.org/peo/1.2#Echocardiography,,peo2:Cardiac_output,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/82799009,,,,CO - Cardiac output|Cardiac output (observable entity),,,,,,Cardiac output,
http://www.pepathway.org/peo/1.1#SSTR1,SSTR1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:SSTR1,,,,,,,,,,,,,,,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/6751,,,,,,SSTR1,
http://www.pepathway.org/peo/1.1#TNF,TNF,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:TNF,,,,,,,,,http://purl.bioontology.org/ontology/MESH/C439524,,,,,,,,,,,,,,"TNF protein, human|tumor necrosis factor, human|TNF superfamily, member 2 protein, human|tumor necrosis factor-alpha promoter allele-2 protein, human|tumor necrosis factor 2 protein, human|TNFSF2 protein, human|tumor necrosis factor-2 protein, human|TNF-2 protein, human",,,,,,TNF,
http://www.pepathway.org/peo/1.2#isoflurane,isoflurane,,,false,,,http://www.pepathway.org/peo/1.2#drug,,peo2:isoflurane,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_6015,,,,"InChIKey=PIWKPBJCKXDKJR-UHFFFAOYSA-N|isofluranum|FC(F)OC(Cl)C(F)(F)F|1-chloro-2,2,2-trifluoroethyl difluoromethyl ether|2-chloro-2-difluoromethoxy-1,1,1-trifluoroethane|InChI=1S/C3H2ClF5O/c4-1(3(7,8)9)10-2(5)6/h1-2H|Aerrane|C3H2ClF5O|Ethane|Forane|Forene|Isoflurane|isoflurane|isoflurano",,,,An organofluorine compound that has formula C3H2ClF5O.,,isoflurane,
http://www.pepathway.org/peo/1.2#Placental_implantation,Placental implantation,,,false,,,http://www.pepathway.org/peo/1.2#Placentation,,peo2:Placental_implantation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Placental implantation,
http://www.pepathway.org/peo/1.2#Blood_Transfusion_in_life-time,Blood Transfusion in life-time,,,false,,,http://www.pepathway.org/peo/1.2#Blood_Transfusion,,peo2:Blood_Transfusion_in_life-time,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Blood Transfusion in life-time,
http://www.pepathway.org/peo/1.2#Exceptionally_large_at_birth,Exceptionally large at birth,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_fetus_or_newborn,,peo2:Exceptionally_large_at_birth,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/38206000,,,,Macrosomic baby|Exceptionally large at birth (disorder)|Fetal giant|Macrosomic infant|Birth weight 4500 grams OR more|Hypertrophic baby|Macrosomia,,,,,,Exceptionally large at birth,
http://www.pepathway.org/peo/1.1#FLT1,FLT1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:FLT1,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/2321,,,,,,,,,,,,,,,,,,,,FLT1,
http://www.pepathway.org/peo/1.1#SLC17A5,SLC17A5,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:SLC17A5,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/26503,,,,,,,,,,,,,,,,,,,,SLC17A5,
http://www.pepathway.org/peo/1.2#Endothelium-derived_hyperpolarizing_factor,Endothelium-derived hyperpolarizing factor,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:Endothelium-derived_hyperpolarizing_factor,,,,,,,,,,,,,,,,,,,,,,,EDHF,,,,,,Endothelium-derived hyperpolarizing factor,
http://www.pepathway.org/peo/1.2#HIV,HIV,,,false,,,http://www.pepathway.org/peo/1.2#Infection,,peo2:HIV,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D006678,,,,AIDS Viruses,,,,,,HIV,
http://www.pepathway.org/peo/1.2#bilirubin,bilirubin,,,false,,,http://www.pepathway.org/peo/1.2#drug,,peo2:bilirubin,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_16990,,,,"2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropanoic acid|2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-1,10,19,22,23,24-hexahydro-21H-biline-8,12-dipropanoic acid|InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-14,34-35H,1-2,9-12,15H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-|1,10,19,22,23,24-hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinylbiline-8,12-dipropionic acid|CC1=C(C=C)C(NC1=O)=C\c1[nH]c(Cc2[nH]c(\C=C3NC(=O)C(C=C)=C/3C)c(C)c2CCC(O)=O)c(CCC(O)=O)c1C|InChIKey=BPYKTIZUTYGOLE-IFADSCNNSA-N|8,12-bis(2-carboxyethyl)-2,7,13,17-tetramethyl-3,18-divinylbiladiene-ac-1,19(21H,24H)-dione|bilirubin IXalpha|Bilirubin|C33H36N4O6|bilirubin",,,,"A member of the class of biladienes that is a linear tetrapyrrole, product of heme degradation. It is produced in the reticuloendothelial system by the reduction of biliverdin and transported to the liver as a complex with serum albumin.",,bilirubin,
http://www.pepathway.org/peo/1.2#Chronic_active_hepatitis,Chronic active hepatitis,,,false,,,http://www.pepathway.org/peo/1.2#Hepatic_disease,,peo2:Chronic_active_hepatitis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/OMIM/MTHU012239,,,,,,,,,,Chronic active hepatitis,
http://www.pepathway.org/peo/1.2#adrenaline,adrenaline,,,false,,,http://www.pepathway.org/peo/1.2#hormone,,peo2:adrenaline,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_33568,,,,"InChIKey=UCTWMZQNUQWSLP-UHFFFAOYSA-N|racepinefrinum|(+-)-adrenaline|dl-adrenaline|InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3|racepinefrina|racepinefrine|epinephrine racemic|2-(methylamino)-1-(3,4-dihydroxyphenyl)ethanol|4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol|CNCC(O)c1ccc(O)c(O)c1|(+-)-epinephrine|C9H13NO3",,,,A catecholamine in which the aminoethyl side-chain is hydroxy-substituted at C-1 and methylated on nitrogen.,,adrenaline,
http://www.pepathway.org/peo/1.2#Blue-collar_worker,Blue-collar worker,,,false,,,http://www.pepathway.org/peo/1.2#Employment_detail,,peo2:Blue-collar_worker,,,,,,,,,http://en.wikipedia.org/wiki/Blue-collar_worker,,,,,,,,,,,,,,,,,,,,Blue-collar worker,
http://scai.fraunhofer.de/NDDUO#Vertebrate,Vertebrate,,,false,,,http://scai.fraunhofer.de/NDDUO#Animal_species,,NDDUO:Vertebrate,,,,,,,,,,,,,,,,,,,,,,,Vertebrate,,,,,,Vertebrate,
http://www.pepathway.org/peo/1.2#Disorder_of_placenta,Disorder of placenta,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Disorder_of_placenta,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/125586008,,,,Disorder of placenta and placental transfusion|Disorder of placenta (disorder),,,,,,Disorder of placenta,
http://www.pepathway.org/peo/1.2#Vasculitis,Vasculitis,,,false,,,http://www.pepathway.org/peo/1.2#Inflammatory_disorder,,peo2:Vasculitis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/31996006,,,,Vasculitis (disorder)|Angiitis,,,,,,Vasculitis,
http://www.pepathway.org/peo/1.2#Metabolic_syndrome_X,Metabolic syndrome X,,,false,,,http://www.pepathway.org/peo/1.2#Metabolic_disease,,peo2:Metabolic_syndrome_X,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/237602007,,,,Metabolic syndrome X (disorder)|Reaven's syndrome|Dysmetabolic syndrome X|Metabolic syndrome|Insulin resistance syndrome,,,,,,Metabolic syndrome X,
http://www.pepathway.org/peo/1.2#Vasodilatory_effects,Vasodilatory effects,,,false,,,http://scai.fraunhofer.de/NDDUO#drug_role,,peo2:Vasodilatory_effects,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Vasodilatory effects,
http://scai.fraunhofer.de/NDDUO#In_silico,In silico thing,,,false,,,http://scai.fraunhofer.de/NDDUO#Non_clinical,,NDDUO:In_silico,,,,,,,,,,,,,,,,,,,,,,,In silico,,,,,,In silico thing,
http://www.pepathway.org/peo/1.2#Cough,Cough,,,false,,,http://scai.fraunhofer.de/NDDUO#Symptoms,,peo2:Cough,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/49727002,,,,Finding of cough|Cough (finding)|Observation of cough,,,,,,Cough,
http://www.pepathway.org/peo/1.2#Education_and_schooling_detail,Education and schooling detail,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Education_and_schooling_detail,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/224285004,,,,Education and schooling detail (observable entity)|Education and schooling,,,,,,Education and schooling detail,
http://www.pepathway.org/peo/1.2#Arteries,Arteries,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Arteries,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D001158,,,,Artery,,,,The vessels carrying blood away from the heart.,,Arteries,
http://www.pepathway.org/peo/1.2#Postpartum_Infections,Postpartum Infections,,,false,,,http://www.pepathway.org/peo/1.2#Infection,,peo2:Postpartum_Infections,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Postpartum Infections,
http://www.pepathway.org/peo/1.2#Systolic_arterial_pressure,Systolic arterial pressure,,,false,,,http://www.pepathway.org/peo/1.2#Blood_pressure_finding,,peo2:Systolic_arterial_pressure,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/72313002,,,,Systolic blood pressure|Systolic arterial pressure (observable entity),,,,,,Systolic arterial pressure,
http://www.pepathway.org/peo/1.2#Case_fatality_rate,Case fatality rate,,AD302,false,,,http://www.pepathway.org/peo/1.2#Incidence,,peo2:Case_fatality_rate,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD302,Case fatality rate,
http://www.pepathway.org/peo/1.1#MMP2,MMP2,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:MMP2,,,,,,,,,,,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/4313,,,,,,,,,,MMP2,
http://www.pepathway.org/peo/1.1#MMPs,MMPs,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:MMPs,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D020782,,,,,,,,,,,,,,"Metalloproteinases, Matrix|Matrix Metalloproteinases",,,,A family of zinc-dependent metalloendopeptidases that is involved in the degradation of EXTRACELLULAR MATRIX components.,,MMPs,
http://www.pepathway.org/peo/1.1#MMP9,MMP9,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:MMP9,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/4318,,,,,,,,,,,,,,,,,,,,MMP9,
http://www.ifomis.org/bfo/1.1/snap#Continuant,continuant,,"Definition: An entity [bfo:Entity] that exists in full at any time in which it exists at all, persists through time while maintaining its identity and has no temporal parts.|Examples: a heart, a person, the color of a tomato, the mass of a cloud, a symphony orchestra, the disposition of blood to coagulate, the lawn and atmosphere in front of our building|Synonyms: endurant",false,,,http://www.ifomis.org/bfo/1.1#Entity,,snap:Continuant,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Definition: An entity [bfo:Entity] that exists in full at any time in which it exists at all, persists through time while maintaining its identity and has no temporal parts.|Examples: a heart, a person, the color of a tomato, the mass of a cloud, a symphony orchestra, the disposition of blood to coagulate, the lawn and atmosphere in front of our building|Synonyms: endurant",continuant,
http://scai.fraunhofer.de/NDDUO#Risk_factor,Risk factor,,"this should be filled via inference, not via direct assertions",false,,,http://www.ifomis.org/bfo/1.1/snap#Disposition,,NDDUO:Risk_factor,,,,,,,,,,,,,,,,,,,,,,,risk factors for Alzheimer|risk factor|increased risk|lifestyle factor|lifestyle factors|Risk factors|risk,,,,,"this should be filled via inference, not via direct assertions",Risk factor,
http://www.pepathway.org/peo/1.2#Extravillous_cytotrophoblast,Extravillous cytotrophoblast,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:Extravillous_cytotrophoblast,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Extravillous cytotrophoblast,
http://www.pepathway.org/peo/1.2#Genomic_features,Genomic features,,,false,,,http://www.w3.org/2002/07/owl#Thing,,peo2:Genomic_features,,,,,,,,,,,,,,,,,,,,,,,Genomic factor|Genomic factors|Genomic feature,,,,,,Genomic features,
http://www.pepathway.org/peo/1.2#Entire_placental_cotyledon,Entire placental cotyledon,,,false,,,http://www.pepathway.org/peo/1.2#Entire_placenta,,peo2:Entire_placental_cotyledon,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/256491001,,,,Placental cotyledon|Entire placental cotyledon (body structure),,,,,,Entire placental cotyledon,
http://www.ifomis.org/bfo/1.1/span#TemporalInstant,temporal_instant,,"Definition: A connected temporal region [span:ConnectedTemporalRegion] comprising a single moment of time.|Examples: right now, the moment at which a finger is detached in an industrial accident, the moment at which a child is born, the moment of death",false,,,http://www.ifomis.org/bfo/1.1/span#ConnectedTemporalRegion,,span:TemporalInstant,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Definition: A connected temporal region [span:ConnectedTemporalRegion] comprising a single moment of time.|Examples: right now, the moment at which a finger is detached in an industrial accident, the moment at which a child is born, the moment of death",temporal_instant,
http://www.pepathway.org/peo/1.2#Mann_Whitney_test,Mann-Whitney test,,from manual annotation of text corpus,false,,,http://www.ifomis.org/bfo/1.1/snap#GenericallyDependentContinuant,,peo2:Mann_Whitney_test,,,,,,,,,,,,,,,,,,,,,,,Mann-Whitney tests|Mann-Whitney,,,,,from manual annotation of text corpus,Mann-Whitney test,
http://www.pepathway.org/peo/1.2#adipose_control,adipose control,,,false,,,http://www.pepathway.org/peo/1.2#Therapeutics,,peo2:adipose_control,,,,,,,,,,,,,,,,,,,,,,,,,,,,,adipose control,
http://www.pepathway.org/peo/1.2#Platelet_active_drugs,Platelet active drugs,,,false,,,http://www.pepathway.org/peo/1.2#drug,,peo2:Platelet_active_drugs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Platelet active drugs,
http://www.pepathway.org/peo/1.2#Seasons,Seasons,,,false,,,http://www.pepathway.org/peo/1.2#Climate,,peo2:Seasons,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D012621,,,,"Seasonal Variation|Seasonal Variations|Variations, Seasonal|Variation, Seasonal|Season",,,,"Divisions of the year according to some regularly recurrent phenomena usually astronomical or climatic. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)",,Seasons,
http://www.pepathway.org/peo/1.2#Periconceptional,Periconceptional,,,false,,,http://www.ifomis.org/bfo/1.1/span#TemporalInterval,,peo2:Periconceptional,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Periconceptional,
http://scai.fraunhofer.de/NDDUO#Death_to_case_ratio,Death to case ratio,,,false,,,http://scai.fraunhofer.de/NDDUO#rate,,NDDUO:Death_to_case_ratio,,,,,,,,,,,,,,,,,,,,,,,Death to case ratios,,,,,,Death to case ratio,
http://www.pepathway.org/peo/1.2#Family_history_of_preeclampsia,Family history of preeclampsia,,,false,,,http://www.pepathway.org/peo/1.2#Family_History,,peo2:Family_history_of_preeclampsia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Family history of preeclampsia,
http://www.pepathway.org/peo/1.2#Incidence,Incidence,,AD301,false,,,http://www.pepathway.org/peo/1.2#Analysis_of_cohort_studies,,peo2:Incidence,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD301,Incidence,
http://www.pepathway.org/peo/1.1#WNT,WNT,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:WNT,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D051153,,,,Wingless Type Proteins|Wnt Factors|Wnt Proteins,,,,"Wnt proteins are a large family of secreted glycoproteins that play essential roles in EMBRYONIC AND FETAL DEVELOPMENT, and tissue maintenance. They bind to FRIZZLED RECEPTORS and act as PARACRINE PROTEIN FACTORS to initiate a variety of SIGNAL TRANSDUCTION PATHWAYS. The canonical Wnt signaling pathway stabilizes the transcriptional coactivator BETA CATENIN.",,WNT,
http://scai.fraunhofer.de/NDDUO#Mortility_rate,Mortility rate,,,false,,,http://scai.fraunhofer.de/NDDUO#rate,,NDDUO:Mortility_rate,,,,,,,,,,,,,,,,,,,,,,,Mortility rates,,,,,,Mortility rate,
http://www.pepathway.org/peo/1.2#thing_that_acts_as_a_genetic_biomarker,thing that acts as a genetic biomarker,,,false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,peo2:thing_that_acts_as_a_genetic_biomarker,,,,,,,,,,,,,,,,,,,,,,,genetic biomarker,,,,,,thing that acts as a genetic biomarker,
http://www.pepathway.org/peo/1.2#Maintaining_overall_health_through_regular_medical_care__diet__and_exercise,"Maintaining overall health through regular medical care, diet, and exercise",,AD087,false,,,http://www.ifomis.org/bfo/1.1/span#Process,,peo2:Maintaining_overall_health_through_regular_medical_care__diet__and_exercise,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD087,"Maintaining overall health through regular medical care, diet, and exercise",
http://www.pepathway.org/peo/1.2#Intracranial_hemorrhage,Intracranial hemorrhage,,,false,,,http://www.pepathway.org/peo/1.2#Finding_of_brain,,peo2:Intracranial_hemorrhage,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/1386000,,,,Intracranial hemorrhage (disorder)|Intracranial haemorrhage,,,,,,Intracranial hemorrhage,
http://www.pepathway.org/peo/1.2#Singleton_delivery,Singleton delivery,,,false,,,http://www.pepathway.org/peo/1.2#Birth,,peo2:Singleton_delivery,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Singleton delivery,
http://www.pepathway.org/peo/1.2#Pregnancy_time_period,Pregnancy time period,,,false,,,http://www.ifomis.org/bfo/1.1/span#ConnectedTemporalRegion,,peo2:Pregnancy_time_period,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/307159006,,,,Pregnancy time period (qualifier value),,,,,,Pregnancy time period,
http://www.pepathway.org/peo/1.2#D-dimer,D-dimer,,,false,,,http://www.pepathway.org/peo/1.2#Blood_Biomarker,,peo2:D-dimer,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/25607008,,,,D-dimer (substance)|DDimer,,,,,,D-dimer,
http://www.pepathway.org/peo/1.2#Massive_perivillous_fibrin_deposition,Massive perivillous fibrin deposition,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Massive_perivillous_fibrin_deposition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Massive perivillous fibrin deposition,
http://www.pepathway.org/peo/1.2#Haemorrhage_finding,Haemorrhage finding,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_observable,,peo2:Haemorrhage_finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Haemorrhage finding,
http://www.pepathway.org/peo/1.2#Eventual_causes,Eventual cause,,AD445,false,,,http://scai.fraunhofer.de/NDDUO#disease_cause,,peo2:Eventual_causes,,,,,,,,,,,,,,,,,,,,,,,Eventual causes,,,,,AD445,Eventual cause,
http://www.pepathway.org/peo/1.2#Multiparous,Multiparous,,,false,,,http://www.pepathway.org/peo/1.2#Parity,,peo2:Multiparous,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/28079008,,,,Multiparous (finding),,,,,,Multiparous,
http://www.pepathway.org/peo/1.2#Previous_gestational_diabetes,Previous gestational diabetes,,,false,,,http://www.pepathway.org/peo/1.2#Medical_history,,peo2:Previous_gestational_diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Previous gestational diabetes,
http://www.pepathway.org/peo/1.2#Antiproliferative_effects,Antiproliferative effects,,,false,,,http://scai.fraunhofer.de/NDDUO#drug_role,,peo2:Antiproliferative_effects,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Antiproliferative effects,
http://www.pepathway.org/peo/1.2#baseline_state,baseline state,,from NP chunking,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:baseline_state,,,,,,,,,,,,,,,,,,,,,,,baseline states|baseline,,,,,from NP chunking,baseline state,
http://www.pepathway.org/peo/1.2#thing_related_to_past_physical_status,thing related to past physical status,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_medical_history,,peo2:thing_related_to_past_physical_status,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to past physical status,
http://www.pepathway.org/peo/1.2#Premature_Birth,Premature Birth,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:Premature_Birth,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D047928,,,,"Premature Births|Birth, Premature|Birth, Preterm|Births, Premature|Preterm Births|Preterm Birth|Births, Preterm",,,,"CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).",,Premature Birth,
http://www.pepathway.org/peo/1.2#Blood_test,Blood test,,,false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity|http://www.pepathway.org/peo/1.2#Biochemical_test,,peo2:Blood_test,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/396550006,,,,Blood test (procedure),,,,,,Blood test,
http://www.pepathway.org/peo/1.2#Malignant_tumor_of_breast,Malignant tumor of breast,,,false,,,http://www.pepathway.org/peo/1.2#Neoplasm_by_body_site,,peo2:Malignant_tumor_of_breast,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/254837009,,,,Malignant tumor of breast (disorder)|CA - Breast cancer|Malignant tumour of breast|Breast cancer,,,,,,Malignant tumor of breast,
http://www.ifomis.org/bfo/1.1/span#ProcessAggregate,process_aggregate,,"Examples: the beating of the hearts of each of seven individuals in the room, the playing of each of the members of an orchestra, a process of digestion and a process of thinking taken together|Definition: A processual entity [span:ProcessualEntity] that is a mereological sum of process [span:Process] entities and possesses non-connected boundaries.",false,,,http://www.ifomis.org/bfo/1.1/span#ProcessualEntity,,span:ProcessAggregate,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Examples: the beating of the hearts of each of seven individuals in the room, the playing of each of the members of an orchestra, a process of digestion and a process of thinking taken together|Definition: A processual entity [span:ProcessualEntity] that is a mereological sum of process [span:Process] entities and possesses non-connected boundaries.",process_aggregate,
http://www.pepathway.org/peo/1.2#Ovarian_hyperstimulation_syndrome,Ovarian hyperstimulation syndrome,,,false,,,http://www.pepathway.org/peo/1.2#Ovarian_Diseases,,peo2:Ovarian_hyperstimulation_syndrome,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/129635004,,,,Secondary Meig's syndrome|Ovarian hyperstimulation syndrome (disorder),,,,,,Ovarian hyperstimulation syndrome,
http://www.ifomis.org/bfo/1.1/snap#ObjectAggregate,object_aggregate,,"Synonyms: substance aggregate|Examples: a heap of stones, a group of commuters on the subway, a collection of random bacteria, a flock of geese, the patients in a hospital|Definition: A material entity [snap:MaterialEntity] that is a mereological sum of separate object [snap:Object] entities and possesses non-connected boundaries.",false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,snap:ObjectAggregate,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Synonyms: substance aggregate|Examples: a heap of stones, a group of commuters on the subway, a collection of random bacteria, a flock of geese, the patients in a hospital|Definition: A material entity [snap:MaterialEntity] that is a mereological sum of separate object [snap:Object] entities and possesses non-connected boundaries.",object_aggregate,
http://www.pepathway.org/peo/1.2#Miscarriage_in_first_trimester,Miscarriage in first trimester,,,false,,,http://www.pepathway.org/peo/1.2#Earlier_miscarriage,,peo2:Miscarriage_in_first_trimester,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/19169002,,,,Miscarriage in first trimester (disorder)|Spontaneous abortion in first trimester,,,,,,Miscarriage in first trimester,
http://www.pepathway.org/peo/1.2#Thromboembolic_disorder,Thromboembolic disorder,,,false,,,http://www.pepathway.org/peo/1.2#Thrombosis,,peo2:Thromboembolic_disorder,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/371039008,,,,Thromboembolism|Thromboembolic disease|Thromboembolic disorder (disorder),,,,,,Thromboembolic disorder,
http://www.pepathway.org/peo/1.2#thing_related_to_medicational_history,thing related to medicational history,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_medical_history,,peo2:thing_related_to_medicational_history,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to medicational history,
http://www.pepathway.org/peo/1.2#Autoimmune_Diseases,Autoimmune Diseases,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Autoimmune_Diseases,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D001327,,,,"Autoimmune Disease|Disease, Autoimmune|Diseases, Autoimmune",,,,Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.,,Autoimmune Diseases,
http://www.pepathway.org/peo/1.2#Cellular_uptake,Cellular uptake,,AD482,false,,,http://www.pepathway.org/peo/1.2#processes_all_cells,,peo2:Cellular_uptake,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD482,Cellular uptake,
http://www.pepathway.org/peo/1.2#treatment_during_pregnancy,treatment during pregnancy,,,false,,,http://scai.fraunhofer.de/NDDUO#Clinical_treatment,,peo2:treatment_during_pregnancy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,treatment during pregnancy,
http://www.pepathway.org/peo/1.2#School_attendance,School attendance,,,false,,,http://www.pepathway.org/peo/1.2#Education_and_schooling_detail,,peo2:School_attendance,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/228134009,,,,School attendance (observable entity),,,,,,School attendance,
http://www.pepathway.org/peo/1.2#Ischemic_heart_disease,Ischemic heart disease,,,false,,,http://www.pepathway.org/peo/1.2#Heart_disease,,peo2:Ischemic_heart_disease,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/414545008,,,,Ischaemic heart disease|IHD - Ischemic heart disease|Ischemic heart disease (disorder)|IHD - Ischaemic heart disease,,,,,,Ischemic heart disease,
http://www.pepathway.org/peo/1.1#ROS1,ROS1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:ROS1,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/6098,,,,,,,,,,,,,,,,,,,,ROS1,
http://www.pepathway.org/peo/1.2#Ubiquitination,Ubiquitination,,AD629,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:Ubiquitination,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD629,Ubiquitination,
http://www.pepathway.org/peo/1.2#thing_related_to_medical_history,thing related to medical history,,,false,,,http://www.pepathway.org/peo/1.2#Environmental_features,,peo2:thing_related_to_medical_history,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to medical history,
http://scai.fraunhofer.de/NDDUO#Intervention,Thing related to intervention,,,false,,,http://www.ifomis.org/bfo/1.1#Entity,,NDDUO:Intervention,,,,,,,,,,,,,,,,,,,,,,,intervention|treatment,,,,,,Thing related to intervention,
http://www.pepathway.org/peo/1.2#Person_time_incidence_rate,Person time incidence rate,,AD311,false,,,http://www.pepathway.org/peo/1.2#Incidence_rate,,peo2:Person_time_incidence_rate,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD311,Person time incidence rate,
http://www.pepathway.org/peo/1.2#zinc,zinc,,from manual annotation of text corpus,false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,peo2:zinc,,,,,,,,,,,,,,,,,,,,,,,Zn,,,,,from manual annotation of text corpus,,
http://www.ifomis.org/bfo/1.1/snap#GenericallyDependentContinuant,generically_dependent_continuant,,Definition: A continuant [snap:Continuant] that is dependent on one or other independent continuant [snap:IndependentContinuant] bearers. For every instance of A requires some instance of (an independent continuant [snap:IndependentContinuant] type) B but which instance of B serves can change from time to time.|Examples: a certain PDF file that exists in different and in several hard drives,false,,,http://www.ifomis.org/bfo/1.1/snap#DependentContinuant,,snap:GenericallyDependentContinuant,,,,,,,,,,,,,,,,,,,,,,,,,,,,Definition: A continuant [snap:Continuant] that is dependent on one or other independent continuant [snap:IndependentContinuant] bearers. For every instance of A requires some instance of (an independent continuant [snap:IndependentContinuant] type) B but which instance of B serves can change from time to time.|Examples: a certain PDF file that exists in different and in several hard drives,generically_dependent_continuant,
http://www.pepathway.org/peo/1.2#Amnesia,Amnesia,,,false,,,http://www.pepathway.org/peo/1.2#Mental_disorder,,peo2:Amnesia,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/48167000,,,,Memory gone|Memory loss|LOM - Loss of memory|Loss of memory|Amnesia (finding)|Memory loss - amnesia|Dysmnesia,,,,,,Amnesia,
http://www.pepathway.org/peo/1.1#ATF6,ATF6,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:ATF6,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/22926,,,,,,,,,,,,,,,,,,,,ATF6,
http://www.pepathway.org/peo/1.1#TNFSF14,TNFSF14,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:TNFSF14,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/8740,,,,,,,,,,,,,,,,,,,,TNFSF14,
http://www.pepathway.org/peo/1.2#clinical_main_complaint_context,clinical main complaint context,,,false,,,http://www.pepathway.org/peo/1.2#clinical_observation_context,,peo2:clinical_main_complaint_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,clinical main complaint context,
http://www.pepathway.org/peo/1.2#Placental_microvesicles,Placental microvesicles,,,false,,,http://www.pepathway.org/peo/1.2#Entire_placenta,,peo2:Placental_microvesicles,,,,,,,,,,,,,,,,,,,,,,,Syncytiotrophoblast microvesicles|STBM,,,,,,Placental microvesicles,
http://www.pepathway.org/peo/1.2#Purpose,Purpose,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Role,,peo2:Purpose,,,,,,,,,,,,,,,,,,,http://semanticscience.org/resource/SIO_000359,,,,,,,,,,Purpose,
http://scai.fraunhofer.de/NDDUO#Cohort_study,Cohort study,,,false,,,http://scai.fraunhofer.de/NDDUO#Descriptive_study,,NDDUO:Cohort_study,,,,,,,,,,,,,,,,,,,,,,,cohort study|Cohort studies,,,,,,Cohort study,
http://www.pepathway.org/peo/1.2#Cytotrophoblast_invasion,Cytotrophoblast invasion,,,false,,,http://www.pepathway.org/peo/1.2#Placentation,,peo2:Cytotrophoblast_invasion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Cytotrophoblast invasion,
http://www.pepathway.org/peo/1.2#Acetylation,Acetylation,,AD594,false,,,http://www.pepathway.org/peo/1.2#Epigenetics,,peo2:Acetylation,,,,,,,,,,,,,,,,,,,,,,,protein amino acid acetylation,,,,,AD594,Acetylation,
http://www.pepathway.org/peo/1.2#Body_height_measure,Body height measure,,,false,,,http://www.pepathway.org/peo/1.2#Body_measure,,peo2:Body_height_measure,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/50373000,,,,Body height|Body height measure (observable entity),,,,,,Body height measure,
http://www.pepathway.org/peo/1.2#nitric_oxide,nitric oxide,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:nitric_oxide,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_16480,,,,oxido nitrico|nitrogen monooxide|Stickstoff(II)-oxid|mononitrogen monoxide|oxido de nitrogeno(II)|NITRIC OXIDE|nitric oxide|monoxyde d'azote|oxyde azotique|Nitrogen monoxide|oxyde nitrique|Stickstoffmonoxid|monoxido de nitrogeno|endothelium-derived relaxing factor|InChIKey=MWUXSHHQAYIFBG-UHFFFAOYSA-N|InChI=1S/NO/c1-2|Nitric oxide|oxidonitrogen(.)|nitrogen monoxide|(.)NO|(NO)(.)|EDRF|NO|NO(.)|[NO]|[N]=O|nitrosyl|oxoazanyl,,,,"A nitrogen oxide which is a free radical, each molecule of which consists of one nitrogen and one oxygen atom.",,nitric oxide,
http://scai.fraunhofer.de/NDDUO#Descriptive_study,Descriptive study,,,false,,,http://scai.fraunhofer.de/NDDUO#Epidemiological_study_type,,NDDUO:Descriptive_study,,,,,,,,,,,,,,,,,,,,,,,Descriptive studies,,,,,,Descriptive study,
http://www.pepathway.org/peo/1.2#Overweight,Overweight,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Overweight,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/238131007,,,,Patient overweight|Overweight (finding),,,,,,Overweight,
http://www.pepathway.org/peo/1.2#thing_related_to_stage,thing related to stage,,,false,,,http://scai.fraunhofer.de/NDDUO#Pathology,,peo2:thing_related_to_stage,,,,,,,,,,,,,,,,,,,,,,,Stage|stages,,,,,,thing related to stage,
http://www.pepathway.org/peo/1.2#RYGB,RYGB,,,false,,,http://www.pepathway.org/peo/1.2#Therapeutics,,peo2:RYGB,,,,,,,,,,,,,,,,,,,,,,,Roux-en-Y gastric-bypass,,,,,,RYGB,
http://www.pepathway.org/peo/1.2#Maternal_Organs,Maternal Organs,,,false,,,http://www.pepathway.org/peo/1.2#Normal_functions_of_organs,,peo2:Maternal_Organs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maternal Organs,
http://www.pepathway.org/peo/1.2#Angiotensin_II_system,Angiotensin II system,,,false,,,http://www.pepathway.org/peo/1.2#Pathway,,peo2:Angiotensin_II_system,,,,,,,,,http://www.genome.jp/kegg-bin/show_pathway?map04614,,,,,,,,,,,,,,,,,renin-angiotensin system|RAS,,,Angiotensin II system,
http://www.pepathway.org/peo/1.2#Entire_cytotrophoblast,Entire cytotrophoblast,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:Entire_cytotrophoblast,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/308841008,,,,Cytotrophoblast|Entire cytotrophoblast (body structure),,,,,,Entire cytotrophoblast,
http://www.pepathway.org/peo/1.2#Homeostasis,Homeostasis,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Homeostasis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/21979002,,,,"Homeostasis, function|Homoeostasis|Homeostasis, function (observable entity)",,,,,,Homeostasis,
http://www.pepathway.org/peo/1.2#Placental_infarct,Placental infarct,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_placenta,,peo2:Placental_infarct,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/268585006,,,,Placental infarct (disorder)|Placental infarction,,,,,,Placental infarct,
http://scai.fraunhofer.de/NDDUO#drug_role,drug role,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Role,,NDDUO:drug_role,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,drug roles,,,,,,drug role,
http://scai.fraunhofer.de/NDDUO#model,model,,,false,,,http://www.ifomis.org/bfo/1.1/snap#GenericallyDependentContinuant,,NDDUO:model,,,,,,,,,,,,,,,,,,,,,,,models,,,,,,model,
http://scai.fraunhofer.de/NDDUO#Crude_mortality_rate,Crude mortality rate,,,false,,,http://scai.fraunhofer.de/NDDUO#Mortility_rate,,NDDUO:Crude_mortality_rate,,,,,,,,,,,,,,,,,,,,,,,Crude mortality rates,,,,,,Crude mortality rate,
http://scai.fraunhofer.de/NDDUO#Trend,Trend,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,NDDUO:Trend,,,,,,,,,,,,,,,,,,,,,,,Trends,,,,,,Trend,
http://www.pepathway.org/peo/1.2#Prolonged_labor,Prolonged labor,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:Prolonged_labor,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/53443007,,,,Prolonged labour|Long labour|Prolonged labor (disorder)|Long labor,,,,,,Prolonged labor,
http://scai.fraunhofer.de/NDDUO#Diagnostic_Procedures,Diagnostic Procedure,,,false,,,http://www.ifomis.org/bfo/1.1/span#Process,,NDDUO:Diagnostic_Procedures,,,,,,,,,,,,,,,,,,,http://purl.org/cpr/0.85#diagnostic-procedure,,,,Diagnostic Procedures,,,,,,Diagnostic Procedure,
http://www.pepathway.org/peo/1.2#blinded_study,blinded study,,,false,,,http://scai.fraunhofer.de/NDDUO#Study_type,,peo2:blinded_study,,,,,,,,,,,,,,,,,,,,,,,blinded studies,,,,,,blinded study,
http://www.pepathway.org/peo/1.2#Hyperhomocysteinemia,Hyperhomocysteinemia,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Hyperhomocysteinemia,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/419503008,,,,Hyperhomocysteinemia (disorder),,,,,,Hyperhomocysteinemia,
http://www.pepathway.org/peo/1.2#trans-Golgi_Network,trans-Golgi Network,,,false,,,http://www.pepathway.org/peo/1.2#Organelle,,peo2:trans-Golgi_Network,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D021601,,,,"trans Golgi Network|Region, trans-Golgi|trans Golgi Region|Network, trans-Golgi|trans-Golgi Region|trans-Golgi Regions|Regions, trans-Golgi",,,,"A network of membrane compartments, located at the cytoplasmic side of the GOLGI APPARATUS, where proteins and lipids are sorted for transport to various locations in the cell or cell membrane.",,trans-Golgi Network,
http://www.pepathway.org/peo/1.2#thing_that_can_increase_the_risk,thing that can increase the risk,,,false,,,http://scai.fraunhofer.de/NDDUO#Epidemiology,,peo2:thing_that_can_increase_the_risk,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing that can increase the risk,
http://scai.fraunhofer.de/NDDUO#Sampling,Sampling,,,false,,,http://scai.fraunhofer.de/NDDUO#Diagnostic_Procedures,,NDDUO:Sampling,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sampling,
http://www.pepathway.org/peo/1.2#Velocity_time_integral_ratio,Velocity time integral ratio,,,false,,,http://www.pepathway.org/peo/1.2#Echocardiography,,peo2:Velocity_time_integral_ratio,,,,,,,,,,,,,,,,,,,,,,,VTI ratio,,,,,,Velocity time integral ratio,
http://www.pepathway.org/peo/1.2#Pro-inflammatory_responses,Pro-inflammatory responses,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:Pro-inflammatory_responses,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pro-inflammatory responses,
http://www.pepathway.org/peo/1.2#Chronic_hypertension_in_obstetric_context,Chronic hypertension in obstetric context,,,false,,,http://www.pepathway.org/peo/1.2#Hypertension_associated_disorders_of_pregnancy,,peo2:Chronic_hypertension_in_obstetric_context,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/8762007,,,,Chronic hypertension in obstetric context (disorder),,,,,,Chronic hypertension in obstetric context,
http://www.pepathway.org/peo/1.1#ERN1,ERN1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:ERN1,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/2081,,,,,,,,,,,,,,,,,,,,ERN1,
http://www.pepathway.org/peo/1.2#Placebo_controlled_study,Placebo controlled study,,,false,,,http://scai.fraunhofer.de/NDDUO#Study_type,,peo2:Placebo_controlled_study,,,,,,,,,,,,,,,,,,,,,,,Placebo controlled studies|placebo-controlled studies|placebo-controlled study|placebo-controlled trial|placebo-controlled trials,,,,,,Placebo controlled study,
http://www.pepathway.org/peo/1.2#Morphine_abuse,Morphine abuse,,,false,,,http://www.pepathway.org/peo/1.2#Drug_abuse,,peo2:Morphine_abuse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Morphine abuse,
http://www.pepathway.org/peo/1.2#Twin_birth,Twin birth,,,false,,,http://www.pepathway.org/peo/1.2#Birth,,peo2:Twin_birth,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/28030000,,,,Twin birth (finding),,,,,,Twin birth,
http://www.pepathway.org/peo/1.2#Hysterectomy,Hysterectomy,,,false,,,http://www.pepathway.org/peo/1.2#Therapeutics,,peo2:Hysterectomy,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/236886002,,,,Uterus excision|Hysterectomy (procedure)|Excision procedure on uterus,,,,,,Hysterectomy,
http://scai.fraunhofer.de/NDDUO#Statistics,statistics entity,,AD257,false,,,http://scai.fraunhofer.de/NDDUO#Descriptive_epidemiology,,NDDUO:Statistics,,,,,,,,,,,,,,,,,,,,,,,Statistics,,,,,AD257,statistics entity,
http://www.pepathway.org/peo/1.2#potassium,potassium(1+),,,false,,,http://www.pepathway.org/peo/1.2#ion,,peo2:potassium,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_29103,,,,InChIKey=NPYPAHLBTDXSSS-UHFFFAOYSA-N|potassium cation|potassium(I) cation|POTASSIUM ION|InChI=1S/K/q+1|potassium(1+)|potassium(1+) ion|K|K(+)|K+|[K+]|potassium,,,,A monoatomic monocation obtained from potassium.,,potassium(1+),
http://www.pepathway.org/peo/1.2#clinical_observation_context,clinical observation context,,,false,,,http://www.pepathway.org/peo/1.2#clinical_phenotypic_context,,peo2:clinical_observation_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,clinical observation context,
http://www.pepathway.org/peo/1.2#Eclamptic_encephalopathy,Eclamptic encephalopathy,,,false,,,http://www.pepathway.org/peo/1.2#Finding_of_brain,,peo2:Eclamptic_encephalopathy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Eclamptic encephalopathy,
http://www.pepathway.org/peo/1.2#Precursors,Precursors,,,false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,peo2:Precursors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Precursors,
http://www.pepathway.org/peo/1.2#vitamin_C,Vitamin C,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:vitamin_C,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_21241,,,,vitaminum C|Vitamin C|vitamina C|vitamine C,,,,,,Vitamin C,
http://www.pepathway.org/peo/1.2#Arterial_thrombosis,Arterial thrombosis,,,false,,,http://www.pepathway.org/peo/1.2#Thrombosis,,peo2:Arterial_thrombosis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/65198009,,,,Arterial thrombosis (disorder),,,,,,Arterial thrombosis,
http://www.pepathway.org/peo/1.2#thing_related_to_complication_for_child,thing related to complication for child,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_complications,,peo2:thing_related_to_complication_for_child,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to complication for child,
http://www.pepathway.org/peo/1.2#Placental_edema,Placental edema,,,false,,,http://www.pepathway.org/peo/1.2#Edema,,peo2:Placental_edema,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Placental edema,
http://scai.fraunhofer.de/NDDUO#genetic_cause_context,genetic cause context,,,false,,,http://scai.fraunhofer.de/NDDUO#etiological_context,,NDDUO:genetic_cause_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,genetic cause context,
http://www.pepathway.org/peo/1.2#Kallidin_I,Kallidin I,,,false,,,http://www.pepathway.org/peo/1.2#Peptide,,peo2:Kallidin_I,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/56448008,,,,Kallidin I (substance)|Bradykinin,,,,,,Kallidin I,
http://scai.fraunhofer.de/NDDUO#add_on_treatment_context,add-on treatment context,,,false,,,http://scai.fraunhofer.de/NDDUO#pharmacotherapy_treatment_context,,NDDUO:add_on_treatment_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,add-on treatment context,
http://www.pepathway.org/peo/1.2#disease_onset,disease onset,,from NP chunking,false,,,http://www.ifomis.org/bfo/1.1/span#TemporalInterval,,peo2:disease_onset,,,,,,,,,,,,,,,,,,,,,,,onset of AD|onset,,,,,from NP chunking,disease onset,
http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,material_entity,,"Definition: An independent continuant [snap:IndependentContinuant] that is spatially extended whose identity is independent of that of other entities and can be maintained through time. Note: Material entity [snap:MaterialEntity] subsumes object [snap:Object], fiat object part [snap:FiatObjectPart], and object aggregate [snap:ObjectAggregate], which assume a three level theory of granularity, which is inadequate for some domains, such as biology.|Examples: collection of random bacteria, a chair, dorsal surface of the body",false,,,http://www.ifomis.org/bfo/1.1/snap#IndependentContinuant,,snap:MaterialEntity,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Definition: An independent continuant [snap:IndependentContinuant] that is spatially extended whose identity is independent of that of other entities and can be maintained through time. Note: Material entity [snap:MaterialEntity] subsumes object [snap:Object], fiat object part [snap:FiatObjectPart], and object aggregate [snap:ObjectAggregate], which assume a three level theory of granularity, which is inadequate for some domains, such as biology.|Examples: collection of random bacteria, a chair, dorsal surface of the body",material_entity,
http://www.pepathway.org/peo/1.2#Education_received_in_the_past,Education received in the past,,,false,,,http://www.pepathway.org/peo/1.2#Education_and_schooling_detail,,peo2:Education_received_in_the_past,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/224293004,,,,Education received in the past (observable entity),,,,,,Education received in the past,
http://www.pepathway.org/peo/1.2#Lower_class_economic_status,Lower class economic status,,,false,,,http://www.pepathway.org/peo/1.2#Economic_status,,peo2:Lower_class_economic_status,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/36877009|http://purl.obolibrary.org/obo/ExO_0000015,,,,low socio economic status|Low income status|Lower class economic status (social concept)|low regional economic status|low socio-economic|poor socio-economic status|lower socio-economic status|poverty,,,,,,Lower class economic status,
http://www.pepathway.org/peo/1.2#Single_person,Single person,,,false,,,http://www.pepathway.org/peo/1.2#Marital_status,,peo2:Single_person,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/125681006,,,,Single person (finding)|Single,,,,Not currently married,,Single person,
http://www.pepathway.org/peo/1.2#Antenatal,Antenatal,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_time_period,,peo2:Antenatal,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/263675000,,,,AN - Antenatal|Antenatal (qualifier value),,,,,,Antenatal,
http://www.pepathway.org/peo/1.2#Thrombocytopenic_disorder,Thrombocytopenic disorder,,,false,,,http://www.pepathway.org/peo/1.2#Thrombosis,,peo2:Thrombocytopenic_disorder,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/302215000,,,,Thrombocytopenic disorder (disorder)|Thrombocytopenia,,,,,,Thrombocytopenic disorder,
http://www.pepathway.org/peo/1.2#thing_related_to_variants,thing related to variants,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_gene,,peo2:thing_related_to_variants,,,,,,,,,,,,,,,,,,,,,,,genetic risk factor|genetic risk factors,,,,,,thing related to variants,
http://www.pepathway.org/peo/1.2#Maternal_floor_infarction,Maternal floor infarction,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Maternal_floor_infarction,,,,,,,,,,,,,,,,,,,,,,,MFI,,,,,,Maternal floor infarction,
http://www.pepathway.org/peo/1.2#In_vitro_fertilization,In vitro fertilization,,,false,,,http://www.pepathway.org/peo/1.2#Reproductive_Techniques_Assisted,,peo2:In_vitro_fertilization,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/52637005,,,,Test tube ovum fertilization|Test tube baby technique|In vitro fertilisation|In vitro fertilisation procedure|Test tube ovum fertilization (procedure)|Test tube ovum fertilisation|In vitro fertilization procedure|IVF,,,,,,In vitro fertilization,
http://www.pepathway.org/peo/1.2#Collateral_flow_index,Collateral flow index,,,false,,,http://www.pepathway.org/peo/1.2#Echocardiography,,peo2:Collateral_flow_index,,,,,,,,,,,,,,,,,,,,,,,CFI,,,,,,Collateral flow index,
http://www.pepathway.org/peo/1.1#Groucho,Groucho,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:Groucho,,,,,,,,,,,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/100303594,,,,,,,Gro,,,Groucho,
http://www.pepathway.org/peo/1.2#Diabetic_renal_disease,Diabetic renal disease,,,false,,,http://www.pepathway.org/peo/1.2#Kidney_disease,,peo2:Diabetic_renal_disease,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/127013003,,,,Renal disorder associated with diabetes mellitus|Diabetic nephropathy|Diabetic renal disease (disorder),,,,,,Diabetic renal disease,
http://scai.fraunhofer.de/NDDUO#In_vitro_models,In vitro model,,,false,,,http://scai.fraunhofer.de/NDDUO#model,,NDDUO:In_vitro_models,,,,,,,,,,,,,,,,,,,http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#in_vitro_Model,,,,In vitro models,,,,,,In vitro model,
http://www.pepathway.org/peo/1.2#Thyroid_disease,Thyroid disease,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Thyroid_disease,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/OMIM/MTHU018343,,,,,,,,,,Thyroid disease,
http://www.pepathway.org/peo/1.2#thing_related_to_regional_status,thing related to regional status,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_social_factors,,peo2:thing_related_to_regional_status,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to regional status,
http://www.pepathway.org/peo/1.2#thing_related_to_complications,thing related to complications,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_observations,,peo2:thing_related_to_complications,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to complications,
http://www.pepathway.org/peo/1.2#Regulation_of_transcription,Regulation of transcription,,AD614,false,,,http://scai.fraunhofer.de/NDDUO#Regulation_of_gene_expression,,peo2:Regulation_of_transcription,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/GO#GO_0006355,,,,"regulation of cellular transcription, DNA-dependent",,,,,AD614,Regulation of transcription,
http://www.pepathway.org/peo/1.2#progesterone,progesterone,,,false,,,http://www.pepathway.org/peo/1.2#hormone,,peo2:progesterone,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_17026,,,,"InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1|Gelbkoerperhormon|progesterone|PROGESTERONE|Delta(4)-pregnene-3,20-dione|luteohormone|pregn-4-ene-3,20-dione|(S)-Progesterone|InChIKey=RJKFOVLPORLFTN-LEKSSAKUSA-N|17alpha-progesterone|[H][C@@]12CCC3=CC(=O)CC[C@]3(C)[C@@]1([H])CC[C@]1(C)[C@H](CC[C@|(S)-4-Pregnene-3,20-dione|Progesterone|(S)-Pregn-4-en-3,20-dione|4-Pregnene-3,20-dione|Progesteron|corpus luteum hormone|Agolutin|Akrolutin|C21H30O2|Crinone",,,,"A C21-steroid hormone in which a pregnane skeleton carries oxo substituents at positions 3 and 20 and is unsaturated at C(4)-C(5). As a hormone, it is involved in the female menstrual cycle, pregnancy and embryogenesis of humans and other species.",,progesterone,
http://www.pepathway.org/peo/1.2#Uteroplacental_blood_flow,Uteroplacental blood flow,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_uterine_artery_Doppler,,peo2:Uteroplacental_blood_flow,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Uteroplacental blood flow,
http://www.pepathway.org/peo/1.2#Th2_Cells,Th2 Cells,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:Th2_Cells,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D018418,,,,"Cell, Th2|Cells, Th2|Th2 Cell",,,,"Subset of helper-inducer T-lymphocytes which synthesize and secrete the interleukins IL-4, IL-5, IL-6, and IL-10. These cytokines influence B-cell development and antibody production as well as augmenting humoral responses.",,Th2 Cells,
http://www.pepathway.org/peo/1.2#Endothelial_cell,Endothelial cell,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:Endothelial_cell,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/45709008,,,,Endothelial cell (cell),,,,,,Endothelial cell,
http://www.pepathway.org/peo/1.2#Coagulation_protein,Coagulation protein,,,false,,,http://www.pepathway.org/peo/1.2#Molecular_rolls,,peo2:Coagulation_protein,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/116181003,,,,Coagulation protein (substance),,,,,,Coagulation protein,
http://www.pepathway.org/peo/1.2#Placental_Villous_Explant,Placental Villous Explant,,,false,,,http://www.pepathway.org/peo/1.2#Entire_placenta,,peo2:Placental_Villous_Explant,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Placental Villous Explant,
http://www.pepathway.org/peo/1.2#Sporadic_miscarriage,Sporadic miscarriage,,,false,,,http://www.pepathway.org/peo/1.2#Miscarriage,,peo2:Sporadic_miscarriage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sporadic miscarriage,
http://www.pepathway.org/peo/1.2#oxygen_atom,oxygen atom,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:oxygen_atom,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_25805,,,,InChIKey=QVGXLLKOCUKJST-UHFFFAOYSA-N|8O|InChI=1S/O|O|Sauerstoff|[O]|oxigeno|oxygen|oxygene,,,,A chalcogen that has formula O.,,oxygen atom,
http://www.pepathway.org/peo/1.2#Left-sided_unilateral_notching,Left-sided unilateral notching,,,false,,,http://www.pepathway.org/peo/1.2#Unilateral_notching,,peo2:Left-sided_unilateral_notching,,,,,,,,,,,,,,,,,,,,,,,left unilateral notch,,,,,,Left-sided unilateral notching,
http://www.pepathway.org/peo/1.2#Intracerebral_hemorrhage,Intracerebral hemorrhage,,,false,,,http://www.pepathway.org/peo/1.2#Finding_of_brain,,peo2:Intracerebral_hemorrhage,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/OMIM/MTHU036748,,,,,,,,,,Intracerebral hemorrhage,
http://www.pepathway.org/peo/1.2#Endothelial_dysfunction,Endothelial dysfunction,,,false,,,http://www.pepathway.org/peo/1.2#Vascular_disorders,,peo2:Endothelial_dysfunction,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10048554,,,,,,,,,,Endothelial dysfunction,
http://www.pepathway.org/peo/1.2#Antipsychotic_drugs,Antipsychotic drug,,AD004,false,,,http://scai.fraunhofer.de/NDDUO#drug_role,,peo2:Antipsychotic_drugs,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_35476,,,http://www.omnimedicalsearch.com/conditions-diseases/alzheimers-disease-treatment-prevention.html,antipsychotic|Antipsychotic drugs|antipsychotics|Neuroleptic,,,,,AD004,Antipsychotic drug,
http://www.pepathway.org/peo/1.2#Realtive_risk,Relative risk,,AD306,false,,,http://www.pepathway.org/peo/1.2#Cumulative_incidence,,peo2:Realtive_risk,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD306,Relative risk,
http://www.pepathway.org/peo/1.1#EIF2,EIF2,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:EIF2,,,,,,,,,,,,,,,,,,,,,,,eukaryotic translation initiation factor 2,,,,,,EIF2,
http://www.pepathway.org/peo/1.2#thing_related_to_social_support,thing related to social support,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_social_factors,,peo2:thing_related_to_social_support,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to social support,
http://www.pepathway.org/peo/1.2#Cell_invasion,Cell invasion,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Cell_invasion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Cell invasion,
http://www.pepathway.org/peo/1.2#Transaminases,Transaminases,,,false,,,http://www.pepathway.org/peo/1.2#Molecular_rolls,,peo2:Transaminases,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D000637,,,,Aminotransferases,,,,"A subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Most of these enzymes are pyridoxyl phosphate proteins. (Dorland, 28th ed) EC 2.6.1.",,Transaminases,
http://www.pepathway.org/peo/1.2#Upper_middle_class_economic_status,Upper middle class economic status,,,false,,,http://www.pepathway.org/peo/1.2#Economic_status,,peo2:Upper_middle_class_economic_status,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/64816001,,,,Upper middle class economic status (social concept),,,,,,Upper middle class economic status,
http://www.pepathway.org/peo/1.2#Echocardiographic_calcium_score,Echocardiographic calcium score,,,false,,,http://www.pepathway.org/peo/1.2#Echocardiography,,peo2:Echocardiographic_calcium_score,,,,,,,,,,,,,,,,,,,,,,,ECS,,,,,,Echocardiographic calcium score,
http://www.pepathway.org/peo/1.2#thing_related_to_economic_status,thing related to economic status,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_social_factors,,peo2:thing_related_to_economic_status,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to economic status,
http://scai.fraunhofer.de/NDDUO#descriptive_statistical_context,descriptive statistical context,,,false,,,http://scai.fraunhofer.de/NDDUO#statistical_context,,NDDUO:descriptive_statistical_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,descriptive statistical context,
http://www.pepathway.org/peo/1.2#Apgar_score_low,Apgar score low,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:Apgar_score_low,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10002944,,,,,,,,,,Apgar score low,
http://www.pepathway.org/peo/1.2#chi_square,Chi-Square test,,from manual annotation of text corpus,false,,,http://www.ifomis.org/bfo/1.1/snap#GenericallyDependentContinuant,,peo2:chi_square,,,,,,,,,,,,,,,,,,,,,,,Chi-Square tests|Chi-Square,,,,,from manual annotation of text corpus,Chi-Square test,
http://www.pepathway.org/peo/1.2#Low_physical_activity,Low physical activity,,,false,,,http://www.pepathway.org/peo/1.2#Physically_active,,peo2:Low_physical_activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Low physical activity,
http://www.pepathway.org/peo/1.2#Vitamin_E,Vitamin E,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:Vitamin_E,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_33234,,,,,,,,,,Vitamin E,
http://www.pepathway.org/peo/1.2#calcium_signalling,calcium signalling,,from manual annotation of text corpus,false,,,http://scai.fraunhofer.de/NDDUO#Cell_cell_interaction,,peo2:calcium_signalling,,,,,,,,,,,,,,,,,,,,,,,,,,,,from manual annotation of text corpus,calcium signalling,
http://www.pepathway.org/peo/1.2#Headache,Headache,,AD039,false,,,http://scai.fraunhofer.de/NDDUO#Symptoms,,peo2:Headache,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/SYMP#SYMP_0000504,,,,cephalalgia|Headaches,,,,,AD039,Headache,
http://www.pepathway.org/peo/1.2#Antiphospholipid_syndrome_in_pregnancy,Antiphospholipid syndrome in pregnancy,,,false,,,http://www.pepathway.org/peo/1.2#Mixed_collagen_vascular_disease,,peo2:Antiphospholipid_syndrome_in_pregnancy,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/72161000119100,,,,systemic lupus erythematosus|Antiphospholipid syndrome in pregnancy (disorder),,,,,,Antiphospholipid syndrome in pregnancy,
http://www.pepathway.org/peo/1.2#younger_than_marriageable_age,younger than marriageable age,,,false,,,http://www.pepathway.org/peo/1.2#Age_at_onset,,peo2:younger_than_marriageable_age,,,,,,,,,,,,,,,,,,,,,,,adolescents of <17 years old|biological immature,,,,,,younger than marriageable age,
http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,Pregnancy Outcome,,,false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,peo2:Pregnancy_Outcome,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D011256,,,,"Outcomes, Pregnancy|Pregnancy Outcomes|Outcome, Pregnancy",,,,"Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; SPONTANEOUS ABORTION; INDUCED ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO.",,Pregnancy Outcome,
http://www.pepathway.org/peo/1.2#Invloving_patient_in_structured_therapeutic_activities,Involving patient in structured therapeutic activities,,AD086,false,,,http://www.ifomis.org/bfo/1.1/span#Process,,peo2:Invloving_patient_in_structured_therapeutic_activities,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD086,Involving patient in structured therapeutic activities,
http://scai.fraunhofer.de/NDDUO#Race,Race,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,NDDUO:Race,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Race,
http://scai.fraunhofer.de/NDDUO#Thing_that_can_act_as_a_protective_factor,Thing that can act as a protective factor,,,false,,,http://scai.fraunhofer.de/NDDUO#Epidemiology,,NDDUO:Thing_that_can_act_as_a_protective_factor,,,,,,,,,,,,,,,,,,,,,,,Thing that can act as a protective factor for Alzheimer|protective factor|protective factors,,,,,,Thing that can act as a protective factor,
http://www.pepathway.org/peo/1.2#Vascular_system_finding,Vascular system finding,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_observable,,peo2:Vascular_system_finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Vascular system finding,
http://www.pepathway.org/peo/1.2#clinical_functional_phenotype_context,clinical functional phenotype context,,,false,,,http://www.pepathway.org/peo/1.2#clinical_observation_context,,peo2:clinical_functional_phenotype_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,clinical functional phenotype context,
http://scai.fraunhofer.de/NDDUO#Measure_of_disease_ocurrence,Measure of disease occurrence entity,,,false,,,http://scai.fraunhofer.de/NDDUO#Statistics,,NDDUO:Measure_of_disease_ocurrence,,,,,,,,,,,,,,,,,,,,,,,Measures of disease occurrence|Measure of disease occurrence,,,,,,Measure of disease occurrence entity,
http://www.pepathway.org/peo/1.2#Educational_level_of_parent_of_subject,Educational level of parent of subject,,,false,,,http://www.pepathway.org/peo/1.2#Education_and_schooling_detail,,peo2:Educational_level_of_parent_of_subject,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/443722004,,,,Educational level of parent of subject (observable entity),,,,,,Educational level of parent of subject,
http://www.pepathway.org/peo/1.2#Vasogenic_cerebral_edema,Vasogenic cerebral edema,,,false,,,http://www.pepathway.org/peo/1.2#Vascular_system_finding,,peo2:Vasogenic_cerebral_edema,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/230759001,,,,Vasogenic cerebral edema (disorder)|Vasogenic cerebral oedema,,,,,,Vasogenic cerebral edema,
http://www.pepathway.org/peo/1.1#EIF2AK3,EIF2AK3,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:EIF2AK3,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/9451,,,,,,,,,,,,,,,,,,,,EIF2AK3,
http://www.pepathway.org/peo/1.2#Gestational,Gestational,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_time_period,,peo2:Gestational,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/255402008,,,,Gestational (qualifier value),,,,,,Gestational,
http://scai.fraunhofer.de/NDDUO#secondary_measure_context,secondary measure context,,,false,,,http://scai.fraunhofer.de/NDDUO#clinical_trial_context,,NDDUO:secondary_measure_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,secondary measure context,
http://www.pepathway.org/peo/1.2#Ex-tobacco_user,Ex-tobacco user,,,false,,,http://www.pepathway.org/peo/1.2#Maternal_tobacco_use,,peo2:Ex-tobacco_user,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/702975009,,,,Ex-tobacco user (finding),,,,,,Ex-tobacco user,
http://www.pepathway.org/peo/1.2#biliverdin,biliverdin,,,false,,,http://www.pepathway.org/peo/1.2#drug,,peo2:biliverdin,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_17033,,,,"Biliverdin IXalpha|InChIKey=QBUVFDKTZJNUPP-BBROENKCSA-N|InChI=1S/C33H34N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-15,35H,1-2,9-12H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-,28-15-|CC1=C(CCC(O)=O)C(/N=C1/C=C1NC(=O)C(C=C)=C/1C)=C\c1[nH]c(\C=C2NC(=O)C(C)=C/2C=C)c(C)c1CCC(O)=O|8,12-bis(2-carboxyethyl)-2,7,13,17-tetramethyl-3,18-divinylbilin-1(19)(21H,24H)-dione|Biliverdine|BILIVERDINE IX ALPHA|Biliverdin|C33H34N4O6|biliverdin",,,,"A linear tetrapyrrole produced in the reticuloendothelial system by the first step of heme degradation, catalysed by heme oxygenase.",,biliverdin,
http://www.pepathway.org/peo/1.2#Hypoxia,Hypoxia,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Hypoxia,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/OMIM/MTHU016005,,,,,,,,,,Hypoxia,
http://www.pepathway.org/peo/1.2#Heparin_Low-Molecular-Weight,"Heparin, Low-Molecular-Weight",,,false,,,http://www.pepathway.org/peo/1.2#heparin,,peo2:Heparin_Low-Molecular-Weight,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D006495,,,,"Low Molecular Weight Heparin|Heparin, Low Molecular Weight|Low-Molecular-Weight Heparin|LMWH",,,,"Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.",,"Heparin, Low-Molecular-Weight",
http://www.pepathway.org/peo/1.2#Genetic_Biomarkers,Genetic Biomarker,,AD117,false,,,http://scai.fraunhofer.de/NDDUO#biomarker,,peo2:Genetic_Biomarkers,,,,,,,,,,,,,,,,,,,,,,http://www.benthamscience.com/open/tonmedj/article/V002/SI0010TONMEDJ/12TONMEDJ.pdf,Genetic Biomarkers,,,,,AD117,Genetic Biomarker,
http://www.pepathway.org/peo/1.2#Transgeneic_cells,Transgenic model,,AD646,false,,,http://scai.fraunhofer.de/NDDUO#In_vitro_models,,peo2:Transgeneic_cells,,,,,,,,,,,,,,,,,,,,,,,Transgenic models,,,,,AD646,Transgenic model,
http://www.pepathway.org/peo/1.2#Perfluoroalkylated_acids_and_related_compounds,Perfluoroalkylated acids and related compounds,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:Perfluoroalkylated_acids_and_related_compounds,,,,,,,,,,,,,,,,,,,,,,,PFAS,,,,,,Perfluoroalkylated acids and related compounds,
http://www.pepathway.org/peo/1.2#hemoglobin,hemoglobin,,,false,,,http://www.pepathway.org/peo/1.2#Dimers,,peo2:hemoglobin,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_35143,,,,vertebrate haemoglobin|haemoglobin|hemoglobin,,,,,,hemoglobin,
http://www.pepathway.org/peo/1.2#mitochondrial_dysfunctioning,mitochondrial dysfunctioning,,from NP chunking,false,,,http://www.pepathway.org/peo/1.2#processes_all_cells,,peo2:mitochondrial_dysfunctioning,,,,,,,,,,,,,,,,,,,,,,,,,,,,from NP chunking,mitochondrial dysfunctioning,
http://scai.fraunhofer.de/NDDUO#context,context,,,false,,,http://www.ifomis.org/bfo/1.1/snap#DependentContinuant,,NDDUO:context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,context,
http://www.pepathway.org/peo/1.2#Endocrine_cell,Endocrine cell,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:Endocrine_cell,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/68233007,,,,Endocrine cell (cell),,,,,,Endocrine cell,
http://www.pepathway.org/peo/1.2#Diabetes,Diabetes,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Diabetes,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10012594,,,,,,,,,,Diabetes,
http://scai.fraunhofer.de/NDDUO#clinical_treatment_context,clinical treatment context,,,false,,,http://www.pepathway.org/peo/1.2#clinical_phenotypic_context,,NDDUO:clinical_treatment_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,clinical treatment context,
http://www.pepathway.org/peo/1.1#BCL2,BCL2,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:BCL2,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/596,,,,,,,,,,,,,,,,,,,,BCL2,
http://www.pepathway.org/peo/1.2#Gestational_weight_gain,Gestational weight gain,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_observable,,peo2:Gestational_weight_gain,,,,,,,,,,,,,,,,,,,,,,,GWG,,,,,,Gestational weight gain,
http://scai.fraunhofer.de/NDDUO#Applied_epidemiology,thing related to applied epidemiology,,AD250,false,,,http://scai.fraunhofer.de/NDDUO#Epidemiology,,NDDUO:Applied_epidemiology,,,,,,,,,,,,,,,,,,,,,,,Applied epidemiology,,,,,AD250,thing related to applied epidemiology,
http://www.pepathway.org/peo/1.2#Total_cholesterol:HDL_ratio_measurement,Total cholesterol:HDL ratio measurement,,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:HDL_ratio_measurement,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/166842003,,,,Total cholesterol:HDL ratio|Total cholesterol:high density lipoprotein ratio measurement|Total cholesterol:high density lipoprotein ratio measurement (procedure),,,,,,Total cholesterol:HDL ratio measurement,
http://www.pepathway.org/peo/1.2#Malnourishment,Malnourishment,,,false,,,http://www.pepathway.org/peo/1.2#Prenatal_Nutritional_Physiological_Phenomena,,peo2:Malnourishment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Malnourishment,
http://www.pepathway.org/peo/1.2#Cell_treatment,Cell treatment model,,AD644,false,,,http://scai.fraunhofer.de/NDDUO#In_vitro_models,,peo2:Cell_treatment,,,,,,,,,,,,,,,,,,,,,,,Cell treatment models,,,,,AD644,Cell treatment model,
http://www.pepathway.org/peo/1.2#Albuminuria,Albuminuria,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_test_urine,,peo2:Albuminuria,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/274769005,,,,Albuminuria (finding),,,,,,Albuminuria,
http://www.pepathway.org/peo/1.1#KCNN,KCNN,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:KCNN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,KCNN,
http://www.pepathway.org/peo/1.2#Previous_IUGR,Previous IUGR,,,false,,,http://www.pepathway.org/peo/1.2#Medical_history,,peo2:Previous_IUGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Previous IUGR,
http://www.pepathway.org/peo/1.2#Previous_induced_abortion,Previous induced abortion,,,false,,,http://www.pepathway.org/peo/1.2#Medical_history,,peo2:Previous_induced_abortion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Previous induced abortion,
http://www.pepathway.org/peo/1.2#Low_birthweight,Low birthweight,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:Low_birthweight,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/OMIM/MTHU034621,,,,,,,,,,Low birthweight,
http://www.pepathway.org/peo/1.2#Insulin_resistance,Insulin resistance,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Insulin_resistance,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/HP_0000855,,,,"Sensitivity, Insulin|Resistance, Insulin|Insulin Sensitivity",,,,"`Increased resistance` (PATO:0001650) towards `insulin` (PRO:000009054), that is, diminished effectiveness of insulin in reducing blood glucose levels.",,Insulin resistance,
http://www.pepathway.org/peo/1.2#Red_blood_cell_count,Red blood cell count,,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:Red_blood_cell_count,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/14089001,,,,Red blood cell count (procedure)|RBC - Red blood cell count|RBC count,,,,,,Red blood cell count,
http://www.pepathway.org/peo/1.2#Lymphopoiesis,Lymphopoiesis,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Lymphopoiesis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D038041,,,,,,,,"Formation of LYMPHOCYTES and PLASMA CELLS from the lymphoid stem cells which develop from the pluripotent HEMATOPOIETIC STEM CELLS in the BONE MARROW. These lymphoid stem cells differentiate into T-LYMPHOCYTES; B-LYMPHOCYTES; PLASMA CELLS; or NK-cells (KILLER CELLS, NATURAL) depending on the organ or tissues (LYMPHOID TISSUE) to which they migrate.",,Lymphopoiesis,
http://www.pepathway.org/peo/1.2#Body_mass_index,Body mass index,,,false,,,http://www.pepathway.org/peo/1.2#Body_measure,,peo2:Body_mass_index,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/60621009,,,,Weight: body mass|Body mass index (observable entity)|BMI - Body mass index|Quetelet index,,,,,,Body mass index,
http://www.pepathway.org/peo/1.2#Hemolysis,Hemolysis,,,false,,,http://www.pepathway.org/peo/1.2#Red_blood_cell_disorder,,peo2:Hemolysis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/260882000,,,,Hemolysis (attribute)|Haemolysis,,,,,,Hemolysis,
http://www.pepathway.org/peo/1.2#Hypertension_associated_disorders_of_pregnancy,Hypertension associated disorders of pregnancy,,,false,,,http://www.pepathway.org/peo/1.2#Hypertensive_disorder,,peo2:Hypertension_associated_disorders_of_pregnancy,,,,,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10020776,,,,,,Hypertension associated disorders of pregnancy,
http://www.pepathway.org/peo/1.2#Thyroid_supplements,Thyroid supplements,,,false,,,http://www.pepathway.org/peo/1.2#Supplements,,peo2:Thyroid_supplements,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Thyroid supplements,
http://scai.fraunhofer.de/NDDUO#Prognostic_study,Prognostic study,,,false,,,http://scai.fraunhofer.de/NDDUO#Cohort_study,,NDDUO:Prognostic_study,,,,,,,,,,,,,,,,,,,,,,,Prognostic studies,,,,,,Prognostic study,
http://www.pepathway.org/peo/1.2#Kidney_disease,Kidney disease,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Kidney_disease,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/90708001,,,,Renal disease|Renal disorder|Nephropathy|Kidney disease (disorder)|Disease of kidney|Disorder of kidney|Nephrosis,,,,,,Kidney disease,
http://www.pepathway.org/peo/1.1#PGF,PGF,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:PGF,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/5228,,,,,,,,,,,,,,,,,,,,PGF,
http://www.pepathway.org/peo/1.2#Edema,Edema,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Edema,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/79654002,,,,Oedema - lesion|Edema (morphologic abnormality)|Edema - lesion|Edematous|Oedema|Oedematous,,,,,,Edema,
http://www.pepathway.org/peo/1.2#primary_purpose_design,primary purpose design,,what is this?,false,,,http://scai.fraunhofer.de/NDDUO#Study_design,,peo2:primary_purpose_design,,,,,,,,,,,,,,,,,,,,,,,primary purpose designs,,,,,what is this?,primary purpose design,
http://www.pepathway.org/peo/1.2#thing_related_to_early_onset,thing related to early onset,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_stage,,peo2:thing_related_to_early_onset,,,,,,,,,,,,,,,,,,,,,,,Early onset|EO,,,,,,thing related to early onset,
http://scai.fraunhofer.de/NDDUO#Morbidity,thing related to morbidity,,AD261,false,,,http://scai.fraunhofer.de/NDDUO#Descriptive_statistics,,NDDUO:Morbidity,,,,,,,,,,,,,,,,,,,,,,,Morbidity,,,,,AD261,thing related to morbidity,
http://www.pepathway.org/peo/1.2#Country_of_birth,Country of birth,,,false,,,http://www.pepathway.org/peo/1.2#Geography,,peo2:Country_of_birth,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/315354004,,,,Country of birth (observable entity)|Born in - country,,,,,,Country of birth,
http://www.pepathway.org/peo/1.2#Hyperandrogenization_syndrome,Hyperandrogenization syndrome,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Hyperandrogenization_syndrome,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/237793004,,,,Hyperandrogenization syndrome (disorder)|Hyperandrogenism|Hyperandrogenisation syndrome,,,,,,Hyperandrogenization syndrome,
http://scai.fraunhofer.de/NDDUO#diagnosis_context,diagnosis context,,,false,,,http://www.pepathway.org/peo/1.2#clinical_observation_context,,NDDUO:diagnosis_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,diagnosis context,
http://www.pepathway.org/peo/1.2#lipid_peroxidation,lipid peroxidation,,from manual annotation of text corpus,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:lipid_peroxidation,,,,,,,,,,,,,,,,,,,,,,,,,,,,from manual annotation of text corpus,lipid peroxidation,
http://www.pepathway.org/peo/1.2#Lung_disease,Lung disease,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Lung_disease,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10051054,,,,,,,,,,Lung disease,
http://www.pepathway.org/peo/1.2#Enviornmental_manipulations,Environmental manipulation,,AD085,false,,,http://www.ifomis.org/bfo/1.1/span#Process,,peo2:Enviornmental_manipulations,,,,,,,,,,,,,,,,,,,,,,,Environmental manipulations,,,,,AD085,Environmental manipulation,
http://scai.fraunhofer.de/NDDUO#Migrant_study,Migrant study,,,false,,,http://scai.fraunhofer.de/NDDUO#Descriptive_study,,NDDUO:Migrant_study,,,,,,,,,,,,,,,,,,,,,,,Migrant studies,,,,,,Migrant study,
http://www.pepathway.org/peo/1.2#Metabolic_encephalopathy,Metabolic encephalopathy,,,false,,,http://www.pepathway.org/peo/1.2#Metabolic_disease,,peo2:Metabolic_encephalopathy,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/50122000,,,,Metabolic encephalopathy (disorder)|Metabolic brain syndrome,,,,,,Metabolic encephalopathy,
http://scai.fraunhofer.de/NDDUO#Non_pharmacotherapy,thing related to non pharmacotherapy clinical treatment,,,false,,,http://scai.fraunhofer.de/NDDUO#Clinical_treatment,,NDDUO:Non_pharmacotherapy,,,,,,,,,,,,,,,,,,,,,,,non pharmacotherapy treatment|non pharmacotherapy treatments,,,,,,thing related to non pharmacotherapy clinical treatment,
http://www.pepathway.org/peo/1.2#Amount_of_blood_loss,Amount of blood loss,,,false,,,http://www.pepathway.org/peo/1.2#Haemorrhage_finding,,peo2:Amount_of_blood_loss,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Amount of blood loss,
http://www.pepathway.org/peo/1.2#Hypertensive_Encephalopathy,Hypertensive Encephalopathy,,,false,,,http://www.pepathway.org/peo/1.2#Hypertensive_disorder,,peo2:Hypertensive_Encephalopathy,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D020343,,,,"Encephalopathy, Hypertensive",,,,"Brain dysfunction or damage resulting from sustained MALIGNANT HYPERTENSION. When BLOOD PRESSURE exceeds the limits of cerebral autoregulation, cerebral blood flow is impaired (BRAIN ISCHEMIA). Clinical manifestations include HEADACHE; NAUSEA; VOMITING; SEIZURES; altered mental status (in some cases progressing to COMA); PAPILLEDEMA; and RETINAL HEMORRHAGE.",,Hypertensive Encephalopathy,
http://www.pepathway.org/peo/1.1#Laminins,Laminins,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:Laminins,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D007797,,,,,,,,,,,,,,"Glycoprotein GP 2|Chain, Laminin M|M Chain, Laminin|Glycoprotein GP-2|Laminin M Chain|Laminin M|Merosin",,,,"Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion.",,Laminins,
http://www.pepathway.org/peo/1.2#Postneonatal_death,Postneonatal death,,,false,,,http://www.pepathway.org/peo/1.2#Newborn_death,,peo2:Postneonatal_death,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/391100008,,,,Postneonatal death (event),,,,Death of an infant after 28 days of age and before 1 year of age,,Postneonatal death,
http://www.pepathway.org/peo/1.2#randomized_study,randomized study,,,false,,,http://scai.fraunhofer.de/NDDUO#Study_type,,peo2:randomized_study,,,,,,,,,,,,,,,,,,,,,,from manual annotation of text corpus,randomized studies,,,,,,randomized study,
http://scai.fraunhofer.de/NDDUO#Non_clinical,Non clinical thing,,,false,,,http://www.w3.org/2002/07/owl#Thing,,NDDUO:Non_clinical,,,,,,,,,,,,,,,,,,,,,,,non clinical,,,,,,Non clinical thing,
http://www.pepathway.org/peo/1.2#Incidence_density_ratio,Incidence density ratio,,AD310,false,,,http://www.pepathway.org/peo/1.2#Incidence_rate,,peo2:Incidence_density_ratio,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD310,Incidence density ratio,
http://www.pepathway.org/peo/1.2#Oligohydramnios,Oligohydramnios,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Oligohydramnios,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/59566000,,,,Scanty liquor|Reduced liquor volume|Deficient liquor|Oligohydramnios (disorder),,,,,,Oligohydramnios,
http://www.pepathway.org/peo/1.2#performing_physical_activity,performing physical activity,,,false,,,http://scai.fraunhofer.de/NDDUO#non_pharmacotherapy_procedure,,peo2:performing_physical_activity,,,,,,,,,,,,,,,,,,,,,,,physical activity|physical activities|high physical activity,,,,,,performing physical activity,
http://www.pepathway.org/peo/1.2#Mixed_collagen_vascular_disease,Mixed collagen vascular disease,,,false,,,http://www.pepathway.org/peo/1.2#Connective_tissue_disease_overlap_syndrome,,peo2:Mixed_collagen_vascular_disease,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/398049005,,,,Mixed collagen vascular disease (disorder)|MCTD - Mixed connective tissue disease|Mixed connective tissue disease|Sharp's syndrome,,,,,,Mixed collagen vascular disease,
http://www.ifomis.org/bfo/1.1/snap#FiatObjectPart,fiat_object_part,,"Synonyms: fiat substance part|Definition: A material entity [snap:MaterialEntity] that is part of an object [snap:Object] but is not demarcated by any physical discontinuities.|Examples: upper and lower lobes of the left lung, the dorsal and ventral surfaces of the body, the east side of Saarbruecken, the lower right portion of a human torso",false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,snap:FiatObjectPart,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Synonyms: fiat substance part|Definition: A material entity [snap:MaterialEntity] that is part of an object [snap:Object] but is not demarcated by any physical discontinuities.|Examples: upper and lower lobes of the left lung, the dorsal and ventral surfaces of the body, the east side of Saarbruecken, the lower right portion of a human torso",fiat_object_part,
http://www.pepathway.org/peo/1.2#Spiral_arteries,Spiral arteries,,,false,,,http://www.pepathway.org/peo/1.2#Arteries,,peo2:Spiral_arteries,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Spiral arteries,
http://www.pepathway.org/peo/1.2#survivor,survivor,,from NP chunking,false,,,http://www.ifomis.org/bfo/1.1/snap#Object,,peo2:survivor,,,,,,,,,,,,,,,,,,,,,,,survivors,,,,,from NP chunking,survivor,
http://www.pepathway.org/peo/1.2#Ambulatory_blood_pressure_recording,Ambulatory blood pressure recording,,,false,,,http://www.pepathway.org/peo/1.2#Echocardiography,,peo2:Ambulatory_blood_pressure_recording,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/164783007,,,,Ambulatory blood pressure recording (procedure),,,,,,Ambulatory blood pressure recording,
http://www.pepathway.org/peo/1.2#Methamphetamine_abuse,Methamphetamine abuse,,,false,,,http://www.pepathway.org/peo/1.2#Drug_abuse,,peo2:Methamphetamine_abuse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Methamphetamine abuse,
http://scai.fraunhofer.de/NDDUO#Concurrent_cohort_study,Concurrent cohort study,,,false,,,http://scai.fraunhofer.de/NDDUO#Cohort_study,,NDDUO:Concurrent_cohort_study,,,,,,,,,,,,,,,,,,,,,,,Concurrent cohort studies,,,,,,Concurrent cohort study,
http://www.pepathway.org/peo/1.1#KCNN3,KCNN3,,,false,,,http://www.pepathway.org/peo/1.1#KCNN,,peo:KCNN3,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/3782,,,,,,,,,,,,,,,,,,,,KCNN3,
http://scai.fraunhofer.de/NDDUO#Proportion,Proportion,,,false,,,http://scai.fraunhofer.de/NDDUO#rate,,NDDUO:Proportion,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/PATO#PATO_0001470,,,,Proportions|proportionality|proportionalities|proportion|quotient|quotients|ratio|ratios,,,,,,Proportion,
http://www.pepathway.org/peo/1.2#Dimerization,Dimerization,,AD604,false,,,http://www.pepathway.org/peo/1.2#Post_translational_modification,,peo2:Dimerization,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/GO#GO_0046983,,,,,,,,,AD604,Dimerization,
http://www.pepathway.org/peo/1.2#perfluorononanoic_acid,perfluorononanoic acid,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:perfluorononanoic_acid,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/C584865,,,,PFNA,,,,,,perfluorononanoic acid,
http://www.pepathway.org/peo/1.2#Details_of_education,Details of education,,,false,,,http://www.pepathway.org/peo/1.2#Education_and_schooling_detail,,peo2:Details_of_education,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/276031006,,,,Details of education (observable entity)|Education,,,,,,Details of education,
http://www.pepathway.org/peo/1.2#Immunotolerance,Immunotolerance,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Immunotolerance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Immunotolerance,
http://www.pepathway.org/peo/1.2#Blood_coagulation_disorder,Blood coagulation disorder,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Blood_coagulation_disorder,,,,,,,,,,,,,,,,,,,,,,,Bleeding disorder|Coagulation disorder|Disorder of haemostasis|Blood coagulation disorder (disorder)|Bleeding diathesis|Blood clotting disorder|Bleeding tendency|Coagulopathy|Disorder of hemostasis|Clotting disorder,,,,,,Blood coagulation disorder,
http://scai.fraunhofer.de/NDDUO#in_vitro_context,in vitro context,,,false,,,http://scai.fraunhofer.de/NDDUO#context,,NDDUO:in_vitro_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,in vitro context,
http://scai.fraunhofer.de/NDDUO#Cause_specific_mortality_rate,Cause specific mortality rate,,,false,,,http://scai.fraunhofer.de/NDDUO#Mortility_rate,,NDDUO:Cause_specific_mortality_rate,,,,,,,,,,,,,,,,,,,,,,,Cause specific mortality rates,,,,,,Cause specific mortality rate,
http://www.pepathway.org/peo/1.2#At_delivery_before_labor,At delivery before labor,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_time_period,,peo2:At_delivery_before_labor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,At delivery before labor,
http://www.pepathway.org/peo/1.2#intervention_study,intervention study,,,false,,,http://scai.fraunhofer.de/NDDUO#Study_type,,peo2:intervention_study,,,,,,,,,,,,,,,,,,,,,,,intervention studies,,,,,,intervention study,
http://scai.fraunhofer.de/NDDUO#mild_stage_context,mild stage context,,,false,,,http://scai.fraunhofer.de/NDDUO#stage_context,,NDDUO:mild_stage_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mild stage context,
http://www.pepathway.org/peo/1.2#Fetus_Organs,Fetus Organs,,,false,,,http://www.pepathway.org/peo/1.2#Normal_functions_of_organs,,peo2:Fetus_Organs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Fetus Organs,
http://www.pepathway.org/peo/1.2#Developmental,Developmental,,,false,,,http://www.pepathway.org/peo/1.2#Fetus_Organs,,peo2:Developmental,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/278923009,,,,Developmental (qualifier value),,,,,,Developmental,
http://scai.fraunhofer.de/NDDUO#Sex_specific_mortality_rate,Sex specific mortality rate,,,false,,,http://scai.fraunhofer.de/NDDUO#Mortility_rate,,NDDUO:Sex_specific_mortality_rate,,,,,,,,,,,,,,,,,,,,,,,Sex specific mortality rates,,,,,,Sex specific mortality rate,
http://www.pepathway.org/peo/1.2#Non-HDL-_C,Non-HDL- C,,,false,,,http://www.pepathway.org/peo/1.2#Blood_Biomarker,,peo2:Non-HDL-_C,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Non-HDL- C,
http://www.pepathway.org/peo/1.2#Downregulation,Downregulation,,AD613,false,,,http://scai.fraunhofer.de/NDDUO#Regulation_of_gene_expression,,peo2:Downregulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD613,Downregulation,
http://www.ifomis.org/bfo/1.1/snap#Disposition,disposition,,"Examples: the disposition of vegetables to decay when not refrigerated, the disposition of a vase to brake if dropped, the disposition of blood to coagulate, the disposition of a patient with a weakened immune system to contract disease, the disposition of metal to conduct electricity.|Definition: A realizable entity [snap:RealizableEntity] that essentially causes a specific process or transformation in the object [snap:Object] in which it inheres, under specific circumstances and in conjunction with the laws of nature. A general formula for dispositions is: X (object [snap:Object] has the disposition D to (transform, initiate a process) R under conditions C.",false,,,http://www.ifomis.org/bfo/1.1/snap#RealizableEntity,,snap:Disposition,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Examples: the disposition of vegetables to decay when not refrigerated, the disposition of a vase to brake if dropped, the disposition of blood to coagulate, the disposition of a patient with a weakened immune system to contract disease, the disposition of metal to conduct electricity.|Definition: A realizable entity [snap:RealizableEntity] that essentially causes a specific process or transformation in the object [snap:Object] in which it inheres, under specific circumstances and in conjunction with the laws of nature. A general formula for dispositions is: X (object [snap:Object] has the disposition D to (transform, initiate a process) R under conditions C.",disposition,
http://www.pepathway.org/peo/1.2#White-collar_worker,White-collar worker,,,false,,,http://www.pepathway.org/peo/1.2#Employment_detail,,peo2:White-collar_worker,,,,,,,,,http://en.wikipedia.org/wiki/White-collar_worker,,,,,,,,,,,,,,,,,,,,White-collar worker,
http://www.pepathway.org/peo/1.2#Cardiomegaly,Cardiomegaly,,,false,,,http://www.pepathway.org/peo/1.2#Heart_disease,,peo2:Cardiomegaly,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D006332,,,,"Cardiac Hypertrophy|Heart Hypertrophy|Enlarged Heart|Heart, Enlarged|Heart Enlargement|Enlargement, Heart",,,,"Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix. Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.",,Cardiomegaly,
http://scai.fraunhofer.de/NDDUO#antirheumatic_drug,antirheumatic drug,,,false,,,http://scai.fraunhofer.de/NDDUO#drug_role,,NDDUO:antirheumatic_drug,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_35842,,,,antirheumatic drugs,,,,,,antirheumatic drug,
http://www.pepathway.org/peo/1.2#Social_context,Social context,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Social_context,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/48176007,,,,Social context (social concept),,,,,,Social context,
http://www.pepathway.org/peo/1.2#Vertex_presentation,Vertex presentation,,,false,,,http://www.pepathway.org/peo/1.2#Clinical_situation,,peo2:Vertex_presentation,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/70028003,,,,Vertex presentation (finding)|Cephalic presentation,,,,,,Vertex presentation,
http://scai.fraunhofer.de/NDDUO#primary_outcome_measure,primary outcome measure,,,false,,,http://scai.fraunhofer.de/NDDUO#outcome_measure,,NDDUO:primary_outcome_measure,,,,,,,,,,,,,,,,,,,,,,,primary outcome measures,,,,,,primary outcome measure,
http://www.pepathway.org/peo/1.2#alcohol_molecule,alcohol,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:alcohol_molecule,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_30879,,,,Alcohol|HOR|O[*]|alcohols|an alcohol,,,,"A compound in which a hydroxy group, -OH, is attached to a saturated carbon atom.",,alcohol,
http://www.pepathway.org/peo/1.2#Conscious_blood_pressure_control,Conscious blood pressure control,,,false,,,http://www.pepathway.org/peo/1.2#Therapeutics,,peo2:Conscious_blood_pressure_control,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/183413003,,,,Conscious blood pressure control (regime/therapy)|Conscious B.P. control,,,,,,Conscious blood pressure control,
http://www.pepathway.org/peo/1.2#Bilateral_notching,Bilateral notching,,,false,,,http://www.pepathway.org/peo/1.2#Echocardiography,,peo2:Bilateral_notching,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Bilateral notching,
http://scai.fraunhofer.de/NDDUO#molecular_context,molecular context,,,false,,,http://scai.fraunhofer.de/NDDUO#context,,NDDUO:molecular_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,molecular context,
http://scai.fraunhofer.de/NDDUO#Age,Age,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,NDDUO:Age,,,,,,,,,,,,,,,,,,,,,,,age-at-onset|age at onset|AAO,,,,,,Age,
http://www.pepathway.org/peo/1.2#Vascular_luminal_abnormality,Vascular luminal abnormality,,,false,,,http://www.pepathway.org/peo/1.2#Vascular_disorders,,peo2:Vascular_luminal_abnormality,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Vascular luminal abnormality,
http://www.pepathway.org/peo/1.2#Perinatal_asphyxia,Perinatal asphyxia,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:Perinatal_asphyxia,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/281578009,,,,Perinatal asphyxia (disorder),,,,,,Perinatal asphyxia,
http://www.pepathway.org/peo/1.2#Prothrombin_time,Prothrombin time,,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:Prothrombin_time,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/396451008,,,,Prothrombin time (procedure)|PT - Prothrombin time|Quick one stage prothrombin time|PT assay|Protime,,,,,,Prothrombin time,
http://www.pepathway.org/peo/1.1#GPT,GPT,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:GPT,,,,,,,,,,,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/2875,,,,,,,,,,GPT,
http://www.pepathway.org/peo/1.2#somatostatin,somatostatin,,,false,,,http://www.pepathway.org/peo/1.2#hormone,,peo2:somatostatin,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_64628,,,,"L-alanyl-N-[(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-4-carboxy-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontan-37-yl]glycinamide|somatostatin|somatostatina|somatostatine|InChI=1S/C76H104N18O19S2/c1-41(79)64(100)82-37-61(99)83-58-39-114-115-40-59(76(112)113)92-72(108)57(38-95)91-75(111)63(43(3)97)94-71(107)54(33-46-23-11-6-12-24-46)90-74(110)62(42(2)96)93-66(102)51(28-16-18-30-78)84-69(105)55(34-47-36-81-49-26-14-13-25-48(47)49)88-68(104)53(32-45-21-9-5-10-22-45)86-67(103)52(31-44-19-7-4-8-20-44)87-70(106)56(35-60(80)98)89-65(101)50(85-73(58)109)27-15-17-29-77/h4-14,19-26,36,41-43,50-59,62-63,81,95-97H,15-18,27-35,37-40,77-79H2,1-3H3,(H2,80,98)(H,82,100)(H,83,99)(H,84,105)(H,85,109)(H,86,103)(H,87,106)(H,88,104)(H,89,101)(H,90,110)(H,91,111)(H,92,108)(H,93,102)(H,94,107)(H,112,113)/t41-,42+,43+,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,62-,63-/m0/s1|Ala-Gly-cyclo-[Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys]|InChIKey=NHXLMOGPVYXJNR-ATOGVRKGSA-N|Somatostatin-14|Somatostatin-1|C76H104N18O19S2|L-alanylglycyl-L-cysteinyl-L-lysyl-L-asparaginyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine cyclic (3-14) disulfide|C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC1=O)[C@@H](C)O)C(O)=O)NC(=O)CNC(=O)[C|Synthetic growth hormone release-inhibiting hormone|somatostatinum",,,,A fourteen-membered heterodetic cyclic peptide comprising the sequence Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys cyclised by a disulfide bridge between the two Cys residues at positions 3 and 14.,,somatostatin,
http://www.pepathway.org/peo/1.2#dose_ranging_study,dose ranging study,,,false,,,http://scai.fraunhofer.de/NDDUO#Study_type,,peo2:dose_ranging_study,,,,,,,,,,,,,,,,,,,,,,,dose ranging studies,,,,,,dose ranging study,
http://www.pepathway.org/peo/1.2#Organelle,Organelle,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:Organelle,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/116194001,,,,Organelle structure|Organelle (cell structure),,,,,,Organelle,
http://www.pepathway.org/peo/1.2#Placentation,Placentation,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Placentation,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/112067000,,,,"Placentation, function|Placentation, function (observable entity)",,,,,,Placentation,
http://www.pepathway.org/peo/1.2#Esophageal_Squamous_Cell_Carcinoma,Esophageal Squamous Cell Carcinoma,,,false,,,http://www.pepathway.org/peo/1.2#Neoplasm_by_body_site,,peo2:Esophageal_Squamous_Cell_Carcinoma,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/C562729,,,,,,,,,,Esophageal Squamous Cell Carcinoma,
http://www.pepathway.org/peo/1.2#Hydrops_fetalis,Hydrops fetalis,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_fetus_or_newborn,,peo2:Hydrops_fetalis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/276508000,,,,HF - Hydrops fetalis|Hydrops fetalis (disorder),,,,,,Hydrops fetalis,
http://www.pepathway.org/peo/1.2#Pregnancy_test_urine,Pregnancy test urine,,,false,,,http://www.pepathway.org/peo/1.2#Biochemical_test,,peo2:Pregnancy_test_urine,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10036576,,,,,,,,,,Pregnancy test urine,
http://www.pepathway.org/peo/1.2#Epilepsy,Epilepsy,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Epilepsy,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/84757009,,,,Epilepsy (disorder)|Epileptic attack|EP - Epilepsy,,,,,,Epilepsy,
http://www.pepathway.org/peo/1.2#Incidence_in_non_exposed,Incidence in non exposed,,AD307,false,,,http://www.pepathway.org/peo/1.2#Incidence,,peo2:Incidence_in_non_exposed,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD307,Incidence in non exposed,
http://www.pepathway.org/peo/1.2#Emergency_cesarean_section,Emergency cesarean section,,,false,,,http://www.pepathway.org/peo/1.2#Cesarean_section,,peo2:Emergency_cesarean_section,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/274130007,,,,Emergency cesarean section (procedure)|Emergency caesarean section,,,,,,Emergency cesarean section,
http://scai.fraunhofer.de/NDDUO#epidemiology_context,epidemiology context,,,false,,,http://scai.fraunhofer.de/NDDUO#context,,NDDUO:epidemiology_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,epidemiology context,
http://www.pepathway.org/peo/1.2#Inflammatory_disorder,Inflammatory disorder,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Inflammatory_disorder,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/128139000,,,,Inflammatory disease|Inflammatory disorder (disorder),,,,,,Inflammatory disorder,
http://www.pepathway.org/peo/1.2#ACE_inhibitor,ACE inhibitor,,,false,,,http://scai.fraunhofer.de/NDDUO#inhibitor,,peo2:ACE_inhibitor,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_35457,,,,angiotensin-converting enzyme inhibitor|ACE inhibitors,,,,,,ACE inhibitor,
http://www.pepathway.org/peo/1.1#BTC,BTC,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:BTC,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/685,,,,,,,,,,,,,,,,,,,,BTC,
http://www.pepathway.org/peo/1.2#Exocytosis,Exocytosis,,AD484,false,,,http://www.pepathway.org/peo/1.2#processes_all_cells,,peo2:Exocytosis,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/GO#GO_0006887,,,,vesicle exocytosis|Reverse Pinocytosis,,,,,AD484,Exocytosis,
http://www.pepathway.org/peo/1.2#hormone,hormone,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:hormone,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_24621,,,,endocrine|hormones,,,,"Originally referring to an endogenous compound that is formed in specialized organ or group of cells and carried to another organ or group of cells, in the same organism, upon which it has a specific regulatory function, the term is now commonly used to include non-endogenous, semi-synthetic and fully synthetic analogues of such compounds.",,hormone,
http://www.pepathway.org/peo/1.2#Incidence_rate,Incidence rate,,AD308,false,,,http://www.pepathway.org/peo/1.2#Incidence,,peo2:Incidence_rate,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD308,Incidence rate,
http://www.pepathway.org/peo/1.2#Methylation,Methylation,,AD597,false,,,http://www.pepathway.org/peo/1.2#Epigenetics,,peo2:Methylation,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/GO#GO_0032259,,,,,,,,,AD597,Methylation,
http://www.pepathway.org/peo/1.2#Trophoblasts,Trophoblasts,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:Trophoblasts,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D014327,,,,Trophoblast|Cytotrophoblasts|Cytotrophoblast|Syncytiotrophoblast|Syncytiotrophoblasts,,,,"Cells lining the outside of the BLASTOCYST. After binding to the ENDOMETRIUM, trophoblasts develop into two distinct layers, an inner layer of mononuclear cytotrophoblasts and an outer layer of continuous multinuclear cytoplasm, the syncytiotrophoblasts, which form the early fetal-maternal interface (PLACENTA). Trophoblasts with multinuclear cytoplasm and undefined cellular structures. Syncytiotrophoblasts secrete proteolytic enzymes that erode the ENDOMETRIUM for EMBRYO IMPLANTATION. They also produce steroid, peptide, and protein hormones (PLACENTAL HORMONES). Trophoblasts with single nucleus and defined cellular structures. As the PLACENTA develops, pockets of cytotrophoblasts serve as stem cells for syncytiotrophoblasts.",,Trophoblasts,
http://www.pepathway.org/peo/1.1#FASLG,FASLG,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:FASLG,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/356,,,,,,,,,,,,,,,,,,,,FASLG,
http://www.pepathway.org/peo/1.2#case_report,case report,,from NP chunking,false,,,http://www.ifomis.org/bfo/1.1/snap#GenericallyDependentContinuant,,peo2:case_report,,,,,,,,,,,,,,,,,,,,,,,case reports,,,,,from NP chunking,case report,
http://www.pepathway.org/peo/1.2#Renal_failure,Renal failure,,,false,,,http://www.pepathway.org/peo/1.2#Kidney_disease,,peo2:Renal_failure,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/OMIM/MTHU000623,,,,,,,,,,Renal failure,
http://www.pepathway.org/peo/1.2#ADRB_blockers,ADRB blockers,,,false,,,http://scai.fraunhofer.de/NDDUO#drug_role,,peo2:ADRB_blockers,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ADRB blockers,
http://www.pepathway.org/peo/1.2#Transient_cerebral_ischemia,Transient cerebral ischemia,,,false,,,http://www.pepathway.org/peo/1.2#Brain_Diseases,,peo2:Transient_cerebral_ischemia,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/266257000,,,,Transient ischaemic attack|Transient ischemic attack|Temporary cerebral vascular dysfunction|Intermittent cerebral ischemia|Transient ischemic attack (disorder)|Intermittent cerebral ischaemia|Transient cerebral ischaemia|TIA - Transient ischaemic attack|TIA,,,,,,Transient cerebral ischemia,
http://www.pepathway.org/peo/1.2#Serum_testosterone_measurement,Serum testosterone measurement,,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:Serum_testosterone_measurement,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/270973006,,,,Serum testosterone measurement (procedure)|Serum testosterone level,,,,,,Serum testosterone measurement,
http://www.pepathway.org/peo/1.2#beta_Carotene,beta Carotene,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:beta_Carotene,,,,,,,,,,,,,,,,,,,,,,,BellaCarotin|Marlyn Brand of Betacarotene|Betacarotene Roche Brand|Betacarotene Hermal Brand|Betacarotene Solgar Brand|Carotaben|Max Caro|Max-Caro|MaxCaro|Solatene,,,,,,beta Carotene,
http://scai.fraunhofer.de/NDDUO#Mortality,Mortality,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,NDDUO:Mortality,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mortality,
http://www.pepathway.org/peo/1.2#Antithyroid_agent,Antithyroid agent,,,false,,,http://www.pepathway.org/peo/1.2#drug,,peo2:Antithyroid_agent,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/418416001,,,,Antithyroid agent (substance),,,,,,Antithyroid agent,
http://www.pepathway.org/peo/1.2#Length_of_gestation_at_time_of_procedure,Length of gestation at time of procedure,,,false,,,http://www.pepathway.org/peo/1.2#Fetal_gestational_age,,peo2:Length_of_gestation_at_time_of_procedure,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/445872007,,,,Length of gestation at time of procedure (observable entity),,,,,,Length of gestation at time of procedure,
http://scai.fraunhofer.de/NDDUO#Study_type,clinical trial study,,,false,,,http://www.ifomis.org/bfo/1.1/span#Process,,NDDUO:Study_type,,,,,,,,,,,,,,,,,,,,,,,clinical trial studies|studies|study,,,,,,clinical trial study,
http://www.pepathway.org/peo/1.2#Metabolic_Markers,Metabolic Marker,,AD132,false,,,http://scai.fraunhofer.de/NDDUO#biomarker,,peo2:Metabolic_Markers,,,,,,,,,,,,,,,,,,,,,,http://www.benthamscience.com/open/tonmedj/article/V002/SI0010TONMEDJ/12TONMEDJ.pdf,metabolic biomarker|Metabolic Markers|metabolic biomarkers,,,,,AD132,Metabolic Marker,
http://www.pepathway.org/peo/1.2#Maternal_tobacco_use,Maternal tobacco use,,,false,,,http://www.pepathway.org/peo/1.2#Tobacco_use_and_exposure_-_finding,,peo2:Maternal_tobacco_use,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/427189007,,,,Maternal tobacco use (finding),,,,,,Maternal tobacco use,
http://scai.fraunhofer.de/NDDUO#ex_vivo_context,ex vivo context,,,false,,,http://scai.fraunhofer.de/NDDUO#context,,NDDUO:ex_vivo_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ex vivo context,
http://www.pepathway.org/peo/1.2#Fetal_observable,Fetal observable,,,false,,,http://www.pepathway.org/peo/1.2#Physiological_test,,peo2:Fetal_observable,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/364599001,,,,Fetal observable (observable entity),,,,,,Fetal observable,
http://www.pepathway.org/peo/1.2#Termination_of_pregnancy,Termination of pregnancy,,,false,,,http://www.pepathway.org/peo/1.2#Therapeutics|http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:Termination_of_pregnancy,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/386639001,,,,Induced abortion|Induced termination of pregnancy (disorder)|Termination of pregnancy (procedure)|Induced termination of pregnancy|Abortion,,,,,,Termination of pregnancy,
http://www.pepathway.org/peo/1.2#Standardized_incidence_ratio,Standardized incidence ratio,,AD315,false,,,http://www.pepathway.org/peo/1.2#Incidence,,peo2:Standardized_incidence_ratio,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD315,Standardized incidence ratio,
http://www.pepathway.org/peo/1.2#Erythrocyte_production,Erythrocyte production,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Erythrocyte_production,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/69611006,,,,"Erythropoiesis|Erythrocyte production, function|Erythrocyte production, function (observable entity)",,,,,,Erythrocyte production,
http://www.ifomis.org/bfo/1.1/snap#IndependentContinuant,independent_continuant,,"Examples: an organism, a heart, a leg, a person, a symphony orchestra, a chair, the bottom right portion of a human torso, the lawn and atmosphere in front of our building|Definition: A continuant [snap:Continuant] that is a bearer of quality [snap:Quality] and realizable entity [snap:RealizableEntity] entities, in which other entities inhere and which itself cannot inhere in anything.|Synonyms: substantial entity",false,,,http://www.ifomis.org/bfo/1.1/snap#Continuant,,snap:IndependentContinuant,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Examples: an organism, a heart, a leg, a person, a symphony orchestra, a chair, the bottom right portion of a human torso, the lawn and atmosphere in front of our building|Definition: A continuant [snap:Continuant] that is a bearer of quality [snap:Quality] and realizable entity [snap:RealizableEntity] entities, in which other entities inhere and which itself cannot inhere in anything.|Synonyms: substantial entity",independent_continuant,
http://www.pepathway.org/peo/1.2#estrogen,estrogen,,,false,,,http://www.pepathway.org/peo/1.2#hormone,,peo2:estrogen,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_50114,,,,oestrogenes|estrogenes Hormon|Estrogene|Oestrogen|Oestrogene|estrogene|estrogenes|estrogeno|estrogenos|estrogens|oestrogen|oestrogene|oestrogens,,,,"A hormone that stimulates or controls the development and maintenance of female sex characteristics in mammals by binding to oestrogen receptors. The oestrogens are named for their importance in the oestrous cycle. The oestrogens that occur naturally in the body, notably estrone, estradiol, estriol, and estetrol are steroids. Other compounds with oestrogenic activity are produced by plants (phytoestrogens) and fungi (mycoestrogens); synthetic compounds with oestrogenic activity are known as xenoestrogens.",,estrogen,
http://scai.fraunhofer.de/NDDUO#Gender,Gender,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,NDDUO:Gender,,,,,,,,,,,,,,,,,,,,,,,sex,,,,,,Gender,
http://www.pepathway.org/peo/1.2#Selenium,Selenium,,,false,,,http://www.pepathway.org/peo/1.2#drug,,peo2:Selenium,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/22038003,,,,Se - Selenium|Selenium (substance),,,,,,Selenium,
http://scai.fraunhofer.de/NDDUO#applied_epidemiology_context,applied epidemiology context,,,false,,,http://scai.fraunhofer.de/NDDUO#epidemiology_context,,NDDUO:applied_epidemiology_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,applied epidemiology context,
http://www.pepathway.org/peo/1.2#sFlt1-PlGF_ratio,sFlt1-PlGF ratio,,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:sFlt1-PlGF_ratio,,,,,,,,,,,,,,,,,,,,,,,,,,,,,sFlt1-PlGF ratio,
http://www.pepathway.org/peo/1.2#triglyceride-rich_lipoprotein,triglyceride-rich lipoprotein,,,false,,,http://www.pepathway.org/peo/1.2#cholesterol,,peo2:triglyceride-rich_lipoprotein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,triglyceride-rich lipoprotein,
http://scai.fraunhofer.de/NDDUO#Cross_sectional_survey,Cross sectional survey,,,false,,,http://scai.fraunhofer.de/NDDUO#Descriptive_study,,NDDUO:Cross_sectional_survey,,,,,,,,,,,,,,,,,,,,,,,Cross sectional surveys,,,,,,Cross sectional survey,
http://www.pepathway.org/peo/1.2#Coronary_arteriosclerosis,Coronary arteriosclerosis,,,false,,,http://www.pepathway.org/peo/1.2#Heart_disease,,peo2:Coronary_arteriosclerosis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/53741008,,,,Coronary heart disease|CHD - Coronary heart disease|Coronary artery disease|Coronary sclerosis|Coronary arteriosclerosis (disorder)|Arteriosclerotic heart disease|CAD - Coronary artery disease,,,,,,Coronary arteriosclerosis,
http://www.pepathway.org/peo/1.2#Plasma,Plasma,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Plasma,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/50863008,,,,Plasma (substance),,,,,,Plasma,
http://www.pepathway.org/peo/1.2#Swelling_of_endothelial_cells,Swelling of endothelial cells,,,false,,,http://www.pepathway.org/peo/1.2#Vascular_disorders,,peo2:Swelling_of_endothelial_cells,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/OMIM/MTHU040828,,,,,,,,,,Swelling of endothelial cells,
http://www.pepathway.org/peo/1.2#Never_used_tobacco,Never used tobacco,,,false,,,http://www.pepathway.org/peo/1.2#Maternal_tobacco_use,,peo2:Never_used_tobacco,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/702979003,,,,Never used tobacco (finding),,,,,,Never used tobacco,
http://scai.fraunhofer.de/NDDUO#Clinical_treatment,thing related to clinical treatment,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_phenotypic_features,,NDDUO:Clinical_treatment,,,,,,,,,,,,,,,,,,,,,,,clinical treatment|clinical treatments,,,,,,thing related to clinical treatment,
http://www.pepathway.org/peo/1.2#Admission_to_intensive_care_unit,Admission to intensive care unit,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:Admission_to_intensive_care_unit,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/305351004,,,,ICU - Admission to intensive care unit|Admit to intensive care unit|Admit to ITU|Admission to intensive care unit (procedure),,,,,,Admission to intensive care unit,
http://www.pepathway.org/peo/1.2#Endocrine_defects,Endocrine defects,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Endocrine_defects,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Endocrine defects,
http://scai.fraunhofer.de/NDDUO#Nested_case_control_study,Nested case control study,,,false,,,http://scai.fraunhofer.de/NDDUO#Cohort_study,,NDDUO:Nested_case_control_study,,,,,,,,,,,,,,,,,,,,,,,Nested case control studies,,,,,,Nested case control study,
http://www.pepathway.org/peo/1.2#Nonsteroidal_Antiinflamatory_drugs,Nonsteroidal Antiinflamatory drug,,AD047,false,,,http://www.pepathway.org/peo/1.2#antiinflammatory_drugs|http://scai.fraunhofer.de/NDDUO#antirheumatic_drug,,peo2:Nonsteroidal_Antiinflamatory_drugs,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_35475,,,http://www.omnimedicalsearch.com/conditions-diseases/alzheimers-disease-treatment-prevention.html,Non steroidal antiinflamatory analgesics|Non steroidal antiinflamatory medicines|Nonsteroidal Antiinflamatory drugs|Non steroidal antiinflamatory agents|non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs|NAIDs|NSAID|NSAID's|NSAIMS,,,,,AD047,Nonsteroidal Antiinflamatory drug,
http://scai.fraunhofer.de/NDDUO#syndrome_context,syndrome context,,,false,,,http://scai.fraunhofer.de/NDDUO#context,,NDDUO:syndrome_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,syndrome context,
http://www.pepathway.org/peo/1.1#GTSF1,GTSF1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:GTSF1,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/121355,,,,,,,,,,,,,,,,,,,,GTSF1,
http://www.pepathway.org/peo/1.2#peroxynitrite,peroxynitrite,,,false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,peo2:peroxynitrite,,,,,,,,,,,,,,,,,,,,,,,,,,,,,peroxynitrite,
http://www.pepathway.org/peo/1.2#Finding_of_brain,Finding of brain,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_observable,,peo2:Finding_of_brain,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Finding of brain,
http://www.pepathway.org/peo/1.2#phase_0,phase 0,,,false,,,http://scai.fraunhofer.de/NDDUO#Study_phase,,peo2:phase_0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,phase 0,
http://www.pepathway.org/peo/1.2#Lack_of_social_support,Lack of social support,,,false,,,http://www.pepathway.org/peo/1.2#Social_support_status,,peo2:Lack_of_social_support,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Lack of social support,
http://www.pepathway.org/peo/1.2#Ruptured_membranes,Ruptured membranes,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Ruptured_membranes,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/41957003,,,,Rupture of foetal membranes|Waters broken|Spontaneous rupture of fetal membranes|ROM - Ruptured membranes|Rupture of membranes|Ruptured membranes (disorder)|Spontaneous rupture of foetal membranes|Rupture of fetal membranes,,,,,,Ruptured membranes,
http://www.pepathway.org/peo/1.2#Blood_Biomarker,blood Biomarker,,AD108,false,,,http://scai.fraunhofer.de/NDDUO#biomarker,,peo2:Blood_Biomarker,,,,,,,,,,,,,,,,,,,,,,"A. Hye, S. Lynham, and S. Lynham, “Proteome-based plasma biomarkers for Alzheimer's disease,”Brain, vol. 129, no. 11, pp. 3042–3050, 2006.

Y.-M. Kuo, T. A. Kokjohn, and T. A. Kokjohn, “Amyloid-β peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma,” Biochemical and Biophysical Research Communications, vol. 268, no. 3, pp. 750–756, 2000.

H. Fukumoto, M. Tennis, J. J. Locascio, B. T. Hyman, J. H. Growdon, and M. C. Irizarry, “Age but not diagnosis is the main predictor of plasma amyloid β-protein levels,” Archives of Neurology, vol. 60, no. 7, pp. 958–964, 2003",blood Biomarkers,,,,,AD108,blood Biomarker,
http://www.pepathway.org/peo/1.2#body_weigtht_before_14wk,Body weight before 14 wk,,,false,,,http://www.pepathway.org/peo/1.2#Body_weight_measure,,peo2:body_weigtht_before_14wk,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Body weight before 14 wk,
http://www.pepathway.org/peo/1.2#Guinea_pig,Guinea pig,,,false,,,http://scai.fraunhofer.de/NDDUO#Rodents,,peo2:Guinea_pig,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Guinea pig,
http://www.pepathway.org/peo/1.2#Intravascular_Coagulation,Intravascular Coagulation,,,false,,,http://www.pepathway.org/peo/1.2#Thrombosis,,peo2:Intravascular_Coagulation,,,,,,,,,,,,,,,,,,,,,,,"",,,,,,Intravascular Coagulation,
http://scai.fraunhofer.de/NDDUO#Life_time_prevalence,Life time prevalence,,,false,,,http://scai.fraunhofer.de/NDDUO#prevalence,,NDDUO:Life_time_prevalence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Life time prevalence,
http://www.pepathway.org/peo/1.2#Students_t_test,Student's t-test,,from manual annotation of text corpus,false,,,http://www.ifomis.org/bfo/1.1/snap#GenericallyDependentContinuant,,peo2:Students_t_test,,,,,,,,,,,,,,,,,,,,,,,Student's t-tests,,,,,from manual annotation of text corpus,Student's t-test,
http://www.pepathway.org/peo/1.2#inflammation,inflammation,,from NP chunking|from manual annotation of text corpus,false,,,http://www.pepathway.org/peo/1.2#processes_all_cells,,peo2:inflammation,,,,,,,,,,,,,,,,,,,,,,,chronic inflammation|acute inflammatory response|inflammations|inflammatory response|inflammatory cascade|inflammatory cascades|peripheral inflammation|inflammatory responses|inflammatory,,,,,from NP chunking|from manual annotation of text corpus,inflammation,
http://www.pepathway.org/peo/1.2#Pain,Pain,,,false,,,http://scai.fraunhofer.de/NDDUO#Symptoms,,peo2:Pain,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/22253000,,,,Pain (finding)|Pain observations|Dolor|Painful|Part hurts,,,,,,Pain,
http://www.pepathway.org/peo/1.2#N-Acetyl-Cysteine,N-Acetyl-Cysteine,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:N-Acetyl-Cysteine,,,,,,,,,,,,,,,,,,,,,,,NAC,,,,,,N-Acetyl-Cysteine,
http://www.pepathway.org/peo/1.2#Poor_neonatal_condition,Poor neonatal condition,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:Poor_neonatal_condition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Poor neonatal condition,
http://www.pepathway.org/peo/1.2#Mitochondria_transport,Mitochondria transport,,AD485,false,,,http://www.pepathway.org/peo/1.2#processes_all_cells,,peo2:Mitochondria_transport,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/GO#GO_0006839,,,,,,,,,AD485,Mitochondria transport,
http://www.pepathway.org/peo/1.2#noradrenaline,noradrenaline,,,false,,,http://www.pepathway.org/peo/1.2#hormone,,peo2:noradrenaline,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_33569,,,,"InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2|4-(2-amino-1-hydroxyethyl)benzene-1,2-diol|InChIKey=SFLSHLFXELFNJZ-UHFFFAOYSA-N|NCC(O)c1ccc(O)c(O)c1|norepinephrine|noradrenalina|C8H11NO3",,,,A catecholamine in which C-1 of the aminoethyl side-chain is hydroxy-substituted.,,noradrenaline,
http://scai.fraunhofer.de/NDDUO#Evaluation,Evaluation,,,false,,,http://www.ifomis.org/bfo/1.1/span#Process,,NDDUO:Evaluation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Evaluation,
http://www.pepathway.org/peo/1.2#dyslipidemia,dyslipidemia,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:dyslipidemia,,,,,,,,,,,,,,,,,,,,,,from manual annotation of text corpus,,,,,,,dyslipidemia,
http://www.pepathway.org/peo/1.2#Fibrinogen_measurement,Fibrinogen measurement,,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:Fibrinogen_measurement,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/250346004,,,,Fibrinogen measurement (procedure)|Fibrinogen level,,,,,,Fibrinogen measurement,
http://www.pepathway.org/peo/1.2#mitochondrial_change,mitochondrial change,,from manual annotation of text corpus,false,,,http://www.ifomis.org/bfo/1.1/span#Process,,peo2:mitochondrial_change,,,,,,,,,,,,,,,,,,,,,,,mitochondrial changes,,,,,from manual annotation of text corpus,mitochondrial change,
http://scai.fraunhofer.de/NDDUO#inclusion_criterion,inclusion criterion,,,false,,,http://scai.fraunhofer.de/NDDUO#Recruitment_crieteria,,NDDUO:inclusion_criterion,,,,,,,,,,,,,,,,,,,,,,,inclusion criteria,,,,,,inclusion criterion,
http://www.pepathway.org/peo/1.2#Absolute_risk,Absolute risk,,AD299,false,,,http://www.pepathway.org/peo/1.2#Analysis_of_cohort_studies,,peo2:Absolute_risk,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD299,Absolute risk,
http://www.pepathway.org/peo/1.2#Duration_of_dilatation_stage,Duration of dilatation stage,,,false,,,http://www.pepathway.org/peo/1.2#Blood_pressure_finding,,peo2:Duration_of_dilatation_stage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Duration of dilatation stage,
http://www.pepathway.org/peo/1.2#Parents_country_of_birth,Parents’ country of birth,,,false,,,http://www.pepathway.org/peo/1.2#Country_of_birth,,peo2:Parents_country_of_birth,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Parents’ country of birth,
http://www.pepathway.org/peo/1.2#Multiorgan_failure,Multiorgan failure,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Multiorgan_failure,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10028162,,,,,,,,,,Multiorgan failure,
http://www.pepathway.org/peo/1.2#Stillbirth,Stillbirth,,,false,,,http://www.pepathway.org/peo/1.2#Newborn_death,,peo2:Stillbirth,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/237364002,,,,Stillbirth (finding)|SB - Stillbirth,,,,,,Stillbirth,
http://www.pepathway.org/peo/1.2#Calcium_release,Calcium release,,AD591,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:Calcium_release,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/GO#GO_0015278,,,,,,,,,AD591,Calcium release,
http://www.pepathway.org/peo/1.2#thing_related_to_functional_phenotypes,thing related to functional phenotypes,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_observations,,peo2:thing_related_to_functional_phenotypes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to functional phenotypes,
http://www.pepathway.org/peo/1.2#Vertebral_artery_dissection,Vertebral artery dissection,,,false,,,http://www.pepathway.org/peo/1.2#Brain_Diseases,,peo2:Vertebral_artery_dissection,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/230730001,,,,Vertebral artery dissection (disorder),,,,,,Vertebral artery dissection,
http://scai.fraunhofer.de/NDDUO#pathogenesis_context,pathogenesis context,,,false,,,http://scai.fraunhofer.de/NDDUO#etiological_context,,NDDUO:pathogenesis_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pathogenesis context,
http://www.pepathway.org/peo/1.2#Analysis_of_cohort_studies,Analysis of cohort studies,,AD298,false,,,http://scai.fraunhofer.de/NDDUO#Cohort_study,,peo2:Analysis_of_cohort_studies,,,,,,,,,,,,,,,,,,,,,,,check subclasses!!,,,,,AD298,Analysis of cohort studies,
http://www.pepathway.org/peo/1.2#Paralysis_from_birth_trauma,Paralysis from birth trauma,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:Paralysis_from_birth_trauma,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/371129000,,,,Paralysis from birth trauma (disorder),,,,,,Paralysis from birth trauma,
http://www.pepathway.org/peo/1.2#Antihypertensive_therapy,Antihypertensive therapy,,,false,,,http://www.pepathway.org/peo/1.2#Therapeutics,,peo2:Antihypertensive_therapy,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/308116003,,,,Antihypertensive therapy (procedure),,,,,,Antihypertensive therapy,
http://www.pepathway.org/peo/1.2#Fetal_thrombotic_vasculopathy,Fetal thrombotic vasculopathy,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_fetus_or_newborn,,peo2:Fetal_thrombotic_vasculopathy,,,,,,,,,,,,,,,,,,,,,,,,,,FTV,,,Fetal thrombotic vasculopathy,
http://www.pepathway.org/peo/1.1#LDH,LDH,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:LDH,,,,,,,,,,,,,,,,,,,,,,,lactate dehydrogenase,,,,,,LDH,
http://www.pepathway.org/peo/1.2#Acute_disease_of_cardiovascular_system,Acute disease of cardiovascular system,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_cardiovascular_system,,peo2:Acute_disease_of_cardiovascular_system,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/128487001,,,,Acute disorder of cardiovascular system|Acute disease of cardiovascular system (disorder)|Acute cardiovascular disease|Acute cardiovascular disorder,,,,,,Acute disease of cardiovascular system,
http://www.pepathway.org/peo/1.2#arachidonic_acid,arachidonic acid,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:arachidonic_acid,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_15843,,,,"(5Z,8Z,11Z,14Z)-Icosatetraenoic acid|Arachidonic acid|(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid|Arachidonsaeure|Arachidonate|InChIKey=YZXBAPSDXZZRGB-DOFZRALJSA-N|InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-|cis-Delta(5,8,11,14)-eicosatetraenoic acid|all-cis-5,8,11,14-eicosatetraenoic acid|ARACHIDONIC ACID|cis-5,8,11,14-Eicosatetraenoic acid|(5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoic acid|CCCCCC=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O|AA|ARA|C20H32O2",,,,"A long-chain fatty acid that is a C20, polyunsaturated fatty acid having four (Z)-double bonds at positions 5, 8, 11 and 14.",,arachidonic acid,
http://www.ifomis.org/bfo/1.1/snap#ThreeDimensionalRegion,three_dimensional_region,,"Examples: a cube-shaped part of space, a sphere-shaped part of space|Definition: A spatial region [snap:SpatialRegion] with three dimensions.",false,,,http://www.ifomis.org/bfo/1.1/snap#SpatialRegion,,snap:ThreeDimensionalRegion,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Examples: a cube-shaped part of space, a sphere-shaped part of space|Definition: A spatial region [snap:SpatialRegion] with three dimensions.",three_dimensional_region,
http://www.pepathway.org/peo/1.2#perfluorodecanoic_acid,perfluorodecanoic acid,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:perfluorodecanoic_acid,,,,,,,,,,,,,,,,,,,,,,,"OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F|2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-nonadecafluorodecanoic acid|nonadecafluoro-n-decanoic acid|InChI=1S/C10HF19O2/c11-2(12,1(30)31)3(13,14)4(15,16)5(17,18)6(19,20)7(21,22)8(23,24)9(25,26)10(27,28)29/h(H,30,31)|perfluorodecanoic acid|nonadecafluorodecanoic acid|InChIKey=PCIUEQPBYFRTEM-UHFFFAOYSA-N|perfluoro-n-decanoic acid|C10HF19O2|Ndfda|PFDA",,,,A fluoroalkanoic acid that is perfluorinated decanoic acid.,,perfluorodecanoic acid,
http://scai.fraunhofer.de/NDDUO#Animal_species,Animal species,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Object,,NDDUO:Animal_species,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Animal species,
http://www.pepathway.org/peo/1.2#Perfluorohexanesulfonic_acid,Perfluorohexanesulfonic acid,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:Perfluorohexanesulfonic_acid,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/C471071,,,,perfluorohexanesulfonate|PFHS cpd|PFHxS,,,,,,Perfluorohexanesulfonic acid,
http://www.pepathway.org/peo/1.1#TNFRSF14,TNFRSF14,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:TNFRSF14,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/8764,,,,,,,,,,,,,,,,,,,,TNFRSF14,
http://www.pepathway.org/peo/1.2#Admission_to_neonatal_intensive_care_unit,Admission to neonatal intensive care unit,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:Admission_to_neonatal_intensive_care_unit,,,,,,,,,,,,,,,,,,,,,,,Admission to NICU,,,,,,Admission to neonatal intensive care unit,
http://www.pepathway.org/peo/1.2#Obstetric_complications,Obstetric complications,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Obstetric_complications,,,,,,,,,,,,,,,,,,,,,,,Obstetric labor complication,,,,,,Obstetric complications,
http://www.pepathway.org/peo/1.2#Calcium_supplement,Calcium supplement,,,false,,,http://www.pepathway.org/peo/1.2#Supplements,,peo2:Calcium_supplement,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/438581000124107,,,,Calcium supplement (substance),,,,,,Calcium supplement,
http://scai.fraunhofer.de/NDDUO#clinical_context,clinical context,,,false,,,http://scai.fraunhofer.de/NDDUO#context,,NDDUO:clinical_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,clinical context,
http://www.pepathway.org/peo/1.2#Androgen_receptor_level,Androgen receptor level,,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:Androgen_receptor_level,,,,,,,,,,,,,,,,,,,,,,,androgen receptor levels,,,,,,Androgen receptor level,
http://www.pepathway.org/peo/1.2#Status_epilepticus,Status epilepticus,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Status_epilepticus,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/230456007,,,,Status epilepticus (disorder),,,,,,Status epilepticus,
http://scai.fraunhofer.de/NDDUO#masking_design,masking design,,,false,,,http://scai.fraunhofer.de/NDDUO#Study_design,,NDDUO:masking_design,,,,,,,,,,,,,,,,,,,,,,,masking designs,,,,,,masking design,
http://www.pepathway.org/peo/1.1#DNAJC5G,DNAJC5G,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:DNAJC5G,,,,,,,,,,,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/285126,,,,,,,,,,DNAJC5G,
http://www.pepathway.org/peo/1.2#Allergy_to_substance,Allergy to substance,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Allergy_to_substance,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/419199007,,,,Allergy to substance (disorder),,,,,,Allergy to substance,
http://www.pepathway.org/peo/1.2#carbon_monoxide,carbon monoxide,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:carbon_monoxide,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_17245,,,,InChI=1S/CO/c1-2|CARBON MONOXIDE|carbon monoxide|carbon(II) oxide|carbon monooxide|Carbon monoxide|InChIKey=UGFAIRIUMAVXCW-UHFFFAOYSA-N|C#O|CO|[C-]#[O+]|[CO],,,,"A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.",,carbon monoxide,
http://www.pepathway.org/peo/1.2#Chronic_arthritis,Chronic arthritis,,,false,,,http://www.pepathway.org/peo/1.2#Arthritis,,peo2:Chronic_arthritis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/35908007,,,,Chronic arthritis (disorder),,,,,,Chronic arthritis,
http://www.pepathway.org/peo/1.2#thing_related_to_outcomes,thing related to outcomes,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_phenotypic_features,,peo2:thing_related_to_outcomes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to outcomes,
http://www.pepathway.org/peo/1.2#Fetal_umbilical_vein_structure,Fetal umbilical vein structure,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Fetal_umbilical_vein_structure,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/13576009,,,,Fetal umbilical vein|Umbilical vein|Left umbilical vein|Fetal umbilical vein structure (body structure),,,,,,Fetal umbilical vein structure,
http://www.pepathway.org/peo/1.2#Schizophrenia,Schizophrenia,,,false,,,http://www.pepathway.org/peo/1.2#Mental_disorder,,peo2:Schizophrenia,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/58214004,,,,Schizophrenia (disorder),,,,,,Schizophrenia,
http://www.pepathway.org/peo/1.2#Histmorphological_presents,Histmorphological presents,,,false,,,http://www.pepathway.org/peo/1.2#Cytodiagnosis,,peo2:Histmorphological_presents,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Histmorphological presents,
http://www.pepathway.org/peo/1.2#folic_acid,folic acid,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:folic_acid,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_27470,,,,"N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid|pteroyl-L-glutamic acid|pteroyl-L-monoglutamic acid|InChI=1S/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s1|InChIKey=OVBPIULPVIDEAO-LBPRGKRZSA-N|N-pteroyl-L-glutamic acid|Nc1nc2ncc(CNc3ccc(cc3)C(=O)N[C@|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Pteroylglutamic acid|C19H19N7O6|FOLIC ACID|Folate|Folic acid|Folsaeure|PGA|PteGlu|vitamin Bc|vitamin M",,,,An N-acyl-amino acid that is a form of the water-soluble vitamin B9. Its biologically active forms (tetrahydrofolate and others) are essential for nucleotide biosynthesis and homocysteine remethylation.,,folic acid,
http://www.pepathway.org/peo/1.2#Th1_Cells,Th1 Cells,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:Th1_Cells,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D018417,,,,"Cell, Th1|Cells, Th1|Th1 Cell",,,,"Subset of helper-inducer T-lymphocytes which synthesize and secrete interleukin-2, gamma-interferon, and interleukin-12. Due to their ability to kill antigen-presenting cells and their lymphokine-mediated effector activity, Th1 cells are associated with vigorous delayed-type hypersensitivity reactions.",,Th1 Cells,
http://www.pepathway.org/peo/1.2#Second_trimester,Second trimester,,,false,,,http://www.pepathway.org/peo/1.2#Trimesters,,peo2:Second_trimester,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/255247007,,,,Second trimester (qualifier value)|2nd trimester,,,,,,Second trimester,
http://www.pepathway.org/peo/1.2#Schooling,Schooling,,,false,,,http://www.pepathway.org/peo/1.2#Education_and_schooling_detail,,peo2:Schooling,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/266981003,,,,Schooling (observable entity),,,,,,Schooling,
http://www.pepathway.org/peo/1.2#Earlier_miscarriage,Earlier miscarriage,,,false,,,http://www.pepathway.org/peo/1.2#Miscarriage,,peo2:Earlier_miscarriage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Earlier miscarriage,
http://www.pepathway.org/peo/1.2#Economic_independence_status,Economic independence status,,,false,,,http://www.pepathway.org/peo/1.2#Economic_status,,peo2:Economic_independence_status,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/113168001,,,,Economically independent (economic status) (social concept)|Economically independent (economic status),,,,,,Economic independence status,
http://www.pepathway.org/peo/1.2#Direct_injection_of_sperm_into_cytoplasm_of_the_oocyte,Direct injection of sperm into cytoplasm of the oocyte,,,false,,,http://www.pepathway.org/peo/1.2#Reproductive_Techniques_Assisted,,peo2:Direct_injection_of_sperm_into_cytoplasm_of_the_oocyte,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/225244002,,,,Intracytoplasmic sperm injection|ICSI - Intracytoplasmic sperm injection|Direct injection of sperm into cytoplasm of the oocyte (procedure)|DISCO - Direct inject of sperm into cytoplasm of the oocyte,,,,,,Direct injection of sperm into cytoplasm of the oocyte,
http://www.pepathway.org/peo/1.1#SSTR,SSTR,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:SSTR,,,,,,,,,,,,,,,,,,,,,,,somatostatin receptor,,,,,,SSTR,
http://scai.fraunhofer.de/NDDUO#non_pharmacotherapy_treatment_context,non pharmacotherapy clinical treatment context,,,false,,,http://scai.fraunhofer.de/NDDUO#clinical_treatment_context,,NDDUO:non_pharmacotherapy_treatment_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,non pharmacotherapy clinical treatment context,
http://www.pepathway.org/peo/1.2#Ultrasonography,Ultrasonography,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_observable,,peo2:Ultrasonography,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/16310003,,,,Ultrasound scan|Diagnostic ultrasonography (procedure)|Ultrasonogram|Diagnostic sonar|Diagnostic ultrasonography|Ultrasound procedure|US - Ultrasound|USS - Ultrasound scan|Ultrasound,,,,,,Ultrasonography,
http://scai.fraunhofer.de/NDDUO#Birth_defect_rate,Birth defect rate,,,false,,,http://scai.fraunhofer.de/NDDUO#prevalence,,NDDUO:Birth_defect_rate,,,,,,,,,,,,,,,,,,,,,,,Birth defect rates,,,,,,Birth defect rate,
http://scai.fraunhofer.de/NDDUO#Descriptive_epidemiology,thing related to descriptive epidemiology,,AD256,false,,,http://scai.fraunhofer.de/NDDUO#Epidemiology,,NDDUO:Descriptive_epidemiology,,,,,,,,,,,,,,,,,,,,,,,Descriptive epidemiology,,,,,AD256,thing related to descriptive epidemiology,
http://www.pepathway.org/peo/1.2#Alcohol_abuse,Alcohol abuse,,,false,,,http://www.pepathway.org/peo/1.2#Alcohol_intake,,peo2:Alcohol_abuse,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/15167005,,,,Alcohol abuse (disorder)|Ethanol abuse|AA - Alcohol abuse,,,,,,Alcohol abuse,
http://www.pepathway.org/peo/1.2#Umbilical_cord_finding,Umbilical cord finding,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Umbilical_cord_finding,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/289299005,,,,Umbilical cord finding (finding)|Umbilical cord observations,,,,,,Umbilical cord finding,
http://www.pepathway.org/peo/1.2#Glycosylation,Glycosylation,,AD605,false,,,http://www.pepathway.org/peo/1.2#Post_translational_modification,,peo2:Glycosylation,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/GO#GO_0070085,,,,,,,,,AD605,Glycosylation,
http://www.pepathway.org/peo/1.2#Amniotic_fluid,Amniotic fluid,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Amniotic_fluid,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/77012006,,,,AF - Amniotic fluid|Amniotic fluid (substance)|Liquor,,,,,,Amniotic fluid,
http://scai.fraunhofer.de/NDDUO#Prevalence,thing related to prevalence,,AD262,false,,,http://scai.fraunhofer.de/NDDUO#Morbidity,,NDDUO:Prevalence,,,,,,,,,,,,,,,,,,,,,,,Prevalence,,,,,AD262,thing related to prevalence,
http://www.pepathway.org/peo/1.2#anti-PLAP,anti-PLAP,,,false,,,http://www.pepathway.org/peo/1.2#Antibody,,peo2:anti-PLAP,,,,,,,,,,,,,,,,,,,,,,,anti-placental alkaline phosphatase,,,,,,anti-PLAP,
http://www.pepathway.org/peo/1.2#Rheumatoid_arthritis,Rheumatoid arthritis,,,false,,,http://www.pepathway.org/peo/1.2#Arthritis,,peo2:Rheumatoid_arthritis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/69896004,,,,Rheumatoid arthritis (disorder)|Rheumatic gout|Chronic rheumatic arthritis|RhA - Rheumatoid arthritis|Proliferative arthritis|Atrophic arthritis|RA - Rheumatoid arthritis|Rheumatoid disease,,,,,,Rheumatoid arthritis,
http://www.ifomis.org/bfo/1.1/snap#TwoDimensionalRegion,two_dimensional_region,,"Examples: the surface of a cube-shaped part of space, the surface of a sphere-shaped part of space, the surface of a rectilinear planar figure-shaped part of space|Definition: A spatial region [snap:SpatialRegion] with two dimensions.",false,,,http://www.ifomis.org/bfo/1.1/snap#SpatialRegion,,snap:TwoDimensionalRegion,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Examples: the surface of a cube-shaped part of space, the surface of a sphere-shaped part of space, the surface of a rectilinear planar figure-shaped part of space|Definition: A spatial region [snap:SpatialRegion] with two dimensions.",two_dimensional_region,
http://www.pepathway.org/peo/1.2#Higher_education,Higher education,,,false,,,http://www.pepathway.org/peo/1.2#Education_and_schooling_detail,,peo2:Higher_education,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/161122005,,,,Higher education (finding),,,,,,Higher education,
http://www.pepathway.org/peo/1.1#TNFSF15,TNFSF15,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:TNFSF15,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/9966,,,,,,,,,,,,,,,,,,,,TNFSF15,
http://www.pepathway.org/peo/1.2#Miscarriage,Miscarriage,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder|http://www.pepathway.org/peo/1.2#Newborn_death,,peo2:Miscarriage,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/17369002,,,,Spontaneous abortion|Vaginal expulsion of product of conception|Vaginal expulsion of fetus|Miscarriage (disorder),,,,,,Miscarriage,
http://www.pepathway.org/peo/1.2#Prothrombotic_state,Prothrombotic state,,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:Prothrombotic_state,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Prothrombotic state,
http://www.pepathway.org/peo/1.2#aortic_smooth_muscle_cell,aortic smooth muscle cell,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:aortic_smooth_muscle_cell,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CL_0002539,,,,,,,,A smooth muscle cell of the aorta,,aortic smooth muscle cell,
http://www.pepathway.org/peo/1.2#Uterine_blood_flow,Uterine blood flow,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_uterine_artery_Doppler,,peo2:Uterine_blood_flow,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Uterine blood flow,
http://www.pepathway.org/peo/1.2#phosphatidylinositol_signalling,phospatidylinositol signalling,,from manual annotation of text corpus,false,,,http://scai.fraunhofer.de/NDDUO#Cell_cell_interaction,,peo2:phosphatidylinositol_signalling,,,,,,,,,,,,,,,,,,,,,,,,,,,,from manual annotation of text corpus,phospatidylinositol signalling,
http://www.pepathway.org/peo/1.2#Cytoprotection,Cytoprotection,,,false,,,http://www.pepathway.org/peo/1.2#processes_all_cells,,peo2:Cytoprotection,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D019610,,,,"Protection, Cell|Cell Protection",,,,The process by which chemical compounds provide protection to cells against harmful agents.,,Cytoprotection,
http://www.pepathway.org/peo/1.2#HELLP_syndrome,HELLP syndrome,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:HELLP_syndrome,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/95605009,,,,"Haemolysis-elevated liver enzymes-low platelet count syndrome|Hemolysis-elevated liver enzymes-low platelet count syndrome|HELLP - Syndrome of haemolysis, elevated liver enzymes and low platelet|HELLP - Syndrome of hemolysis, elevated liver enzymes and low platelet|Hemolysis-elevated liver enzymes-low platelet count syndrome (disorder)",,,,,,HELLP syndrome,
http://www.pepathway.org/peo/1.2#anticoagulation,anticoagulation,,,false,,,http://www.pepathway.org/peo/1.2#Therapeutics,,peo2:anticoagulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,anticoagulation,
http://www.pepathway.org/peo/1.2#Previous_eclampsia,Previous eclampsia,,,false,,,http://www.pepathway.org/peo/1.2#Medical_history,,peo2:Previous_eclampsia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Previous eclampsia,
http://www.pepathway.org/peo/1.1#MFSD2A,MFSD2A,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:MFSD2A,,,,,,,,,,,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/84879,,,,,,,,,,MFSD2A,
http://www.pepathway.org/peo/1.2#study_investigator,study investigator,,shouldn't this be a role?,false,,,http://www.ifomis.org/bfo/1.1/snap#Object,,peo2:study_investigator,,,,,,,,,,,,,,,,,,,,,,,study investigators,,,,,shouldn't this be a role?,study investigator,
http://www.pepathway.org/peo/1.2#single_blind_study,single blind study,,,false,,,http://scai.fraunhofer.de/NDDUO#Study_type,,peo2:single_blind_study,,,,,,,,,,,,,,,,,,,,,,,single blind studies|blinded,,,,,,single blind study,
http://www.pepathway.org/peo/1.1#KCNN2,KCNN2,,,false,,,http://www.pepathway.org/peo/1.1#KCNN,,peo:KCNN2,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/3781,,,,,,,,,,,,,,,,,,,,KCNN2,
http://www.pepathway.org/peo/1.2#type_2_immune_response,type 2 immune response,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:type_2_immune_response,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/GO_0042092,,,,T-helper 2 type immune response|Th2 immune response,,,,"An immune response which is associated with resistance to extracellular organisms such as helminths and pathological conditions such as allergy, which is orchestrated by the production of particular cytokines, most notably IL-4, IL-5, IL-10, and IL-13, by any of a variety of cell types including T-helper 2 cells, eosinophils, basophils, mast cells, and nuocytes, resulting in enhanced production of certain antibody isotypes and other effects.",,type 2 immune response,
http://www.pepathway.org/peo/1.2#Peptide,Peptide,,,false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,peo2:Peptide,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Peptide,
http://www.ifomis.org/bfo/1.1/span#ScatteredTemporalRegion,scattered_temporal_region,,"Definition: A temporal region [span:TemporalRegion] every point of which is not mediately or immediately connected with every other point of which.|Examples: the time occupied by the individual games of the World Cup, the time occupied by the individual liaisons in a romantic affair",false,,,http://www.ifomis.org/bfo/1.1/span#TemporalRegion,,span:ScatteredTemporalRegion,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Definition: A temporal region [span:TemporalRegion] every point of which is not mediately or immediately connected with every other point of which.|Examples: the time occupied by the individual games of the World Cup, the time occupied by the individual liaisons in a romantic affair",scattered_temporal_region,
http://www.pepathway.org/peo/1.2#Closed_populations_,Closed populations,,AD313,false,,,http://www.pepathway.org/peo/1.2#Populations,,peo2:Closed_populations_,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD313,Closed populations,
http://www.pepathway.org/peo/1.2#Glucose_transport,Glucose transport,,AD599,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:Glucose_transport,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/GO#GO_0015758,,,,,,,,,AD599,Glucose transport,
http://www.pepathway.org/peo/1.2#Heroin_abuse,Heroin abuse,,,false,,,http://www.pepathway.org/peo/1.2#Drug_abuse,,peo2:Heroin_abuse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Heroin abuse,
http://www.ifomis.org/bfo/1.1/snap#Quality,quality,,"Examples: the color of a tomato, the ambient temperature of air, the circumference of a waist, the shape of a nose, the mass of a piece of gold, the weight of a chimpanzee|Definition: A specifically dependent continuant [snap:SpecificallyDependentContinuant] that is exhibited if it inheres in an entity or entities at all (a categorical property).",false,,,http://www.ifomis.org/bfo/1.1/snap#SpecificallyDependentContinuant,,snap:Quality,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Examples: the color of a tomato, the ambient temperature of air, the circumference of a waist, the shape of a nose, the mass of a piece of gold, the weight of a chimpanzee|Definition: A specifically dependent continuant [snap:SpecificallyDependentContinuant] that is exhibited if it inheres in an entity or entities at all (a categorical property).",quality,
http://www.pepathway.org/peo/1.2#Fetus_with_chromosomal_abnormality,Fetus with chromosomal abnormality,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_fetus_or_newborn,,peo2:Fetus_with_chromosomal_abnormality,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/267253006,,,,Fetus with chromosomal abnormality (disorder),,,,,,Fetus with chromosomal abnormality,
http://www.pepathway.org/peo/1.2#Whole_blood_folate_level_-_finding,Whole blood folate level - finding,,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:Whole_blood_folate_level_-_finding,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/365609009,,,,Finding of whole blood folate level|Whole blood folate level|Finding of whole blood folate level (finding),,,,,,Whole blood folate level - finding,
http://www.pepathway.org/peo/1.2#Apoptosis,Apoptosis,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Apoptosis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D017209,,,,"Apoptosis, Extrinsic Pathway|Apoptoses, Intrinsic Pathway|Apoptoses, Extrinsic Pathway|Apoptosis, Intrinsic Pathway|Programmed Cell Death, Type I|Extrinsic Pathway Apoptoses|Intrinsic Pathway Apoptosis|Intrinsic Pathway Apoptoses|Extrinsic Pathway Apoptosis",,,,"Apoptosis that is triggered via cell stress and mitochondrial damage. One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis that is triggered via CELL SURFACE RECEPTORS such as TUMOR NECROSIS FACTOR RECEPTORS and DEATH DOMAIN RECEPTORS.",,Apoptosis,
http://www.pepathway.org/peo/1.2#thing_related_to_functional_units,thing related to functional units,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_protein,,peo2:thing_related_to_functional_units,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to functional units,
http://www.pepathway.org/peo/1.2#Type_2_diabetes_mellitus,Type 2 diabetes mellitus,,,false,,,http://www.pepathway.org/peo/1.2#Diabetes,,peo2:Type_2_diabetes_mellitus,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/44054006,,,,Diabetes mellitus type 2|Diabetes mellitus type II|Diabetes mellitus type 2 (disorder)|Type II diabetes mellitus,,,,,,Type 2 diabetes mellitus,
http://www.pepathway.org/peo/1.2#Placental_vascularization,Placental vascularization,,,false,,,http://www.pepathway.org/peo/1.2#Placentation,,peo2:Placental_vascularization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Placental vascularization,
http://www.pepathway.org/peo/1.2#thing_related_to_severe_stage,thing related to severe stage,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_stage,,peo2:thing_related_to_severe_stage,,,,,,,,,,,,,,,,,,,,,,,severe,,,,,,thing related to severe stage,
http://www.pepathway.org/peo/1.2#Alcohol_intake,Alcohol intake,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Alcohol_intake,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/160573003,,,,AI - Alcohol intake|Alcoholic drink intake|Alcohol consumption|Alcohol intake (observable entity)|ETOH - Alcohol intake|Ethanol intake,,,,,,Alcohol intake,
http://www.pepathway.org/peo/1.2#Climate,Climate,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Climate,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D002980,,,,Climates,,,,"The longterm manifestations of WEATHER. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)",,Climate,
http://www.pepathway.org/peo/1.1#CUEDC1,CUEDC1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:CUEDC1,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/404093,,,,,,,,,,,,,,,,,,,,CUEDC1,
http://www.pepathway.org/peo/1.2#Echocardiography,Echocardiography,,,false,,,http://www.pepathway.org/peo/1.2#Ultrasonography,,peo2:Echocardiography,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/40701008,,,,Echocardiographic procedure|Ultrasonography of heart|Echocardiography (procedure)|US scan of heart|Diagnostic ultrasound of heart|Echocardiogram|US heart scan|Cardiac US scan|Cardiac echo,,,,,,Echocardiography,
http://www.pepathway.org/peo/1.2#Longitudinal_study,Longitudinal study,,,false,,,http://scai.fraunhofer.de/NDDUO#Descriptive_study,,peo2:Longitudinal_study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Longitudinal study,
http://www.pepathway.org/peo/1.2#Artificial_insemination,Artificial insemination,,,false,,,http://www.pepathway.org/peo/1.2#Reproductive_Techniques_Assisted,,peo2:Artificial_insemination,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/58533008,,,,AI - Artificial insemination|Artificial insemination (procedure),,,,,,Artificial insemination,
http://www.pepathway.org/peo/1.2#Pathway,Pathway,,,false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,peo2:Pathway,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pathway,
http://www.pepathway.org/peo/1.1#SERPINC1,SERPINC1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:SERPINC1,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/462,,,,,,,,,,,,,,,,,,,,SERPINC1,
http://www.pepathway.org/peo/1.2#Placental_Apoptosis,Placental Apoptosis,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_placenta,,peo2:Placental_Apoptosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Placental Apoptosis,
http://www.pepathway.org/peo/1.2#Meconium,Meconium,,,false,,,http://www.pepathway.org/peo/1.2#Fetal_observable,,peo2:Meconium,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D008470,,,,Meconiums,,,,The thick green-to-black mucilaginous material found in the intestines of a full-term fetus. It consists of secretions of the INTESTINAL GLANDS; BILE PIGMENTS; FATTY ACIDS; AMNIOTIC FLUID; and intrauterine debris. It constitutes the first stools passed by a newborn.,,Meconium,
http://www.pepathway.org/peo/1.2#Circulating,Circulating,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Circulating,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/65929005,,,,Circulating (qualifier value),,,,,,Circulating,
http://www.pepathway.org/peo/1.2#Age_at_starting_school,Age at starting school,,,false,,,http://www.pepathway.org/peo/1.2#Education_and_schooling_detail,,peo2:Age_at_starting_school,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/224286003,,,,Age at starting school (observable entity),,,,,,Age at starting school,
http://scai.fraunhofer.de/NDDUO#in_vivo_context,in vivo context,,,false,,,http://scai.fraunhofer.de/NDDUO#context,,NDDUO:in_vivo_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,in vivo context,
http://www.pepathway.org/peo/1.2#De_methylation,De-methylation,,AD596,false,,,http://www.pepathway.org/peo/1.2#Epigenetics,,peo2:De_methylation,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD596,De-methylation,
http://www.pepathway.org/peo/1.2#mononuclear_cell,mononuclear cell,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:mononuclear_cell,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CL_0000842,,,,peripheral blood mononuclear cell,,,,,,mononuclear cell,
http://www.pepathway.org/peo/1.2#Total_cholesterol,Total cholesterol,,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:Total_cholesterol,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/301860006,,,,Total cholesterol (substance),,,,,,Total cholesterol,
http://www.pepathway.org/peo/1.2#Cardiomyocyte_death,Cardiomyocyte death,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_cardiovascular_system,,peo2:Cardiomyocyte_death,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Cardiomyocyte death,
http://www.pepathway.org/peo/1.2#lipid,lipid,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:lipid,,,,,,,,,,,,,,,,,,,,,,,Lipid|lipids,,,,,,lipid,
http://www.pepathway.org/peo/1.2#Zero_flow_pressure,Zero flow pressure,,,false,,,http://www.pepathway.org/peo/1.2#Echocardiography,,peo2:Zero_flow_pressure,,,,,,,,,,,,,,,,,,,,,,,ZFP,,,,,,Zero flow pressure,
http://www.pepathway.org/peo/1.2#Hazard_ratio,Hazard ratio,,AD309,false,,,http://www.pepathway.org/peo/1.2#Incidence_rate,,peo2:Hazard_ratio,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD309,Hazard ratio,
http://www.pepathway.org/peo/1.2#Metabolic_disease,Metabolic disease,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Metabolic_disease,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/75934005,,,,Metabolic disease (disorder)|Metabolic disorder|MD - Metabolic disorders,,,,,,Metabolic disease,
http://www.pepathway.org/peo/1.2#Social_support_status,Social support status,,,false,,,http://www.pepathway.org/peo/1.2#Social_context,,peo2:Social_support_status,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/445051000124100,,,,Social support status (finding),,,,,,Social support status,
http://www.pepathway.org/peo/1.2#steroid_biosynthetic_process,steroid biosynthetic process,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:steroid_biosynthetic_process,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/GO_0006694,,,,steroid synthesis|steroid anabolism|steroid biosynthesis|steroidogenesis|steroid formation,,,,"The chemical reactions and pathways resulting in the formation of steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus; includes de novo formation and steroid interconversion by modification.",,steroid biosynthetic process,
http://www.pepathway.org/peo/1.1#INGX,INGX,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:INGX,,,,,,,,,,,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/27160,,,,,,,,,,INGX,
http://www.pepathway.org/peo/1.2#Androgen_level,Androgen level,,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:Androgen_level,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/407709006,,,,Androgen level (procedure)|Androgen measurement,,,,,,Androgen level,
http://scai.fraunhofer.de/NDDUO#mechanism_of_action_context,mechanism of action context,,,false,,,http://scai.fraunhofer.de/NDDUO#pharmacotherapy_treatment_context,,NDDUO:mechanism_of_action_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mechanism of action context,
http://www.pepathway.org/peo/1.2#Post_translational_modification,Post translational modification,,AD602,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:Post_translational_modification,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/GO#GO_0043687,,,,posttranslational amino acid modifications|post-translational modification|posttranslational amino acid modification|post-translational amino acid modification|post-translational amino acid modifications|posttranslational protein modification|posttranslational protein modifications|posttranslational modification|posttranslational modifications|Post translational modifications|post-translational modifications|PTM,,,,,AD602,Post translational modification,
http://www.pepathway.org/peo/1.2#Intrapartum,Intrapartum,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_time_period,,peo2:Intrapartum,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/276987000,,,,Intrapartum (qualifier value),,,,,,Intrapartum,
http://www.pepathway.org/peo/1.2#Rupture_of_gravid_uterus,Rupture of gravid uterus,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Rupture_of_gravid_uterus,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/15504009,,,,Rupture of gravid uterus (disorder)|Obstetrical rupture of uterus,,,,,,Rupture of gravid uterus,
http://www.pepathway.org/peo/1.2#Exosomes,Exosomes,,,false,,,http://www.pepathway.org/peo/1.2#Organelle,,peo2:Exosomes,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D055354,,,,,,,,"Vesicles secreted from MULTIVESICULAR BODIES into the extracellular environment when the multivesicular bodies fuse with the PLASMA MEMBRANE. Multivesicular bodies are formed from ENDOSOMES when they accumulate vesicles (sometimes referred to as ""intraluminal vesicles"") from inward budding of the endosome membrane.",,Exosomes,
http://www.pepathway.org/peo/1.2#First_trimester,First trimester,,,false,,,http://www.pepathway.org/peo/1.2#Trimesters,,peo2:First_trimester,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/255246003,,,,1st trimester|First trimester (qualifier value),,,,,,First trimester,
http://scai.fraunhofer.de/NDDUO#Case_cohort_studies,Case cohort study,,,false,,,http://scai.fraunhofer.de/NDDUO#Cohort_study,,NDDUO:Case_cohort_studies,,,,,,,,,,,,,,,,,,,,,,,Case cohort studies,,,,,,Case cohort study,
http://www.pepathway.org/peo/1.2#Obesity,Obesity,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Obesity,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/414916001,,,,Obesity (disorder)|Adiposis|Adiposity,,,,BMI over 30,,Obesity,
http://scai.fraunhofer.de/NDDUO#Descriptive_statistics,descriptive statistics entity,,AD258,false,,,http://scai.fraunhofer.de/NDDUO#Statistics,,NDDUO:Descriptive_statistics,,,,,,,,,,,,,,,,,,,,,,,Descriptive statistics,,,,,AD258,descriptive statistics entity,
http://www.pepathway.org/peo/1.2#Molecular_rolls,Molecular rolls,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Role,,peo2:Molecular_rolls,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Molecular rolls,
http://www.pepathway.org/peo/1.2#Hyperlipidemia,Hyperlipidemia,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Hyperlipidemia,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10020667,,,,,,,,,,Hyperlipidemia,
http://www.pepathway.org/peo/1.2#Change_of_partner,Change of partner,,,false,,,http://www.pepathway.org/peo/1.2#Marital_status,,peo2:Change_of_partner,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Change of partner,
http://www.pepathway.org/peo/1.2#Reperfusion_Injury,Reperfusion Injury,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Reperfusion_Injury,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D015427,,,,"Injury, Ischemia-Reperfusion|Ischemia-Reperfusion Injuries|Damages, Reperfusion|Injury, Ischemia Reperfusion|Injuries, Reperfusion|Ischemia-Reperfusion Injury|Injuries, Ischemia-Reperfusion|Reperfusion Injuries|Injury, Reperfusion|Damage, Reperfusion|Reperfusion Damage|Reperfusion Damages|Ischemia Reperfusion Injury",,,,"Adverse functional, metabolic, or structural changes in ischemic tissues resulting from the restoration of blood flow to the tissue (REPERFUSION), including swelling; HEMORRHAGE; NECROSIS; and damage from FREE RADICALS. The most common instance is MYOCARDIAL REPERFUSION INJURY.",,Reperfusion Injury,
http://www.pepathway.org/peo/1.2#Asian_race,Asian race,,,false,,,http://scai.fraunhofer.de/NDDUO#Race,,peo2:Asian_race,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/413582008,,,,Asian race (racial group)|Asian,,,,,,Asian race,
http://scai.fraunhofer.de/NDDUO#Screening,Screening,,,false,,,http://scai.fraunhofer.de/NDDUO#Diagnostic_Procedures,,NDDUO:Screening,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Screening,
http://www.pepathway.org/peo/1.1#EMD,EMD,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:EMD,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/2010,,,,,,,,,,,,,,,,,,,,EMD,
http://www.pepathway.org/peo/1.2#Substances_used,Substances used,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Substances_used,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/246480001,,,,Substances used (attribute),,,,,,Substances used,
http://www.ifomis.org/bfo/1.1/span#ProcessBoundary,process_boundary,,"Examples: birth, death, the forming of a synapse, the onset of REM sleep, the detaching of a finger in an industrial accident, the final separation of two cells at the end of cell-division, the incision at the beginning of a surgery|Definition: A processual entity [span:ProcessualEntity] that is the fiat or bona fide instantaneous temporal process boundary.",false,,,http://www.ifomis.org/bfo/1.1/span#ProcessualEntity,,span:ProcessBoundary,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Examples: birth, death, the forming of a synapse, the onset of REM sleep, the detaching of a finger in an industrial accident, the final separation of two cells at the end of cell-division, the incision at the beginning of a surgery|Definition: A processual entity [span:ProcessualEntity] that is the fiat or bona fide instantaneous temporal process boundary.",process_boundary,
http://www.pepathway.org/peo/1.1#CXCL8,CXCL8,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:CXCL8,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/3576,,,,,,,,,,,,,,,,,,,,CXCL8,
http://scai.fraunhofer.de/NDDUO#phase_3,phase 3,,,false,,,http://scai.fraunhofer.de/NDDUO#Study_phase,,NDDUO:phase_3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,phase 3,
http://scai.fraunhofer.de/NDDUO#phase_1,phase 1,,,false,,,http://scai.fraunhofer.de/NDDUO#Study_phase,,NDDUO:phase_1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,phase 1,
http://scai.fraunhofer.de/NDDUO#phase_2,phase 2,,,false,,,http://scai.fraunhofer.de/NDDUO#Study_phase,,NDDUO:phase_2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,phase 2,
http://scai.fraunhofer.de/NDDUO#phase_4,phase 4,,,false,,,http://scai.fraunhofer.de/NDDUO#Study_phase,,NDDUO:phase_4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,phase 4,
http://scai.fraunhofer.de/NDDUO#non_clinical_context,non clinical context,,,false,,,http://scai.fraunhofer.de/NDDUO#context,,NDDUO:non_clinical_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,non clinical context,
http://www.pepathway.org/peo/1.2#aldosterone,aldosterone,,,false,,,http://www.pepathway.org/peo/1.2#hormone,,peo2:aldosterone,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_27584,,,,"aldosterone|InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1|11beta,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al|(11beta)-11,21-dihydroxy-3,20-dioxopregn-4-en-18-al|11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al|Aldosterone|[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])[C@@H](O)C[C|(11alpha,14beta,17alpha)-11,21-dihydroxy-3,20-dioxopregn-4-en-18-al|(+)-aldosterone|ALDOSTERONE|InChIKey=PQSUYGKTWSAVDQ-ZVIOFETBSA-N|C21H28O5",,,,"A pregnane-based steroidal hormone produced by the outer-section (zona glomerulosa) of the adrenal cortex in the adrenal gland, and acts on the distal tubules and collecting ducts of the kidney to cause the conservation of sodium, secretion of potassium, increased water retention, and increased blood pressure. The overall effect of aldosterone is to increase reabsorption of ions and water in the kidney.",,aldosterone,
http://www.pepathway.org/peo/1.2#Chorioallantoic_placenta,Chorioallantoic placenta,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_placenta,,peo2:Chorioallantoic_placenta,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/75428007,,,,Chorioallantoic placenta (disorder),,,,,,Chorioallantoic placenta,
http://www.pepathway.org/peo/1.2#Entire_testis,Entire testis,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Entire_testis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/181431007,,,,Entire testis (body structure)|Testis,,,,,,Entire testis,
http://www.pepathway.org/peo/1.2#Chorionic_villi_structure,Chorionic villi structure,,,false,,,http://www.pepathway.org/peo/1.2#Entire_placenta,,peo2:Chorionic_villi_structure,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/2049008,,,,Chorionic villi structure (body structure)|Chorionic villi,,,,,,Chorionic villi structure,
http://www.pepathway.org/peo/1.2#Exosome_entry,Exosome entry,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Exosome_entry,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Exosome entry,
http://www.pepathway.org/peo/1.2#Developed_Countries,Developed Countries,,,false,,,http://www.pepathway.org/peo/1.2#Geography,,peo2:Developed_Countries,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D019049,,,,"Nations, Industrialized|Nation, Industrialized|Countries, Industrialized|Developed Country|Industrialized Countries|Country, Industrialized|Country, Developed|Industrialized Nations|Nation, Developed|Countries, Developed|Industrialized Nation|Industrialized Country|Nations, Developed|Developed Nation|Developed Nations",,,,"Countries that have reached a level of economic achievement through an increase of production, per capita income and consumption, and utilization of natural and human resources.",,Developed Countries,
http://www.ifomis.org/bfo/1.1/span#ScatteredSpatiotemporalRegion,scattered_spatiotemporal_region,,"Examples: the space and time occupied by the individual games of the World Cup, the space and time occupied by the individual liaisons in a romantic affair|Definition: A spatiotemporal region [span:SpatiotemporalRegion] that has spatial and temporal dimensions and every spatial and temporal point of which is not connected with every other spatial and temporal point of which.",false,,,http://www.ifomis.org/bfo/1.1/span#SpatiotemporalRegion,,span:ScatteredSpatiotemporalRegion,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Examples: the space and time occupied by the individual games of the World Cup, the space and time occupied by the individual liaisons in a romantic affair|Definition: A spatiotemporal region [span:SpatiotemporalRegion] that has spatial and temporal dimensions and every spatial and temporal point of which is not connected with every other spatial and temporal point of which.",scattered_spatiotemporal_region,
http://www.pepathway.org/peo/1.1#KNG1,KNG1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:KNG1,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/3827,,,,,,,,,,,,,,,,,,,,KNG1,
http://www.pepathway.org/peo/1.2#study_caregiver,study caregiver,,shouldn't this be a role?,false,,,http://www.ifomis.org/bfo/1.1/snap#Object,,peo2:study_caregiver,,,,,,,,,,,,,,,,,,,,,,,study caregivers,,,,,shouldn't this be a role?,study caregiver,
http://www.pepathway.org/peo/1.1#Angiogenic_factors,Angiogenic factors,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:Angiogenic_factors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Angiogenic factors,
http://www.pepathway.org/peo/1.2#Subarachnoid_hemorrhage,Subarachnoid hemorrhage,,,false,,,http://www.pepathway.org/peo/1.2#Brain_Diseases,,peo2:Subarachnoid_hemorrhage,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/21454007,,,,Subarachnoid intracranial hemorrhage|SAH - Subarachnoid haemorrhage|Subarachnoid intracranial hemorrhage (disorder)|Subarachnoid intracranial haemorrhage|SAH - Subarachnoid hemorrhage|Subarachnoid haemorrhage,,,,,,Subarachnoid hemorrhage,
http://www.pepathway.org/peo/1.2#Prepregnancy_BMI,Prepregnancy BMI,,,false,,,http://www.pepathway.org/peo/1.2#Body_mass_index,,peo2:Prepregnancy_BMI,,,,,,,,,,,,,,,,,,,,,,,pre-gestational BMI|prepregnancy body mass index,,,,,,Prepregnancy BMI,
http://scai.fraunhofer.de/NDDUO#Pharmacotherapy,thing related to pharmacotherapy clinical treatment,,,false,,,http://scai.fraunhofer.de/NDDUO#Clinical_treatment,,NDDUO:Pharmacotherapy,,,,,,,,,,,,,,,,,,,,,,,pharmacotherapy clinical treatment|pharmacotherapy clinical treatments|Pharmacotherapy,,,,,,thing related to pharmacotherapy clinical treatment,
http://www.ifomis.org/bfo/1.1/snap#Role,role,,"Definition: A realizable entity [snap:RealizableEntity] the manifestation of which brings about some result or end that is not essential to a continuant [snap:Continuant] in virtue of the kind of thing that it is but that can be served or participated in by that kind of continuant [snap:Continuant] in some kinds of natural, social or institutional contexts.|Examples: the role of a person as a surgeon, the role of a chemical compound in an experiment, the role of a patient relative as defined by a hospital administrative form, the role of a woman as a legal mother in the context of system of laws, the role of a biological grandfather as legal guardian in the context of a system of laws, the role of ingested matter in digestion, the role of a student in a university",false,,,http://www.ifomis.org/bfo/1.1/snap#RealizableEntity,,snap:Role,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Definition: A realizable entity [snap:RealizableEntity] the manifestation of which brings about some result or end that is not essential to a continuant [snap:Continuant] in virtue of the kind of thing that it is but that can be served or participated in by that kind of continuant [snap:Continuant] in some kinds of natural, social or institutional contexts.|Examples: the role of a person as a surgeon, the role of a chemical compound in an experiment, the role of a patient relative as defined by a hospital administrative form, the role of a woman as a legal mother in the context of system of laws, the role of a biological grandfather as legal guardian in the context of a system of laws, the role of ingested matter in digestion, the role of a student in a university",role,
http://www.pepathway.org/peo/1.1#LY6K,LY6K,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:LY6K,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/54742,,,,,,,,,,,,,,,,,,,,LY6K,
http://www.pepathway.org/peo/1.2#Gynecological_history,Gynecological history,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy,,peo2:Gynecological_history,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/267011001,,,,Gynecological history (observable entity)|Gynaecological history,,,,,,Gynecological history,
http://www.pepathway.org/peo/1.2#Vaginal_delivery,Vaginal delivery,,,false,,,http://www.pepathway.org/peo/1.2#delivery_mode,,peo2:Vaginal_delivery,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/289259007,,,,Vaginal delivery (finding),,,,,,Vaginal delivery,
http://www.pepathway.org/peo/1.2#double_blinded_study,double blinded study,,,false,,,http://scai.fraunhofer.de/NDDUO#Study_type,,peo2:double_blinded_study,,,,,,,,,,,,,,,,,,,,,,,double blinded studies|double-blind|blinded,,,,,,double blinded study,
http://www.pepathway.org/peo/1.2#De_acetylations,De-acetylation,,AD595,false,,,http://www.pepathway.org/peo/1.2#Epigenetics,,peo2:De_acetylations,,,,,,,,,,,,,,,,,,,,,,,protein amino acid deacetylation,,,,,AD595,De-acetylation,
http://www.pepathway.org/peo/1.2#early_onset_context,early onset context,,,false,,,http://scai.fraunhofer.de/NDDUO#stage_context,,peo2:early_onset_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,early onset context,
http://www.pepathway.org/peo/1.1#IGF,IGF,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:IGF,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10062735,,,,,,,,,,,,,,insulin-like growth factor,,,,,,IGF,
http://www.pepathway.org/peo/1.2#Multivitamins,Multivitamins,,,false,,,http://www.pepathway.org/peo/1.2#Supplements,,peo2:Multivitamins,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/NDFRT/N0000020121,,,,,,,,,,Multivitamins,
http://www.pepathway.org/peo/1.2#Maternal_death,Maternal death,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:Maternal_death,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/59283008,,,,Maternal death (event)|Maternal mortality,,,,,,Maternal death,
http://www.pepathway.org/peo/1.2#Environmental_features,Environmental features,,,false,,,http://www.w3.org/2002/07/owl#Thing,,peo2:Environmental_features,,,,,,,,,,,,,,,,,,,,,,,Environmental factor|Environmental factors|Environmental feature,,,,,,Environmental features,
http://www.pepathway.org/peo/1.2#Bilateral_protodiastolic_notches,Bilateral protodiastolic notches,,,false,,,http://www.pepathway.org/peo/1.2#Doppler_studies,,peo2:Bilateral_protodiastolic_notches,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Bilateral protodiastolic notches,
http://www.pepathway.org/peo/1.2#Physically_active,Physically active,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Physically_active,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/228447005,,,,Physically active (finding),,,,,,Physically active,
http://scai.fraunhofer.de/NDDUO#severe_stage_context,severe stage context,,,false,,,http://scai.fraunhofer.de/NDDUO#stage_context,,NDDUO:severe_stage_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,severe stage context,
http://www.pepathway.org/peo/1.2#Remote_Hypertension,Remote Hypertension,,,false,,,http://www.pepathway.org/peo/1.2#Hypertensive_disorder,,peo2:Remote_Hypertension,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Remote Hypertension,
http://scai.fraunhofer.de/NDDUO#Clinical,Clinical thing,,,false,,,http://www.w3.org/2002/07/owl#Thing,,NDDUO:Clinical,,,,,,,,,,,,,,,,,,,,,,,clinical,,,,,,Clinical thing,
http://www.pepathway.org/peo/1.2#Previous_preeclampsia,Previous preeclampsia,,,false,,,http://www.pepathway.org/peo/1.2#Medical_history,,peo2:Previous_preeclampsia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Previous preeclampsia,
http://www.pepathway.org/peo/1.2#Availability_of_caesarean_section,Availability of caesarean section,,,false,,,http://www.pepathway.org/peo/1.2#Availability_of_medical_resources,,peo2:Availability_of_caesarean_section,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Availability of caesarean section,
http://www.pepathway.org/peo/1.1#KLK,KLK,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:KLK,,,,,,,,,kallikrein-related peptidase,,,,,,,,,,,,,,,,,,,,KLK,
http://www.pepathway.org/peo/1.1#IL17A,IL17A,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:IL17A,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/3605,,,,,,,,,,,,,,,,,,,,IL17A,
http://www.pepathway.org/peo/1.2#lamina-associated_polypeptide_2,lamina-associated polypeptide 2,,,false,,,http://www.pepathway.org/peo/1.2#Peptide,,peo2:lamina-associated_polypeptide_2,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/C093413,,,,LAP2 (protein)|LAP2alpha|LAP2beta,,,,,,lamina-associated polypeptide 2,
http://scai.fraunhofer.de/NDDUO#Etiology,Etiological thing,,AD444,false,,,http://www.w3.org/2002/07/owl#Thing,,NDDUO:Etiology,,,,,,,,,,,,,,,,,,,,,,,Etiology,,,,,AD444,Etiological thing,
http://www.pepathway.org/peo/1.2#double_masked_study,double masked study,,,false,,,http://scai.fraunhofer.de/NDDUO#Study_type,,peo2:double_masked_study,,,,,,,,,,,,,,,,,,,,,,,double masked studies,,,,,,double masked study,
http://www.pepathway.org/peo/1.1#MADCAM1,MADCAM1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:MADCAM1,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/8174,,,,,,,,,,,,,,,,,,,,MADCAM1,
http://www.pepathway.org/peo/1.2#Cerebral_perfusion_pressure,Cerebral perfusion pressure,,,false,,,http://www.pepathway.org/peo/1.2#Echocardiography,,peo2:Cerebral_perfusion_pressure,,,,,,,,,,,,,,,,,,,,,,,CPP,,,,,,Cerebral perfusion pressure,
http://www.pepathway.org/peo/1.2#Biochemical_test,Biochemical test,,,false,,,http://scai.fraunhofer.de/NDDUO#Diagnostic_tests,,peo2:Biochemical_test,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/183821000,,,,,,,,,,Biochemical test,
http://www.pepathway.org/peo/1.2#Sexually_transmitted_infectious_disease,Sexually transmitted infectious disease,,,false,,,http://www.pepathway.org/peo/1.2#Infection,,peo2:Sexually_transmitted_infectious_disease,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/8098009,,,,STD - Sexually transmitted disease|VD - Venereal disease|Disease with a predominantly sexual mode of transmission|Sexually transmitted disease,,,,,,Sexually transmitted infectious disease,
http://scai.fraunhofer.de/NDDUO#Age_specific_mortality_rate,Age specific mortality rate,,,false,,,http://scai.fraunhofer.de/NDDUO#Mortility_rate,,NDDUO:Age_specific_mortality_rate,,,,,,,,,,,,,,,,,,,,,,,Age specific mortality rates,,,,,,Age specific mortality rate,
http://scai.fraunhofer.de/NDDUO#allocation_design,allocation design,,,false,,,http://scai.fraunhofer.de/NDDUO#Study_design,,NDDUO:allocation_design,,,,,,,,,,,,,,,,,,,,,,,allocation designs,,,,,,allocation design,
http://scai.fraunhofer.de/NDDUO#exclusion_criterion,exclusion criterion,,,false,,,http://scai.fraunhofer.de/NDDUO#Recruitment_crieteria,,NDDUO:exclusion_criterion,,,,,,,,,,,,,,,,,,,,,,,exclusion criteria,,,,,,exclusion criterion,
http://www.pepathway.org/peo/1.2#Craniocerebral_Trauma,Craniocerebral Trauma,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Craniocerebral_Trauma,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D006259,,,,"Forehead Traumas|Traumas, Parietal Region|Crushing Skull Injuries|Head Injury, Superficial|Region Trauma, Parietal|Craniocerebral Injury|Trauma, Occipital|Head Injury, Multiple|Forehead Trauma|Head Traumas|Minor Head Injuries|Occipital Region Trauma|Head Injury, Open|Injury, Multiple Head|Injury, Head|Frontal Region Trauma|Head Injury|Injuries, Minor Head|Occipital Region Traumas|Craniocerebral Injuries|Region Trauma, Occipital|Traumas, Occipital|Trauma, Craniocerebral|Trauma, Occipital Region|Injuries, Craniocerebral|Region Traumas, Parietal|Minor Head Injury|Injury, Open Head|Head Injuries, Superficial|Multiple Head Injuries|Head Injuries, Minor|Trauma, Head|Trauma, Forehead|Head Injuries, Multiple|Injury, Craniocerebral|Occipital Trauma|Occipital Traumas|Region Traumas, Occipital|Multiple Head Injury|Parietal Region Trauma|Parietal Region Traumas|Craniocerebral Traumas|Open Head Injury|Trauma, Frontal Region|Trauma, Temporal Region|Open Head Injuries|Traumas, Occipital Region|Crushing Skull Injury|Injuries, Multiple Head|Head Injuries|Injuries, Superficial Head|Frontal Region Traumas|Traumas, Temporal Region|Region Trauma, Frontal|Temporal Region Trauma|Temporal Region Traumas|Superficial Head Injuries|Traumas, Forehead|Head Injury, Minor|Traumas, Frontal Region|Injuries, Open Head|Skull Injuries, Crushing|Traumas, Head|Head Injuries, Open|Trauma, Parietal Region|Superficial Head Injury|Traumas, Craniocerebral|Head Trauma|Injury, Minor Head|Injuries, Head|Region Traumas, Frontal|Injury, Superficial Head|Skull Injury, Crushing",,,,"Traumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage.",,Craniocerebral Trauma,
http://www.pepathway.org/peo/1.2#Fetal_gestational_age,Fetal gestational age,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Fetal_gestational_age,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/57036006,,,,Length of gestation|Fetal gestational age (observable entity),,,,,,Fetal gestational age,
http://www.pepathway.org/peo/1.1#AGT,AGT,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:AGT,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/183,,,,,,,,,,,,,,,,,,,,AGT,
http://www.pepathway.org/peo/1.1#AGTR,AGTR,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:AGTR,,,,,,,,,,,,,,,,,,,,,,,AGTR family,,,,,,AGTR,
http://www.pepathway.org/peo/1.2#diuretic,diuretic,,,false,,,http://scai.fraunhofer.de/NDDUO#drug_role,,peo2:diuretic,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_35498,,,,diuretics,,,,An agent that promotes the excretion of urine through its effects on kidney function.,,diuretic,
http://www.pepathway.org/peo/1.2#Placental_remodeling,Placental remodeling,,,false,,,http://www.pepathway.org/peo/1.2#Maternal_Organs,,peo2:Placental_remodeling,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Placental remodeling,
http://www.pepathway.org/peo/1.2#Gestational_diabetes_mellitus,Gestational diabetes mellitus,,,false,,,http://www.pepathway.org/peo/1.2#Diabetes,,peo2:Gestational_diabetes_mellitus,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/11687002,,,,Diabetes mellitus arising in pregnancy|Gestational diabetes mellitus (disorder)|Gestational diabetes|Maternal gestational diabetes mellitus|GDM - Gestational diabetes mellitus|GDM,,,,,,Gestational diabetes mellitus,
http://www.pepathway.org/peo/1.2#Embryo_Implantation,Embryo Implantation,,,false,,,http://www.pepathway.org/peo/1.2#Placental_implantation,,peo2:Embryo_Implantation,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D010064,,,,"Ovum Implantations|Implantations, Ovum|Blastocyst Implantations|Implantation, Ovum|Implantations, Embryo|Blastocyst Implantation|Implantations, Blastocyst|Ovum Implantation|Embryo Implantations|Implantation, Embryo|Decidual Cell Reaction|Decidual Cell Reactions|Implantation, Blastocyst|Nidation|Nidations",,,,"Endometrial implantation of EMBRYO, MAMMALIAN at the BLASTOCYST stage.",,Embryo Implantation,
http://scai.fraunhofer.de/NDDUO#clinical_trial_context,clinical trial context,,,false,,,http://scai.fraunhofer.de/NDDUO#clinical_context,,NDDUO:clinical_trial_context,,,,,,,,,,,,,,,,,,,,,, ,,,,,,,clinical trial context,
http://www.pepathway.org/peo/1.2#Ovarian_Diseases,Ovarian Diseases,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Ovarian_Diseases,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D010049,,,,"Disease, Ovarian|Ovarian Disease|Diseases, Ovarian",,,,,,Ovarian Diseases,
http://scai.fraunhofer.de/NDDUO#secondary_outcome_measure,secondary outcome measure,,,false,,,http://scai.fraunhofer.de/NDDUO#outcome_measure,,NDDUO:secondary_outcome_measure,,,,,,,,,,,,,,,,,,,,,,,secondary outcome measure,,,,,,secondary outcome measure,
http://www.pepathway.org/peo/1.2#Attributable_risks,Attributable risks,,AD300,false,,,http://www.pepathway.org/peo/1.2#Analysis_of_cohort_studies,,peo2:Attributable_risks,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD300,Attributable risks,
http://www.pepathway.org/peo/1.2#Pregnancy_termination_care,Pregnancy termination care,,,false,,,http://www.pepathway.org/peo/1.2#Therapeutics,,peo2:Pregnancy_termination_care,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/386394001,,,,Pregnancy termination care (regime/therapy),,,,,,Pregnancy termination care,
http://www.pepathway.org/peo/1.1#TNFRSF6B,TNFRSF6B,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:TNFRSF6B,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/8771,,,,,,,,,,,,,,,,,,,,TNFRSF6B,
http://www.pepathway.org/peo/1.2#Diet_poor,Diet poor,,,false,,,http://www.pepathway.org/peo/1.2#Prenatal_Nutritional_Physiological_Phenomena,,peo2:Diet_poor,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/310502008,,,,Diet poor (finding),,,,,,Diet poor,
http://www.pepathway.org/peo/1.1#IFNG,IFNG,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:IFNG,,,,,,,,,,,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/3458,,,,,,,,,,IFNG,
http://www.pepathway.org/peo/1.2#Dyslipidemia,Dyslipidemia,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Dyslipidemia,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/370992007,,,,Dyslipidemia (disorder)|Dyslipidaemia,,,,,,Dyslipidemia,
http://www.pepathway.org/peo/1.2#Complementry_health_approaches,Complementary health approach,,classification??|AD084,false,,,http://scai.fraunhofer.de/NDDUO#Non_pharmacotherapy,,peo2:Complementry_health_approaches,,,,,,,,,,,,,,,,,,,,,,,Complementary health approaches,,,,,classification??|AD084,Complementary health approach,
http://www.pepathway.org/peo/1.2#Insufficient_endocervical_transformation_zone_component_in_a_cervical_specimen,Insufficient endocervical / transformation zone component in a cervical specimen,,,false,,,http://www.pepathway.org/peo/1.2#Finding_of_measures_of_cervix,,peo2:Insufficient_endocervical_transformation_zone_component_in_a_cervical_specimen,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/373877006,,,,Insufficient endocervical / transformation zone component in a cervical specimen (finding),,,,,,Insufficient endocervical / transformation zone component in a cervical specimen,
http://www.pepathway.org/peo/1.2#Obstetric_umbilical_artery_Doppler,Obstetric umbilical artery Doppler,,,false,,,http://www.pepathway.org/peo/1.2#Doppler_studies,,peo2:Obstetric_umbilical_artery_Doppler,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/427623005,,,,Obstetric umbilical artery Doppler (procedure)|Doppler ultrasound scan of umbilical artery,,,,,,Obstetric umbilical artery Doppler,
http://www.pepathway.org/peo/1.2#cell_signalling,cell signalling,,from manual annotation of text corpus,false,,,http://www.ifomis.org/bfo/1.1/snap#Role,,peo2:cell_signalling,,,,,,,,,,,,,,,,,,,,,,,,,,,,from manual annotation of text corpus,cell signalling,
http://www.pepathway.org/peo/1.2#Angiotensin_II,Angiotensin II,,,false,,,http://www.pepathway.org/peo/1.2#Peptide,,peo2:Angiotensin_II,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D000804,,,,,,,"II, 5-L-Isoleucine Angiotensin|Isoleucyl(5)-Angiotensin II|Valyl(5)-Angiotensin II|5-L-Isoleucine Angiotensin II|Angiotensin II, Ile(5)-|5 L Isoleucine Angiotensin II|Angiotensin II, Valine(5)-|Angiotensin II, Isoleucine(5)-|Isoleucine(5)-Angiotensin|Angiotensin-(1-8) Octapeptide|ANG-(1-8)Octapeptide|Angiotensin II, 5-L-Isoleucine|Angiotensin II, Val(5)-","An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS.",,Angiotensin II,
http://www.pepathway.org/peo/1.2#Finding_of_measures_of_cervix,Finding of measures of cervix,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_observable,,peo2:Finding_of_measures_of_cervix,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/289824002,,,,Observation of measures of cervix|Finding of measures of cervix (finding),,,,,,Finding of measures of cervix,
http://www.pepathway.org/peo/1.2#vacular_inflammation,vascular inflammation,,from manual annotation of text corpus,false,,,http://www.pepathway.org/peo/1.2#inflammation,,peo2:vacular_inflammation,,,,,,,,,,,,,,,,,,,,,,,inflammation of vessel,,,,,from manual annotation of text corpus,vascular inflammation,
http://www.pepathway.org/peo/1.1#ADRB2,ADRB2,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:ADRB2,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/154,,,,,,,,,,,,,,,,,,,,ADRB2,
http://www.pepathway.org/peo/1.2#Populations,Population,,AD312,false,,,http://www.pepathway.org/peo/1.2#Incidence_rate,,peo2:Populations,,,,,,,,,,,,,,,,,,,,,,,Populations,,,,,AD312,Population,
http://www.pepathway.org/peo/1.2#NS1619,NS1619,,,false,,,http://www.pepathway.org/peo/1.2#drug,,peo2:NS1619,,,,,,,,,,,,,,,,,,,,,,,A selective large conductance calcium activated potassium channel activator,,,,,,NS1619,
http://scai.fraunhofer.de/NDDUO#Correlation_study,Correlation study,,,false,,,http://scai.fraunhofer.de/NDDUO#Descriptive_study,,NDDUO:Correlation_study,,,,,,,,,,,,,,,,,,,,,,,Correlation studies,,,,,,Correlation study,
http://www.ifomis.org/bfo/1.1/snap#Function,function,,"Definition: A realizable entity [snap:RealizableEntity] the manifestation of which is an essentially end-directed activity of a continuant [snap:Continuant] entity in virtue of that continuant [snap:Continuant] entity being a specific kind of entity in the kind or kinds of contexts that it is made for.|Examples: the function of a birth canal to enable transport, the function of the heart in the body: to pump blood, to receive de-oxygenated and oxygenated blood, etc., the function of reproduction in the transmission of genetic material, the digestive function of the stomach to nutriate the body, the function of a hammer to drive in nails, the function of a computer program to compute mathematical equations, the function of an automobile to provide transportation, the function of a judge in a court of law",false,,,http://www.ifomis.org/bfo/1.1/snap#RealizableEntity,,snap:Function,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Definition: A realizable entity [snap:RealizableEntity] the manifestation of which is an essentially end-directed activity of a continuant [snap:Continuant] entity in virtue of that continuant [snap:Continuant] entity being a specific kind of entity in the kind or kinds of contexts that it is made for.|Examples: the function of a birth canal to enable transport, the function of the heart in the body: to pump blood, to receive de-oxygenated and oxygenated blood, etc., the function of reproduction in the transmission of genetic material, the digestive function of the stomach to nutriate the body, the function of a hammer to drive in nails, the function of a computer program to compute mathematical equations, the function of an automobile to provide transportation, the function of a judge in a court of law",function,
http://www.pepathway.org/peo/1.2#Vomiting,Vomiting,,,false,,,http://scai.fraunhofer.de/NDDUO#Symptoms,,peo2:Vomiting,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/422400008,,,,Vomiting (disorder)|Emesis,,,,,,Vomiting,
http://www.pepathway.org/peo/1.1#SGSM1,SGSM1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:SGSM1,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/129049,,,,,,,,,,,,,,,,,,,,SGSM1,
http://www.pepathway.org/peo/1.2#Epigastric_pain,Epigastric pain,,,false,,,http://www.pepathway.org/peo/1.2#Pain,,peo2:Epigastric_pain,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/79922009,,,,Epigastric pain (finding),,,,,,Epigastric pain,
http://www.pepathway.org/peo/1.2#Connective_tissue_disease_overlap_syndrome,Connective tissue disease overlap syndrome,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Connective_tissue_disease_overlap_syndrome,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/398021003,,,,Connective tissue disease overlap syndrome (disorder),,,,,,Connective tissue disease overlap syndrome,
http://www.pepathway.org/peo/1.2#thing_related_to_phenotypic_features,thing related to phenotypic features,,,false,,,http://scai.fraunhofer.de/NDDUO#Clinical,,peo2:thing_related_to_phenotypic_features,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to phenotypic features,
http://scai.fraunhofer.de/NDDUO#non_pharmacotherapy_procedure,non-pharmacotherapy procedure,,,false,,,http://www.ifomis.org/bfo/1.1/span#Process|http://scai.fraunhofer.de/NDDUO#Non_pharmacotherapy,,NDDUO:non_pharmacotherapy_procedure,,,,,,,,,,,,,,,,,,,,,,,non-pharmacotherapy procedures,,,,,,non-pharmacotherapy procedure,
http://scai.fraunhofer.de/NDDUO#male,male,,,false,,,http://scai.fraunhofer.de/NDDUO#Gender,,NDDUO:male,,,,,,,,,,,,,,,,,,,,,,,men,,,,,,male,
http://www.pepathway.org/peo/1.2#Hydropic_placenta,Hydropic placenta,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Hydropic_placenta,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/HP_0011414,,,,Hydropic placenta,,,,,,Hydropic placenta,
http://scai.fraunhofer.de/NDDUO#procedures_using_biomarkers_context,procedures using biomarkers context,,,false,,,http://scai.fraunhofer.de/NDDUO#diagnosis_context,,NDDUO:procedures_using_biomarkers_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,procedures using biomarkers context,
http://www.pepathway.org/peo/1.2#Postpartum,Postpartum,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_time_period,,peo2:Postpartum,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/255410009,,,,Postpartum (qualifier value)|Puerperal,,,,,,Postpartum,
http://www.pepathway.org/peo/1.2#Inflammatory_markers,Inflammatory marker,,AD120,false,,,http://scai.fraunhofer.de/NDDUO#biomarker,,peo2:Inflammatory_markers,,,,,,,,,,,,,,,,,,,,,,,Inflammatory markers|inflammatory biomarker|inflammatory biomarkers,,,,,AD120,Inflammatory marker,
http://www.pepathway.org/peo/1.2#Estimated_fetal_gestational_age_at_delivery,Estimated fetal gestational age at delivery,,,false,,,http://www.pepathway.org/peo/1.2#Fetal_gestational_age,,peo2:Estimated_fetal_gestational_age_at_delivery,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/444135009,,,,Estimated fetal gestational age at delivery (observable entity)|Estimated foetal gestational age at delivery,,,,,,Estimated fetal gestational age at delivery,
http://www.pepathway.org/peo/1.1#SYNC,SYNC,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:SYNC,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/81493,,,,,,,,,,,,,,,,,,,,SYNC,
http://www.pepathway.org/peo/1.2#Neurodegeneration,Neurodegeneration,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:Neurodegeneration,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/OMIM/MTHU007383,,,,,,,,,,Neurodegeneration,
http://www.pepathway.org/peo/1.2#Aspirin_allergy,Aspirin allergy,,,false,,,http://www.pepathway.org/peo/1.2#Allergy_to_substance,,peo2:Aspirin_allergy,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/293586001,,,,Aspirin allergy (disorder),,,,,,Aspirin allergy,
http://www.pepathway.org/peo/1.2#Tobacco_use_and_exposure_-_finding,Tobacco use and exposure - finding,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Tobacco_use_and_exposure_-_finding,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/365980008,,,,Finding of tobacco use and exposure|Finding of tobacco use and exposure (finding),,,,,,Tobacco use and exposure - finding,
http://scai.fraunhofer.de/NDDUO#Standardized_mortality_ratio,Standardized mortality ratio,,,false,,,http://scai.fraunhofer.de/NDDUO#Standardized_mortality_rate,,NDDUO:Standardized_mortality_ratio,,,,,,,,,,,,,,,,,,,,,,,Standardized mortality ratios,,,,,,Standardized mortality ratio,
http://www.pepathway.org/peo/1.2#Cytodiagnosis,Cytodiagnosis,,,false,,,http://scai.fraunhofer.de/NDDUO#Diagnostic_tests,,peo2:Cytodiagnosis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D003581,,,,Cytodiagnoses,,,,"Diagnosis of the type and, when feasible, the cause of a pathologic process by means of microscopic study of cells in an exudate or other form of body fluid. (Stedman, 26th ed)",,Cytodiagnosis,
http://www.pepathway.org/peo/1.2#Urinary_tract_infections,Urinary tract infections,,,false,,,http://www.pepathway.org/peo/1.2#Postpartum_Infections,,peo2:Urinary_tract_infections,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/OMIM/MTHU007522,,,,,,,,,,Urinary tract infections,
http://www.pepathway.org/peo/1.2#Thrombophilia,Thrombophilia,,,false,,,http://www.pepathway.org/peo/1.2#Thrombosis,,peo2:Thrombophilia,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/234467004,,,,Thrombophilia (disorder),,,,,,Thrombophilia,
http://www.pepathway.org/peo/1.2#Hepatic_disease,Hepatic disease,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Hepatic_disease,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10019650,,,,Liver disease,,,,,,Hepatic disease,
http://scai.fraunhofer.de/NDDUO#population_based_study,population based analytical study,,,false,,,http://scai.fraunhofer.de/NDDUO#Analytical_study,,NDDUO:population_based_study,,,,,,,,,,,,,,,,,,,,,,,population based analytical studies,,,,,,population based analytical study,
http://www.pepathway.org/peo/1.2#Upregulation,Upregulation,,AD616,false,,,http://scai.fraunhofer.de/NDDUO#Regulation_of_gene_expression,,peo2:Upregulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD616,Upregulation,
http://www.pepathway.org/peo/1.2#Vascular_tone,Vascular tone,,,false,,,http://www.pepathway.org/peo/1.2#Echocardiography,,peo2:Vascular_tone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Vascular tone,
http://www.pepathway.org/peo/1.2#Entire_placenta,Entire placenta,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Entire_placenta,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/181455002,,,,Entire placenta (body structure)|Placenta,,,,,,Entire placenta,
http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,Cellular and subcellular entity,,,false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,NDDUO:Cellular_and_subcellular_entities,,,,,,,,,,,,,,,,,,,,,,,subcellular entities|cellular entities|cellular entity|subcellular entity,,,,,,Cellular and subcellular entity,
http://www.pepathway.org/peo/1.2#thing_related_to_main_complaint,thing related to main complaint,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_observations,,peo2:thing_related_to_main_complaint,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to main complaint,
http://www.pepathway.org/peo/1.2#Fresh_late_fetal_deaths,Fresh late fetal deaths,,,false,,,http://www.pepathway.org/peo/1.2#Newborn_death,,peo2:Fresh_late_fetal_deaths,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Fresh late fetal deaths,
http://www.pepathway.org/peo/1.2#Endocytosis,Endocytosis,,AD483,false,,,http://www.pepathway.org/peo/1.2#processes_all_cells,,peo2:Endocytosis,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/GO#GO_0006897,,,,plasma membrane invagination|vesicle endocytosis,,,,,AD483,Endocytosis,
http://www.pepathway.org/peo/1.2#Infectious_causes,Infectious cause,,AD455,false,,,http://www.ifomis.org/bfo/1.1/span#ProcessualEntity,,peo2:Infectious_causes,,,,,,,,,,,,,,,,,,,,,,,Infectious causes|infection|infections,,,,,AD455,Infectious cause,
http://www.pepathway.org/peo/1.2#Sodium_transport,Sodium transport,,AD617,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:Sodium_transport,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/GO#GO_0006814,,,,sodium transport,,,,,AD617,Sodium transport,
http://www.pepathway.org/peo/1.2#Case_control_study,Case control study,,,false,,,http://scai.fraunhofer.de/NDDUO#Cohort_study,,peo2:Case_control_study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Case control study,
http://www.pepathway.org/peo/1.2#Miscarriage_in_second_trimester,Miscarriage in second trimester,,,false,,,http://www.pepathway.org/peo/1.2#Earlier_miscarriage,,peo2:Miscarriage_in_second_trimester,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/85116003,,,,Miscarriage in second trimester (disorder)|Spontaneous abortion in second trimester,,,,,,Miscarriage in second trimester,
http://www.pepathway.org/peo/1.2#Gave_up_before_pregnancy_(Alcohol_intake),Gave up before pregnancy (Alcohol intake),,,false,,,http://www.pepathway.org/peo/1.2#Alcohol_intake,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Gave up before pregnancy (Alcohol intake),
http://www.pepathway.org/peo/1.2#Dura_Mater,Dura Mater,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Dura_Mater,,,,,,,,,,,,,,,,,,,,,,,Falx Cerebelli,,,,,,Dura Mater,
http://scai.fraunhofer.de/NDDUO#primary_measure_context,primary measure context,,,false,,,http://scai.fraunhofer.de/NDDUO#clinical_trial_context,,NDDUO:primary_measure_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,primary measure context,
http://www.pepathway.org/peo/1.2#Entire_kidney,Entire kidney,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Entire_kidney,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/181414000,,,,Entire kidney (body structure)|Kidney,,,,,,Entire kidney,
http://www.pepathway.org/peo/1.2#thing_related_to_demographics,thing related to demographics,,,false,,,http://www.pepathway.org/peo/1.2#Environmental_features,,peo2:thing_related_to_demographics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to demographics,
http://www.pepathway.org/peo/1.1#VEGFA,VEGFA,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:VEGFA,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/7422,,,,,,,,,,,,,,,,,,,,VEGFA,
http://www.pepathway.org/peo/1.2#Arthritis,Arthritis,,,false,,,http://www.pepathway.org/peo/1.2#Inflammatory_disorder,,peo2:Arthritis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/3723001,,,,Joint inflammation|Arthritis (disorder)|Inflammatory arthritis,,,,,,Arthritis,
http://www.pepathway.org/peo/1.2#Placental_perfusion,Placental perfusion,,,false,,,http://www.pepathway.org/peo/1.2#Placentation,,peo2:Placental_perfusion,,,,,,,,,,,,,,,,,,,,,,,perfusion,,,,,,Placental perfusion,
http://www.pepathway.org/peo/1.2#Sjogrens_syndrome,Sjögren's syndrome,,,false,,,http://www.pepathway.org/peo/1.2#Mixed_collagen_vascular_disease,,peo2:Sjogrens_syndrome,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/83901003,,,,Sjögren's syndrome (disorder)|Sjögren's disease|Sjogrens syndrome|Sjogren's syndrome|Sicca syndrome|Sjögren syndrome,,,,,,Sjögren's syndrome,
http://www.pepathway.org/peo/1.1#NR3C2,NR3C2,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:NR3C2,,,,,,,,,,,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/4306,,,,,,,,,,NR3C2,
http://scai.fraunhofer.de/NDDUO#Clinical_assesment,Clinical assesment,,,false,,,http://scai.fraunhofer.de/NDDUO#Diagnostic_Procedures,,NDDUO:Clinical_assesment,,,,,,,,,,,,,,,,,,,http://purl.org/cpr/0.85#clinical-examination,,,,Health Assesment|Health Assesments|Clinical assesments,,,,,,Clinical assesment,
http://www.pepathway.org/peo/1.1#RGS2,RGS2,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:RGS2,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/5997,,,,,,,,,,,,,,,,,,,,RGS2,
http://www.pepathway.org/peo/1.2#Collagen_matrix,Collagen matrix,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Collagen_matrix,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Collagen matrix,
http://scai.fraunhofer.de/NDDUO#family_based_study,family based analytical study,,,false,,,http://scai.fraunhofer.de/NDDUO#Analytical_study,,NDDUO:family_based_study,,,,,,,,,,,,,,,,,,,,,,,family based analytical studies,,,,,,family based analytical study,
http://scai.fraunhofer.de/NDDUO#Regulation_of_gene_expression,Regulation of gene expression,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,NDDUO:Regulation_of_gene_expression,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/GO#GO_0010468,,,,,,,,,,Regulation of gene expression,
http://www.pepathway.org/peo/1.2#Unilateral_notching,Unilateral notching,,,false,,,http://www.pepathway.org/peo/1.2#Echocardiography,,peo2:Unilateral_notching,,,,,,,,,,,,,,,,,,,,,,,Bilateral notching,,,,,,Unilateral notching,
http://www.pepathway.org/peo/1.2#G_protein_coupled_signal_transduction_pathway,G protein coupled signal transduction pathway,,,false,,,http://www.pepathway.org/peo/1.2#Pathway,,peo2:G_protein_coupled_signal_transduction_pathway,,,,,,,,,,,,,,,,,,,,,,,Gq/11-coupled signal transduction pathway,,,,,,G protein coupled signal transduction pathway,
http://www.pepathway.org/peo/1.2#treatment_at_delivery,treatment at delivery,,,false,,,http://scai.fraunhofer.de/NDDUO#Clinical_treatment,,peo2:treatment_at_delivery,,,,,,,,,,,,,,,,,,,,,,,,,,,,,treatment at delivery,
http://www.pepathway.org/peo/1.2#Urinary_tract_infection_in_pregnancy,Urinary tract infection in pregnancy,,,false,,,http://www.pepathway.org/peo/1.2#Infection,,peo2:Urinary_tract_infection_in_pregnancy,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/307534009,,,,UTI - urinary tract infection in pregnancy|Urinary tract infection complicating pregnancy|Urinary tract infection in pregnancy (disorder),,,,,,Urinary tract infection in pregnancy,
http://www.pepathway.org/peo/1.1#ERVFRD-1,ERVFRD-1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:ERVFRD-1,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/405754,,,,,,,,,,,,,,,,,,,,ERVFRD-1,
http://www.pepathway.org/peo/1.2#Arterial_Pressure,Arterial Pressure,,,false,,,http://www.pepathway.org/peo/1.2#Blood_pressure_finding,,peo2:Arterial_Pressure,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D062186,,,,"Pressures, Aortic|Blood Pressures, Arterial|Aortic Tension|Aortic Tensions|Tensions, Aortic|Aortic Blood Pressures|Pressure, Aortic Pulse|Aortic Pressures, Mean|Arterial Blood Pressures|Pulse Pressures, Aortic|Arterial Pressure, Mean|Pressures, Aortic Pulse|Tension, Aortic|Mean Arterial Pressures|Mean Arterial Pressure|Pressure, Aortic|Tension, Arterial|Tensions, Arterial|Aortic Pulse Pressures|Pressures, Mean Aortic|Pressures, Aortic Blood|Aortic Pulse Pressure|Pulse Pressure, Aortic|Pressure, Mean Aortic|Pressures, Mean Arterial|Arterial Tension|Arterial Tensions|Aortic Pressure, Mean|Mean Aortic Pressure|Mean Aortic Pressures|Pressures, Arterial Blood|Arterial Blood Pressure|Arterial Pressures, Mean|Blood Pressure, Arterial|Pressure, Aortic Blood|Aortic Blood Pressure|Pressure, Mean Arterial|Blood Pressure, Aortic|Pressures, Arterial|Blood Pressures, Aortic|Arterial Pressures|Pressure, Arterial|Aortic Pressure|Aortic Pressures|Pressure, Arterial Blood",,,,Difference between systolic and diastolic pressures within AORTA Blood pressure within AORTA The blood pressure in the ARTERIES. It is commonly measured with a SPHYGMOMANOMETER on the upper arm which represents the arterial pressure in the BRACHIAL ARTERY. The average pressure during the aortic pulse cycle. The average arterial pressure during a single cardiac cycle. It can be estimated as diastolic blood pressure plus one third of the difference of diastolic and systolic blood pressures.,,Arterial Pressure,
http://www.pepathway.org/peo/1.2#Birth_weight_of_the_pregnant_woman,Birth weight of the pregnant woman,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Birth_weight_of_the_pregnant_woman,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Birth weight of the pregnant woman,
http://www.pepathway.org/peo/1.2#Abortion_Habitual,"Abortion, Habitual",,,false,,,http://www.pepathway.org/peo/1.2#Gynecological_history,,peo2:Abortion_Habitual,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D000026,,,,,,,"Habitual Abortions|Recurrent Miscarriages|Miscarriage, Recurrent|Recurrent Miscarriage|Recurrent Abortion|Recurrent Abortions|Abortion, Recurrent|Abortions, Recurrent|Habitual Abortion|Miscarriages, Recurrent|Abortions, Habitual",Three or more consecutive spontaneous abortions.,,"Abortion, Habitual",
http://www.pepathway.org/peo/1.2#Latitude,Latitude,,,false,,,http://www.pepathway.org/peo/1.2#Geography,,peo2:Latitude,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Latitude,
http://www.pepathway.org/peo/1.2#Cardiac_fibrosis,Cardiac fibrosis,,,false,,,http://www.pepathway.org/peo/1.2#Heart_disease,,peo2:Cardiac_fibrosis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/OMIM/MTHU034875,,,,,,,,,,Cardiac fibrosis,
http://www.pepathway.org/peo/1.2#regulation_of_cell_adhesion,regulation of cell adhesion,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:regulation_of_cell_adhesion,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/GO_0030155,,,,cell adhesion receptor regulator activity,,,,"Any process that modulates the frequency, rate or extent of attachment of a cell to another cell or to the extracellular matrix.",,regulation of cell adhesion,
http://www.pepathway.org/peo/1.2#Cerebral_hyperperfusion_syndrome,Cerebral hyperperfusion syndrome,,,false,,,http://www.pepathway.org/peo/1.2#Brain_Diseases,,peo2:Cerebral_hyperperfusion_syndrome,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10064730,,,,,,,,,,Cerebral hyperperfusion syndrome,
http://www.pepathway.org/peo/1.2#Educational_achievement,Educational achievement,,,false,,,http://www.pepathway.org/peo/1.2#Education_and_schooling_detail,,peo2:Educational_achievement,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/105421008,,,,Level of educational attainment|Educational achievement (observable entity)|Educational qualification|Academic achievement,,,,,,Educational achievement,
http://www.pepathway.org/peo/1.2#Psoriasis_with_arthropathy,Psoriasis with arthropathy,,,false,,,http://www.pepathway.org/peo/1.2#Arthritis,,peo2:Psoriasis_with_arthropathy,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/33339001,,,,PsA - Psoriatic arthritis|Psoriatic arthritis|Psoriasis with arthropathy (disorder)|Psoriatic arthropathy|PA - Psoriatic arthritis,,,,,,Psoriasis with arthropathy,
http://scai.fraunhofer.de/NDDUO#equipment,equipment,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Object|http://scai.fraunhofer.de/NDDUO#Non_pharmacotherapy,,NDDUO:equipment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,equipment,
http://www.pepathway.org/peo/1.1#GOT,GOT,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:GOT,,,,,,,,,,,,,,,,,,,,,,,glutamic-oxaloacetic transaminase,,,,,,GOT,
http://www.pepathway.org/peo/1.2#Cerebrovascular_accident,Cerebrovascular accident,,,false,,,http://www.pepathway.org/peo/1.2#Brain_Diseases,,peo2:Cerebrovascular_accident,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/230690007,,,,Cerebrovascular stroke|Cerebrovascular accident (disorder)|CVA - Cerebrovascular accident|Stroke,,,,,,Cerebrovascular accident,
http://www.pepathway.org/peo/1.2#Disorder_of_fetus_or_newborn,Disorder of fetus or newborn,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Disorder_of_fetus_or_newborn,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/414025005,,,,Disorder of foetus or newborn|Disorder of fetus or newborn (disorder)|Fetus and neonate conditions,,,,,,Disorder of fetus or newborn,
http://www.pepathway.org/peo/1.2#bmi,BMI,,,false,,,http://www.ifomis.org/bfo/1.1/snap#GenericallyDependentContinuant,,peo2:bmi,,,,,,,,,,,,,,,,,,,,,,from manual annotation of text corpus,body mass index,,,,,,BMI,
http://www.pepathway.org/peo/1.2#Acute_pulmonary_edema,Acute pulmonary edema,,,false,,,http://www.pepathway.org/peo/1.2#Edema,,peo2:Acute_pulmonary_edema,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/40541001,,,,Acute oedema of lung|Acute edema of lung|Acute pulmonary edema (disorder)|Pulmonary oedema - acute|Pulmonary edema - acute|Acute pulmonary oedema,,,,,,Acute pulmonary edema,
http://www.ifomis.org/bfo/1.1/span#SpatiotemporalInterval,spatiotemporal_interval,,Definition: A connected spatiotemporal region [span:ConnectedSpatiotemporalRegion] that endures for more than a single moment of time.|Examples: the spatiotemporal region occupied by a process or by a fiat processual part,false,,,http://www.ifomis.org/bfo/1.1/span#ConnectedSpatiotemporalRegion,,span:SpatiotemporalInterval,,,,,,,,,,,,,,,,,,,,,,,,,,,,Definition: A connected spatiotemporal region [span:ConnectedSpatiotemporalRegion] that endures for more than a single moment of time.|Examples: the spatiotemporal region occupied by a process or by a fiat processual part,spatiotemporal_interval,
http://www.pepathway.org/peo/1.2#Placental_damage,Placental damage,,,false,,,http://www.pepathway.org/peo/1.2#Placental_finding,,peo2:Placental_damage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Placental damage,
http://www.pepathway.org/peo/1.2#vitamin_D,vitamin D,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:vitamin_D,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_27300,,,,D vitamins|vitamin Ds,,,,"Vitamin D is a group of fat-soluble prohormones, which can be obtained from sun exposure, food and supplements. Vitamin D is biologically inactive and converted to the biologically active calcitriol via double hydroxylation in the body.",,vitamin D,
http://www.pepathway.org/peo/1.1#SERPINE1,SERPINE1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:SERPINE1,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/5054,,,,,,,,,,,,,,,,,,,,SERPINE1,
http://www.pepathway.org/peo/1.2#Length_of_gestation_at_birth,Length of gestation at birth,,,false,,,http://www.pepathway.org/peo/1.2#Fetal_gestational_age,,peo2:Length_of_gestation_at_birth,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/412726003,,,,Gestational age at birth|Length of gestation at birth (observable entity),,,,Duration of the pregnancy,,Length of gestation at birth,
http://www.pepathway.org/peo/1.2#Nutritional_condition,Nutritional condition,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Nutritional_condition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Nutritional condition,
http://www.pepathway.org/peo/1.1#NME9,NME9,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:NME9,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/347736,,,,,,,,,,,,,,,,,,,,NME9,
http://scai.fraunhofer.de/NDDUO#Retrospective_cohort_study,Retrospective cohort study,,,false,,,http://scai.fraunhofer.de/NDDUO#Cohort_study,,NDDUO:Retrospective_cohort_study,,,,,,,,,,,,,,,,,,,,,,,Retrospective cohort studies,,,,,,Retrospective cohort study,
http://www.pepathway.org/peo/1.2#Neoplasm_by_body_site,Neoplasm by body site,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Neoplasm_by_body_site,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/127331007,,,,Neoplasm by body site (disorder),,,,,,Neoplasm by body site,
http://www.pepathway.org/peo/1.2#Body_weight_measure,Body weight measure,,,false,,,http://www.pepathway.org/peo/1.2#Body_measure,,peo2:Body_weight_measure,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/363808001,,,,Body weight measure (observable entity),,,,,,Body weight measure,
http://www.pepathway.org/peo/1.2#Snuff_user,Snuff user,,,false,,,http://www.pepathway.org/peo/1.2#Maternal_tobacco_use,,peo2:Snuff_user,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/228494002,,,,Snuff taker|Snuff user (finding),,,,,,Snuff user,
http://www.pepathway.org/peo/1.2#Maternal_mortality_rate,Maternal mortality rate,,,false,,,http://scai.fraunhofer.de/NDDUO#Mortility_rate,,peo2:Maternal_mortality_rate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maternal mortality rate,
http://www.pepathway.org/peo/1.2#Hemorrhagic_endovasculitis,Hemorrhagic endovasculitis,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Hemorrhagic_endovasculitis,,,,,,,,,,,,,,,,,,,,,,,hemorrhagic endovasculitis of the placenta|HEV,,,,,,Hemorrhagic endovasculitis,
http://www.pepathway.org/peo/1.2#Peripheral_vascular,Peripheral vascular,,,false,,,http://www.pepathway.org/peo/1.2#Entire_blood_vessel,,peo2:Peripheral_vascular,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Peripheral vascular,
http://www.pepathway.org/peo/1.1#PAPPA,PAPPA,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:PAPPA,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/5069,,,,,,,,,,,,,,,,,,,,PAPPA,
http://www.pepathway.org/peo/1.1#AGTR2,AGTR2,,,false,,,http://www.pepathway.org/peo/1.1#AGTR,,peo:AGTR2,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/186,,,,,,,,,,,,,,,,,,,,AGTR2,
http://www.pepathway.org/peo/1.1#MXRA5,MXRA5,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:MXRA5,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/25878,,,,,,,,,,,,,,,,,,,,MXRA5,
http://www.pepathway.org/peo/1.2#negative_regulation_of_apoptotic_process,negative regulation of apoptotic process,,"This term should only be used when it is not possible to determine which phase or subtype of the apoptotic process is negatively regulated by a gene product. Whenever detailed information is available, the more granular children terms should be used.",false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:negative_regulation_of_apoptotic_process,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/GO_0043066,,,,down-regulation of apoptosis; downregulation of apoptosis; anti-apoptosis; down regulation of apoptosis|pro-survival; apoptosis inhibitor activity|inhibition of apoptosis; negative regulation of apoptosis,,,,"Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.","This term should only be used when it is not possible to determine which phase or subtype of the apoptotic process is negatively regulated by a gene product. Whenever detailed information is available, the more granular children terms should be used.",negative regulation of apoptotic process,
http://scai.fraunhofer.de/NDDUO#In_vivo_models,In vivo model,,,false,,,http://scai.fraunhofer.de/NDDUO#model,,NDDUO:In_vivo_models,,,,,,,,,,,,,,,,,,,http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#in_vivo_Model,,,,animal model|animal models|alzheimer's disease mouse models|mouse models|mouse model|In vivo models|alzheimer's disease mouse model|rat model|rat models,,,,,,In vivo model,
http://www.pepathway.org/peo/1.2#Collagen,Collagen,,,false,,,http://www.pepathway.org/peo/1.2#Peptide,,peo2:Collagen,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D003094,,,,"Collagen Hemostat, Microfibril|Collagenfleece|Microfibril Collagen Hemostat|alpha-Collagen|Collagen Fleece|Collagen Felt|alpha Collagen|Avicon|Avitene|Collagens|Collastat|Dermodress|Pangen|Zyderm",,,,A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). A topical hemostatic agent prepared from collagen.,,Collagen,
http://www.pepathway.org/peo/1.2#RAS_targeting_drugs,RAS targeting drugs,,,false,,,http://scai.fraunhofer.de/NDDUO#drug_role,,peo2:RAS_targeting_drugs,,,,,,,,,,,,,,,,,,,,,,,Renin-angiotensin-aldosterone system-targeting drugs,,,,,,RAS targeting drugs,
http://scai.fraunhofer.de/NDDUO#Distribution,Distribution,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,NDDUO:Distribution,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/PATO#PATO_0001566,,,,Distributions|diffuse|scattered,,,,,,Distribution,
http://www.ifomis.org/bfo/1.1/snap#RealizableEntity,realizable_entity,,"Definition: A specifically dependent continuant [snap:SpecificallyDependentContinuant] that inheres in continuant [snap:Continuant] entities and are not exhibited in full at every time in which it inheres in an entity or group of entities. The exhibition or actualization of a realizable entity is a particular manifestation, functioning or process that occurs under certain circumstances.|Examples: the role of being a doctor, the function of the reproductive organs, the disposition of blood to coagulate, the disposition of metal to conduct electricity|Comment: If a realizable entity [snap:RealizableEntity] inheres in a continuant [snap:Continuant], this does not imply that it is actually realized.",false,,,http://www.ifomis.org/bfo/1.1/snap#SpecificallyDependentContinuant,,snap:RealizableEntity,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Definition: A specifically dependent continuant [snap:SpecificallyDependentContinuant] that inheres in continuant [snap:Continuant] entities and are not exhibited in full at every time in which it inheres in an entity or group of entities. The exhibition or actualization of a realizable entity is a particular manifestation, functioning or process that occurs under certain circumstances.|Examples: the role of being a doctor, the function of the reproductive organs, the disposition of blood to coagulate, the disposition of metal to conduct electricity|Comment: If a realizable entity [snap:RealizableEntity] inheres in a continuant [snap:Continuant], this does not imply that it is actually realized.",realizable_entity,
http://www.pepathway.org/peo/1.2#wk8_10,8–10 wk,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_time_period,,peo2:wk8_10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8–10 wk,
http://www.pepathway.org/peo/1.2#B-lines,B-lines,,,false,,,http://www.pepathway.org/peo/1.2#Ultrasonography,,peo2:B-lines,,,,,,,,,,,,,,,,,,,,,,,comet tail artifact,,,,,,B-lines,
http://www.pepathway.org/peo/1.2#Codeine_abuse,Codeine abuse,,,false,,,http://www.pepathway.org/peo/1.2#Drug_abuse,,peo2:Codeine_abuse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Codeine abuse,
http://www.pepathway.org/peo/1.2#Previous_preterm_delivery,Previous preterm delivery,,,false,,,http://www.pepathway.org/peo/1.2#Medical_history,,peo2:Previous_preterm_delivery,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Previous preterm delivery,
http://www.pepathway.org/peo/1.2#Geography,Geography,,,false,,,http://www.ifomis.org/bfo/1.1/snap#TwoDimensionalRegion,,peo2:Geography,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D005843,,,,"Human Geography|Geography, Human|Factors, Geographic|Geographic Factor|Geographic Factors|Factor, Geographic",,,,"The science dealing with the earth and its life, especially the description of land, sea, and air and the distribution of plant and animal life, including humanity and human industries with reference to the mutual relations of these elements. (From Webster, 3d ed)",,Geography,
http://www.pepathway.org/peo/1.2#Neonatal_mortality_rate,Neonatal mortality rate,,,false,,,http://scai.fraunhofer.de/NDDUO#Mortility_rate,,peo2:Neonatal_mortality_rate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Neonatal mortality rate,
http://www.pepathway.org/peo/1.2#Intervillous_blood_space,Intervillous blood space,,,false,,,http://www.pepathway.org/peo/1.2#Chorionic_villi_structure,,peo2:Intervillous_blood_space,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Intervillous blood space,
http://www.pepathway.org/peo/1.2#At_crowning_of_head,At crowning of head,,,false,,,http://www.pepathway.org/peo/1.2#Intrapartum,,peo2:At_crowning_of_head,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/255615007,,,,At crowning of head (qualifier value),,,,,,At crowning of head,
http://www.pepathway.org/peo/1.2#Atrial_fibrillation,Atrial fibrillation,,,false,,,http://www.pepathway.org/peo/1.2#Heart_disease,,peo2:Atrial_fibrillation,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/49436004,,,,AF - Atrial fibrillation|Atrial fibrillation (disorder),,,,,,Atrial fibrillation,
http://www.pepathway.org/peo/1.2#Cumulative_incidence,Cumulative incidence,,AD304,false,,,http://www.pepathway.org/peo/1.2#Incidence,,peo2:Cumulative_incidence,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD304,Cumulative incidence,
http://www.pepathway.org/peo/1.1#LYZL1,LYZL1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:LYZL1,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/84569,,,,,,,,,,,,,,,,,,,,LYZL1,
http://www.pepathway.org/peo/1.2#Placental_explants,Placental explants,,,false,,,http://www.pepathway.org/peo/1.2#Entire_placenta,,peo2:Placental_explants,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Placental explants,
http://www.pepathway.org/peo/1.2#Previous_stillbirth,Previous stillbirth,,,false,,,http://www.pepathway.org/peo/1.2#Medical_history,,peo2:Previous_stillbirth,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Previous stillbirth,
http://www.pepathway.org/peo/1.2#Cesarean_section,Cesarean section,,,false,,,http://www.pepathway.org/peo/1.2#delivery_mode,,peo2:Cesarean_section,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/11466000,,,,Cesarean section (procedure)|CS - Caesarean section|CS - Cesarean section|Caesarean section,,,,,,Cesarean section,
http://www.pepathway.org/peo/1.2#thing_related_to_complications_for_mother,thing related to complications for mother,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_complications,,peo2:thing_related_to_complications_for_mother,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to complications for mother,
http://www.pepathway.org/peo/1.2#control_subject,control subject,,from NP chunking|shouldn't this be a role?,false,,,http://www.ifomis.org/bfo/1.1/snap#Object,,peo2:control_subject,,,,,,,,,,,,,,,,,,,,,,,control subjects,,,,,from NP chunking|shouldn't this be a role?,control subject,
http://www.pepathway.org/peo/1.2#Irregularly_used,Irregularly used,,,false,,,http://www.pepathway.org/peo/1.2#Maternal_tobacco_use,,peo2:Irregularly_used,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Irregularly used,
http://www.pepathway.org/peo/1.2#thing_related_to_environmental_exposure,thing related to environmental exposure,,,false,,,http://www.pepathway.org/peo/1.2#Environmental_features,,peo2:thing_related_to_environmental_exposure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to environmental exposure,
http://www.pepathway.org/peo/1.2#Placental_finding,Placental finding,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_observable,,peo2:Placental_finding,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/169952004,,,,Placental finding (finding)|Placental details,,,,,,Placental finding,
http://www.pepathway.org/peo/1.2#Energy_metabolism,Energy metabolism,,AD592,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:Energy_metabolism,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD592,Energy metabolism,
http://www.pepathway.org/peo/1.2#Morphologically_abnormal_structure,Morphologically abnormal structure,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Morphologically_abnormal_structure,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/49755003,,,,Abnormal tissue appearance|Morphologically abnormal structure (morphologic abnormality)|Lesion,,,,,,Morphologically abnormal structure,
http://www.pepathway.org/peo/1.2#Physiological_test,Physiological test,,,false,,,http://scai.fraunhofer.de/NDDUO#Diagnostic_tests,,peo2:Physiological_test,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/HL7/C1551303,,,,,,,,,,Physiological test,
http://www.pepathway.org/peo/1.1#AGTR1,AGTR1,,,false,,,http://www.pepathway.org/peo/1.1#AGTR,,peo:AGTR1,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/185,,,,,,,,,,,,,,,,,,,,AGTR1,
http://www.pepathway.org/peo/1.2#Third_trimester,Third trimester,,,false,,,http://www.pepathway.org/peo/1.2#Trimesters,,peo2:Third_trimester,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/255248002,,,,3rd trimester|Third trimester (qualifier value),,,,,,Third trimester,
http://www.pepathway.org/peo/1.2#Atherogenic_lipoprotein,Atherogenic lipoprotein,,,false,,,http://www.pepathway.org/peo/1.2#cholesterol,,peo2:Atherogenic_lipoprotein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Atherogenic lipoprotein,
http://www.pepathway.org/peo/1.2#Insulin,Insulin,,,false,,,http://www.pepathway.org/peo/1.2#drug,,peo2:Insulin,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/67866001,,,,Insulin (substance),,,,,,Insulin,
http://www.pepathway.org/peo/1.2#Borderline_poverty_status,Borderline poverty status,,,false,,,http://www.pepathway.org/peo/1.2#Economic_status,,peo2:Borderline_poverty_status,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/9629004,,,,Borderline poverty (economic status)|Poverty line status|Borderline poverty (economic status) (social concept),,,,,,Borderline poverty status,
http://www.pepathway.org/peo/1.2#Right-sided_unilateral_notching,Right-sided unilateral notching,,,false,,,http://www.pepathway.org/peo/1.2#Unilateral_notching,,peo2:Right-sided_unilateral_notching,,,,,,,,,,,,,,,,,,,,,,,Unilateral right notch,,,,,,Right-sided unilateral notching,
http://www.pepathway.org/peo/1.1#G_protein-coupled_receptors,G protein coupled receptors,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:G_protein-coupled_receptors,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D043562,,,,"Receptors, G Protein Coupled|G Protein Coupled Receptors|G-Protein-Coupled Receptors",,,,The largest family of cell surface receptors involved in SIGNAL TRANSDUCTION. They share a common structure and signal through HETEROTRIMERIC G-PROTEINS.,,G protein coupled receptors,
http://www.pepathway.org/peo/1.2#Bowman_Capsule,Bowman Capsule,,,false,,,http://www.pepathway.org/peo/1.2#Entire_kidney,,peo2:Bowman_Capsule,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D050476,,,,"Bowmans Capsule|Capsule, Bowman|Capsule, Bowman's|Bowman's Capsule",,,,A double-walled epithelial capsule that is the bulbous closed proximal end of the kidney tubular system. It surrounds the cluster of convoluted capillaries of KIDNEY GLOMERULUS and is continuous with the convoluted PROXIMAL KIDNEY TUBULE.,,Bowman Capsule,
http://www.pepathway.org/peo/1.2#ion,ion,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:ion,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_24870,,,,Ion|Ionen|ion|iones|ions,,,,A molecular entity having a net electric charge.,,ion,
http://scai.fraunhofer.de/NDDUO#rate,rate,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,NDDUO:rate,,,,,,,,,,,,,,,,,,,,,,,rates,,,,,,rate,
http://www.pepathway.org/peo/1.2#Initial_causes,Initial cause,,AD456,false,,,http://scai.fraunhofer.de/NDDUO#disease_cause,,peo2:Initial_causes,,,,,,,,,,,,,,,,,,,,,,,Initial causes,,,,,AD456,Initial cause,
http://www.pepathway.org/peo/1.1#PIGF,PIGF,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:PIGF,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/5281,,,,,,,,,,,,,,,,,,,,PIGF,
http://www.pepathway.org/peo/1.2#Protein_degradation,Protein degradation,,AD610,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:Protein_degradation,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/GO#GO_0030163,,,,proteolytic process|protein breakdown|protein degradation|protein catabolism,,,,,AD610,Protein degradation,
http://www.pepathway.org/peo/1.2#Cocaine_abuse,Cocaine abuse,,,false,,,http://www.pepathway.org/peo/1.2#Drug_abuse,,peo2:Cocaine_abuse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Cocaine abuse,
http://scai.fraunhofer.de/NDDUO#Morbidity_survey,Morbidity survey,,,false,,,http://scai.fraunhofer.de/NDDUO#Cross_sectional_survey,,NDDUO:Morbidity_survey,,,,,,,,,,,,,,,,,,,,,,,Morbidity surveys,,,,,,Morbidity survey,
http://www.pepathway.org/peo/1.2#Gestational_hypertension,Gestational hypertension,,,false,,,http://www.pepathway.org/peo/1.2#Hypertension_associated_disorders_of_pregnancy,,peo2:Gestational_hypertension,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MEDDRA/10070538,,,,,,,,,,Gestational hypertension,
http://www.pepathway.org/peo/1.2#Gestational_trophoblastic_disease,Gestational trophoblastic disease,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Gestational_trophoblastic_disease,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/609518007,,,,Gestational trophoblastic disease (morphologic abnormality),,,,,,Gestational trophoblastic disease,
http://www.pepathway.org/peo/1.2#corticosteroid,corticosteroid,,,false,,,http://www.pepathway.org/peo/1.2#hormone,,peo2:corticosteroid,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_50858,,,,corticoides|corticosteroids|corticosteroides,,,,A natural or synthetic analogue of the hormones secreted by the adrenal gland.,,corticosteroid,
http://www.pepathway.org/peo/1.2#Bilirubin_total_measurement,"Bilirubin, total measurement",,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:Bilirubin_total_measurement,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/359986008,,,,"Total bilirubin|Total bilirubin level|Bilirubin, total measurement (procedure)",,,,,,"Bilirubin, total measurement",
http://www.pepathway.org/peo/1.2#Coenzyme_Q10,Coenzyme Q10,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:Coenzyme_Q10,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/412130008,,,,Ubidecarenone|Coenzyme Q10 (product)|Ubiquinone,,,,,,Coenzyme Q10,
http://scai.fraunhofer.de/NDDUO#Standardized_mortality_rate,Standardized mortality rate,,,false,,,http://scai.fraunhofer.de/NDDUO#Mortility_rate,,NDDUO:Standardized_mortality_rate,,,,,,,,,,,,,,,,,,,,,,,Standardized mortality rates,,,,,,Standardized mortality rate,
http://www.pepathway.org/peo/1.2#Stage_2_hypertension,Stage 2 hypertension,,,false,,,http://www.pepathway.org/peo/1.2#Hypertensive_disorder,,peo2:Stage_2_hypertension,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Stage 2 hypertension,
http://www.pepathway.org/peo/1.2#Enlarged_uterus,Enlarged uterus,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Enlarged_uterus,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/198319004,,,,Uterine enlargement|Large uterus|Enlarged uterus (finding),,,,,,Enlarged uterus,
http://www.pepathway.org/peo/1.2#Eclampsia,Eclampsia,,,false,,,http://www.pepathway.org/peo/1.2#Hypertension_associated_disorders_of_pregnancy,,peo2:Eclampsia,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/15938005,,,,Toxemia with convulsions|Eclamptic toxemia|Eclamptic toxaemia|Toxaemia with convulsions|Eclampsia (disorder),,,,,,Eclampsia,
http://www.pepathway.org/peo/1.1#LAMA3,LAMA3,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:LAMA3,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/3909,,,,,,,,,,,,,,,,,,,,LAMA3,
http://www.pepathway.org/peo/1.2#Decidual_lymphocyte,Decidual lymphocyte,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:Decidual_lymphocyte,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Decidual lymphocyte,
http://www.pepathway.org/peo/1.2#Retention_of_placenta,Retention of placenta,,,false,,,http://www.pepathway.org/peo/1.2#Obstetric_complications,,peo2:Retention_of_placenta,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Retention of placenta,
http://www.pepathway.org/peo/1.2#Seizure_disorder,Seizure disorder,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Seizure_disorder,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/128613002,,,,Seizure disorder (disorder),,,,,,Seizure disorder,
http://www.pepathway.org/peo/1.1#gene,gene,,,false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,peo:gene,,,,,,,,,,,,,,,,,,,,,,,,,,genes,,,gene,
http://www.pepathway.org/peo/1.2#Genetics,Genotype,,AD341,false,,,http://www.ifomis.org/bfo/1.1/snap#Quality,,peo2:Genetics,,,,,,,,,,,,,,,,,,,,,,,genetic risk factor|genetic risk factors|Genetics,,,,,AD341,Genotype,
http://www.pepathway.org/peo/1.2#C_H_-_Mental_disorder,C / H - Mental disorder,,,false,,,http://www.pepathway.org/peo/1.2#Medical_history,,peo2:C_H_-_Mental_disorder,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/74732009,,,,Clinical history of mental disorder,,,,,,C / H - Mental disorder,
http://www.pepathway.org/peo/1.2#Blood_pressure_at_first_visit,Blood pressure at first visit,,,false,,,http://www.pepathway.org/peo/1.2#Blood_pressure_finding,,peo2:Blood_pressure_at_first_visit,,,,,,,,,,,,,,,,,,,,,,,Blood pressure at first booking,,,,,,Blood pressure at first visit,
http://www.pepathway.org/peo/1.2#heparin,heparin,,,false,,,http://www.pepathway.org/peo/1.2#drug,,peo2:heparin,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_28304,,,,Heparinic acid|(C26H40N2O36S5)n|Bemiparin|Certoparin|Cy 222|Enoxaparin|Fluxum|Heparin|Parnaparin|Reviparin|Sandoparin|heparin|heparina|heparine|heparinum,,,,"A highly sulfated linear glycosaminoglycan comprising complex patterns of uronic acid-(1->4)-D-glucosamine repeating subunits. Used as an injectable anticoagulant, it has the highest negative charge density of any known biological molecule.",,heparin,
http://www.pepathway.org/peo/1.2#Pulasatility_index,Pulasatility index,,,false,,,http://www.pepathway.org/peo/1.2#Echocardiography,,peo2:Pulasatility_index,,,,,,,,,,,,,,,,,,,,,,,PI,,,,,,Pulasatility index,
http://www.pepathway.org/peo/1.2#Epigenetics,Epigenetics,,AD593,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:Epigenetics,,,,,,,,,,,,,,,,,,,,,,,,,,,,AD593,Epigenetics,
http://www.pepathway.org/peo/1.2#Colitis,Colitis,,,false,,,http://www.pepathway.org/peo/1.2#Inflammatory_disorder,,peo2:Colitis,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/64226004,,,,Colitis (disorder),,,,,,Colitis,
http://www.pepathway.org/peo/1.2#Nonreassuring_fetal_status,Nonreassuring fetal status,,,false,,,http://www.pepathway.org/peo/1.2#Pregnancy_Outcome,,peo2:Nonreassuring_fetal_status,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/130955003,,,,Nonreassuring foetal status|Fetal distress (finding)|Foetal distress|Fetal distress,,,,,,Nonreassuring fetal status,
http://www.pepathway.org/peo/1.2#Iron_supplement,Iron supplement,,,false,,,http://www.pepathway.org/peo/1.2#Supplements,,peo2:Iron_supplement,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/438641000124100,,,,Iron supplement (substance),,,,,,Iron supplement,
http://scai.fraunhofer.de/NDDUO#surgical_context,surgical context,,,false,,,http://scai.fraunhofer.de/NDDUO#context,,NDDUO:surgical_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,surgical context,
http://www.ifomis.org/bfo/1.1/snap#OneDimensionalRegion,one_dimensional_region,,"Definition: A spatial region [snap:SpatialRegion] with one dimension.|Examples: the part of space that is a line stretching from one end of absolute space to the other, an edge of a cube-shaped part of space",false,,,http://www.ifomis.org/bfo/1.1/snap#SpatialRegion,,snap:OneDimensionalRegion,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Definition: A spatial region [snap:SpatialRegion] with one dimension.|Examples: the part of space that is a line stretching from one end of absolute space to the other, an edge of a cube-shaped part of space",one_dimensional_region,
http://www.pepathway.org/peo/1.2#cholesterol,cholesterol,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:cholesterol,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/CHEBI_16113,,,,"cholesterol|Cholesterin|InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1|cholest-5-en-3beta-ol|[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C|(3beta,14beta,17alpha)-cholest-5-en-3-ol|Cholest-5-en-3beta-ol|InChIKey=HVYWMOMLDIMFJA-DPAQBDIFSA-N|CHOLESTEROL|Cholesterol|C27H46O",,,,"A cholestanoid consisting of cholestane having a double bond at the 5,6-position as well as a 3beta-hydroxy group.",,cholesterol,
http://www.pepathway.org/peo/1.2#BK_channel,BK channel,,,false,,,http://www.pepathway.org/peo/1.2#Dimers,,peo2:BK_channel,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BK channel,
http://www.pepathway.org/peo/1.2#Decidual_Arteriopathy,Decidual Arteriopathy,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_placenta,,peo2:Decidual_Arteriopathy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Decidual Arteriopathy,
http://www.pepathway.org/peo/1.2#Left_ventricular_end-diastolic_pressure,Left ventricular end-diastolic pressure,,,false,,,http://www.pepathway.org/peo/1.2#Blood_pressure_finding,,peo2:Left_ventricular_end-diastolic_pressure,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/276781007,,,,Left ventricular end-diastolic pressure (observable entity)|LVEDP - Left ventricular end-diastolic pressure,,,,,,Left ventricular end-diastolic pressure,
http://www.pepathway.org/peo/1.2#Trophoblast_invasion,Trophoblast invasion,,,false,,,http://www.pepathway.org/peo/1.2#Placentation,,peo2:Trophoblast_invasion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Trophoblast invasion,
http://www.ifomis.org/bfo/1.1/span#SpatiotemporalRegion,spatiotemporal_region,,"Comment: Spacetime and spatiotemporal region [span:SpatiotemporalRegion] entities are entities in their own rights which exist independently of any entities which can be located at them. This view of spacetime can be called ""absolutist"" or ""the container view"". In BFO, the class processual context [span:ProcessualContext] allows for a so-called relational view of spacetime, that is to say, a view according to which spatiotemporality is a matter of relative location between entities and not a matter of being tied to spacetime. In BFO, the bridge between these two views is secured through the fact that instances of processual context [span:ProcessualContext] are too spatiotemporal entities.|Comment: An instance of the spatiotemporal region [span:SpatiotemporalRegion] is a part of spacetime. All parts of spacetime are spatiotemporal region [span:SpatiotemporalRegion] entities and only spatiotemporal region [span:SpatiotemporalRegion] entities are parts of spacetime. In particular, neither spatial region [snap:SpatialRegion] entities nor temporal region [span:TemporalRegion] entities are in BFO parts of spacetime. Spacetime is the entire extent of the spatiotemporal universe, a designated individual, which is thus itself a spatiotemporal region [span:SpatiotemporalRegion]. Spacetime is among occurrents the analogous of space among continuant [snap:Continuant] entities.|Examples: the spatiotemporal region occupied by a human life, the spatiotemporal region occupied by the development of a cancer tumor, the spatiotemporal context occupied by a process of cellular meiosis|Comment: All instances of occurrent [span:Occurrent] are spatiotemporal entities, that is, they enter in the relation of (spatiotemporal) location with spatiotemporal region [span:SpatiotemporalRegion] entities. As a particular case, the exact spatiotemporal location of a spatiotemporal region [span:SpatiotemporalRegion] is this region itself.|Definition: An occurrent [span:Occurrent] at or in which processual entity [span:ProcessualEntity] entities can be located.",false,,,http://www.ifomis.org/bfo/1.1/span#Occurrent,,span:SpatiotemporalRegion,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Comment: Spacetime and spatiotemporal region [span:SpatiotemporalRegion] entities are entities in their own rights which exist independently of any entities which can be located at them. This view of spacetime can be called ""absolutist"" or ""the container view"". In BFO, the class processual context [span:ProcessualContext] allows for a so-called relational view of spacetime, that is to say, a view according to which spatiotemporality is a matter of relative location between entities and not a matter of being tied to spacetime. In BFO, the bridge between these two views is secured through the fact that instances of processual context [span:ProcessualContext] are too spatiotemporal entities.|Comment: An instance of the spatiotemporal region [span:SpatiotemporalRegion] is a part of spacetime. All parts of spacetime are spatiotemporal region [span:SpatiotemporalRegion] entities and only spatiotemporal region [span:SpatiotemporalRegion] entities are parts of spacetime. In particular, neither spatial region [snap:SpatialRegion] entities nor temporal region [span:TemporalRegion] entities are in BFO parts of spacetime. Spacetime is the entire extent of the spatiotemporal universe, a designated individual, which is thus itself a spatiotemporal region [span:SpatiotemporalRegion]. Spacetime is among occurrents the analogous of space among continuant [snap:Continuant] entities.|Examples: the spatiotemporal region occupied by a human life, the spatiotemporal region occupied by the development of a cancer tumor, the spatiotemporal context occupied by a process of cellular meiosis|Comment: All instances of occurrent [span:Occurrent] are spatiotemporal entities, that is, they enter in the relation of (spatiotemporal) location with spatiotemporal region [span:SpatiotemporalRegion] entities. As a particular case, the exact spatiotemporal location of a spatiotemporal region [span:SpatiotemporalRegion] is this region itself.|Definition: An occurrent [span:Occurrent] at or in which processual entity [span:ProcessualEntity] entities can be located.",spatiotemporal_region,
http://www.pepathway.org/peo/1.2#Endoplasmic_reticulum,Endoplasmic reticulum,,,false,,,http://www.pepathway.org/peo/1.2#Organelle,,peo2:Endoplasmic_reticulum,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/33761008,,,,Endoplasmic reticulum (cell structure)|ER,,,,,,Endoplasmic reticulum,
http://www.pepathway.org/peo/1.2#Entire_endometrium,Entire endometrium,,,false,,,http://scai.fraunhofer.de/NDDUO#Anatomical,,peo2:Entire_endometrium,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/278867007,,,,Endometrium|Entire endometrium (body structure)|Tunica mucosa uteri,,,,,,Entire endometrium,
http://scai.fraunhofer.de/NDDUO#Mouse_,Mouse,,,false,,,http://scai.fraunhofer.de/NDDUO#Rodents,,NDDUO:Mouse_,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/NCBITaxon#NCBITaxon_10090,,,,mice,,,,,,Mouse,
http://www.pepathway.org/peo/1.2#FGV_parcentage,FGV parcentage,,,false,,,http://www.pepathway.org/peo/1.2#Blood_test,,peo2:FGV_parcentage,,,,,,,,,,,,,,,,,,,,,,,%FGV,,,,,,FGV parcentage,
http://www.pepathway.org/peo/1.1#TRIM31,TRIM31,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:TRIM31,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/11074,,,,,,,,,,,,,,,,,,,,TRIM31,
http://www.pepathway.org/peo/1.1#ERVW-1,ERVW-1,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:ERVW-1,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/30816,,,,,,,,,,,,,,,,,,,,ERVW-1,
http://www.pepathway.org/peo/1.2#apocynin,apocynin,,,false,,,http://www.pepathway.org/peo/1.2#drug,,peo2:apocynin,,,,,,,,,,,,,,,,,,,,,,,4'-hydroxy-3'-methoxyacetophenone,,,,,,apocynin,
http://www.pepathway.org/peo/1.2#Ischemic_stroke,Ischemic stroke,,,false,,,http://www.pepathway.org/peo/1.2#Brain_Diseases,,peo2:Ischemic_stroke,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/422504002,,,,Ischemic stroke (disorder)|Ischaemic stroke,,,,,,Ischemic stroke,
http://scai.fraunhofer.de/NDDUO#etiological_context,etiological context,,,false,,,http://scai.fraunhofer.de/NDDUO#context,,NDDUO:etiological_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,etiological context,
http://www.pepathway.org/peo/1.1#PROC,PROC,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:PROC,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/5624,,,,,,,,,,,,,,,,,,,,PROC,
http://scai.fraunhofer.de/NDDUO#Ex_vivo,Ex vivo thing,,,false,,,http://scai.fraunhofer.de/NDDUO#Non_clinical,,NDDUO:Ex_vivo,,,,,,,,,,,,,,,,,,,,,,,Ex vivo,,,,,,Ex vivo thing,
http://www.pepathway.org/peo/1.2#Antihypertensive_medication,Antihypertensive medication,,,false,,,http://scai.fraunhofer.de/NDDUO#drug_role,,peo2:Antihypertensive_medication,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Antihypertensive medication,
http://www.pepathway.org/peo/1.2#Villous_Hemosiderosis,Villous Hemosiderosis,,,false,,,http://www.pepathway.org/peo/1.2#Disorder_of_placenta,,peo2:Villous_Hemosiderosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Villous Hemosiderosis,
http://www.pepathway.org/peo/1.2#Nitrosylation,Nitrosylation,,AD606,false,,,http://www.pepathway.org/peo/1.2#Post_translational_modification,,peo2:Nitrosylation,,,,,,,,,,,,,,,,,,,http://purl.org/obo/owl/GO#GO_0017014,,,,protein amino acid nitrosylation,,,,,AD606,Nitrosylation,
http://www.pepathway.org/peo/1.2#drug,drug,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_entities,,peo2:drug,,,,,,,,,,,,,,,,,,,,,,,,,,,,,drug,
http://www.pepathway.org/peo/1.1#IL6,IL6,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:IL6,,,,,,,,,http://www.ncbi.nlm.nih.gov/gene/3569,,,,,,,,,,,,,,,,,,,,IL6,
http://www.pepathway.org/peo/1.2#Family_History,Family History,,AD339,false,,,http://www.ifomis.org/bfo/1.1/snap#SpecificallyDependentContinuant,,peo2:Family_History,,,,,,,,,,,,,,,,,,,http://semanticscience.org/resource/SIO_010060,,,,Family History risk factors|family history,,,,,AD339,Family History,
http://scai.fraunhofer.de/NDDUO#intervention_context,intervention context,,,false,,,http://scai.fraunhofer.de/NDDUO#clinical_context,,NDDUO:intervention_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,intervention context,
http://www.pepathway.org/peo/1.2#Immunosuppression,Immunosuppression,,,false,,,http://scai.fraunhofer.de/NDDUO#Molecular_processes,,peo2:Immunosuppression,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/38013005,,,,Immunosuppression (finding),,,,,,Immunosuppression,
http://www.pepathway.org/peo/1.2#Antepartum_hemorrhage,Antepartum hemorrhage,,,false,,,http://www.pepathway.org/peo/1.2#Haemorrhage_finding,,peo2:Antepartum_hemorrhage,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/34842007,,,,Antepartum hemorrhage (disorder)|APH - Antepartum haemorrhage|Antepartum haemorrhage|APH - Antepartum hemorrhage,,,,,,Antepartum hemorrhage,
http://www.pepathway.org/peo/1.2#Thromboprophylaxis,Thromboprophylaxis,,,false,,,http://www.pepathway.org/peo/1.2#Therapeutics,,peo2:Thromboprophylaxis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Thromboprophylaxis,
http://www.pepathway.org/peo/1.2#Female_infertility_of_anovulatory_origin,Female infertility of anovulatory origin,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Female_infertility_of_anovulatory_origin,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/266609001,,,,Anovulatory infertility|Anovular cycle|Female infertility of anovulatory origin (disorder),,,,,,Female infertility of anovulatory origin,
http://www.pepathway.org/peo/1.2#Hyperandrogenemia,Hyperandrogenemia,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Hyperandrogenemia,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/371131009,,,,Hyperandrogenemia (finding),,,,,,Hyperandrogenemia,
http://www.ifomis.org/bfo/1.1/snap#Site,site,,"Comment: An instance of Site [snap:Site] is a mixture of independent continuant [snap:IndependentContinuant] entities which act as surrounding environments for other independent continuant [snap:IndependentContinuant] entities, most importantly for instances of object [snap:Object]. A site [snap:Site] is typically made of object [snap:Object] or fiat object part [snap:FiatObjectPart] entities and a surrounding medium in which is found an object [snap:Object] occupying the site [snap:Site]. Independent continuant [snap:IndependentContinuant] entities may be associated with others (which, then, are site [snap:Site] entities) through a relation of ""occupation"". That relation is connected to, but distinct from, the relation of spatial location. Site [snap:Site] entities are not to be confused with spatial region [snap:SpatialRegion] entities. In BFO, site [snap:Site] allows for a so-called relational view of space which is different from the view corresponding to the class spatial region [snap:SpatialRegion] (see the comment on this class).|Examples: a particular room in a particular hospital, Maria's nostril or her intestines for a variety of bacteria.|Definition: An independent continuant [snap:IndependentContinuant] consisting of a characteristic spatial shape in relation to some arrangement of other continuant [snap:Continuant] entities and of the medium which is enclosed in whole or in part by this characteristic spatial shape. Site [snap:Site] entities are entities that can be occupied by other continuant [snap:Continuant] entities.",false,,,http://www.ifomis.org/bfo/1.1/snap#IndependentContinuant,,snap:Site,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Comment: An instance of Site [snap:Site] is a mixture of independent continuant [snap:IndependentContinuant] entities which act as surrounding environments for other independent continuant [snap:IndependentContinuant] entities, most importantly for instances of object [snap:Object]. A site [snap:Site] is typically made of object [snap:Object] or fiat object part [snap:FiatObjectPart] entities and a surrounding medium in which is found an object [snap:Object] occupying the site [snap:Site]. Independent continuant [snap:IndependentContinuant] entities may be associated with others (which, then, are site [snap:Site] entities) through a relation of ""occupation"". That relation is connected to, but distinct from, the relation of spatial location. Site [snap:Site] entities are not to be confused with spatial region [snap:SpatialRegion] entities. In BFO, site [snap:Site] allows for a so-called relational view of space which is different from the view corresponding to the class spatial region [snap:SpatialRegion] (see the comment on this class).|Examples: a particular room in a particular hospital, Maria's nostril or her intestines for a variety of bacteria.|Definition: An independent continuant [snap:IndependentContinuant] consisting of a characteristic spatial shape in relation to some arrangement of other continuant [snap:Continuant] entities and of the medium which is enclosed in whole or in part by this characteristic spatial shape. Site [snap:Site] entities are entities that can be occupied by other continuant [snap:Continuant] entities.",site,
http://www.pepathway.org/peo/1.2#clinical_outcome_context,clinical outcome context,,,false,,,http://www.pepathway.org/peo/1.2#clinical_phenotypic_context,,peo2:clinical_outcome_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,clinical outcome context,
http://scai.fraunhofer.de/NDDUO#pharmacotherapy_treatment_context,pharmacotherapy clinical treatment context,,,false,,,http://scai.fraunhofer.de/NDDUO#clinical_treatment_context,,NDDUO:pharmacotherapy_treatment_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pharmacotherapy clinical treatment context,
http://www.pepathway.org/peo/1.2#angiogenesis,angiogenesis,,,false,,,http://www.ifomis.org/bfo/1.1/snap#Function,,peo2:angiogenesis,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/GO_0001525,,,,,,,blood vessel formation from pre-existing blood vessels,,,angiogenesis,
http://www.pepathway.org/peo/1.2#Placental_cell,Placental cell,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:Placental_cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Placental cell,
http://www.pepathway.org/peo/1.2#Smooth_muscle_cells_of_vessel,Smooth muscle cells of vessel,,,false,,,http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,,peo2:Smooth_muscle_cells_of_vessel,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Smooth muscle cells of vessel,
http://www.pepathway.org/peo/1.1#Cytokines,Cytokines,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:Cytokines,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/MESH/D016207,,,,,,,,"Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.",,Cytokines,
http://scai.fraunhofer.de/NDDUO#endpoint_classification_design,endpoint classification design,,,false,,,http://scai.fraunhofer.de/NDDUO#Study_design,,NDDUO:endpoint_classification_design,,,,,,,,,,,,,,,,,,,,,,,endpoint classification designs,,,,,,endpoint classification design,
http://www.pepathway.org/peo/1.2#Small_molecules,Small molecules,,,false,,,http://www.pepathway.org/peo/1.2#Cytodiagnosis,,peo2:Small_molecules,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/LNC/LP31415-0,,,,,,,,,,Small molecules,
http://scai.fraunhofer.de/NDDUO#Measurement_scale,Measurement scale,,,false,,,http://scai.fraunhofer.de/NDDUO#Measure_of_disease_ocurrence,,NDDUO:Measurement_scale,,,,,,,,,,,,,,,,,,,,,,,Measurement scales,,,,,,Measurement scale,
http://www.pepathway.org/peo/1.2#Oliguria,Oliguria,,,false,,,http://scai.fraunhofer.de/NDDUO#Symptoms,,peo2:Oliguria,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/83128009,,,,Passes too little urine|Oliguria (finding)|Urine output low|Oligouria,,,,,,Oliguria,
http://www.pepathway.org/peo/1.2#Hernia,Hernia,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Hernia,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/414403008,,,,Herniated structure|Herniated tissue|Herniated structure (morphologic abnormality)|Herniation,,,,,,Hernia,
http://www.pepathway.org/peo/1.2#Mental_disorder,Mental disorder,,,false,,,http://scai.fraunhofer.de/NDDUO#disorder,,peo2:Mental_disorder,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/74732009,,,,Psychiatric disorder|Mental illness|Mental health disorder|Psychiatric illness|Mental disorder (disorder)|Mental disease,,,,,,Mental disorder,
http://www.pepathway.org/peo/1.2#At_delivery_of_anterior_shoulder,At delivery of anterior shoulder,,,false,,,http://www.pepathway.org/peo/1.2#Intrapartum,,peo2:At_delivery_of_anterior_shoulder,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/255614006,,,,At delivery of anterior shoulder (qualifier value),,,,,,At delivery of anterior shoulder,
http://scai.fraunhofer.de/NDDUO#study_design_context,study design context,,,false,,,http://scai.fraunhofer.de/NDDUO#clinical_trial_context,,NDDUO:study_design_context,,,,,,,,,,,,,,,,,,,,,,,,,,,,,study design context,
http://www.pepathway.org/peo/1.2#thing_related_to_medical_resources,thing related to medical resources,,,false,,,http://www.pepathway.org/peo/1.2#thing_related_to_social_factors,,peo2:thing_related_to_medical_resources,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thing related to medical resources,
http://www.pepathway.org/peo/1.2#alcohol,alcohol,,from manual annotation of text corpus,false,,,http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,,peo2:alcohol,,,,,,,,,,,,,,,,,,,,,,,,,,,,from manual annotation of text corpus,alcohol,
http://www.pepathway.org/peo/1.2#VEGF_system,VEGF system,,,false,,,http://www.pepathway.org/peo/1.2#Pathway,,peo2:VEGF_system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,VEGF system,
http://www.pepathway.org/peo/1.2#Family_history,Family history,,AD446,false,,,http://www.ifomis.org/bfo/1.1/snap#GenericallyDependentContinuant,,peo2:Family_history,,,,,,,,,,,,,,,,,,,,,,,http://www.ebi.ac.uk/efo/EFO_0000493|Family histories,,,,,AD446,Family history,
http://www.pepathway.org/peo/1.2#Current_intake,Current intake,,,false,,,http://www.pepathway.org/peo/1.2#Alcohol_intake,,peo2:Current_intake,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Current intake,
http://www.pepathway.org/peo/1.2#Anemia,Anemia,,,false,,,http://www.pepathway.org/peo/1.2#Red_blood_cell_disorder,,peo2:Anemia,,,,,,,,,,,,,,,,,,,http://purl.bioontology.org/ontology/SNOMEDCT/271737000,,,,Absolute anemia|Absolute anaemia|Anemia (disorder)|Anaemia,,,,,,Anemia,
http://www.pepathway.org/peo/1.2#NS309,NS309,,,false,,,http://www.pepathway.org/peo/1.2#drug,,peo2:NS309,,,,,,,,,,,,,,,,,,,,,,,A Ca2+-activated IK/SK potassium channel activator,,,,,,NS309,
http://www.pepathway.org/peo/1.1#F7,F7,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:F7,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/2155,,,,,,,,,,,,,,,,,,,,F7,
http://www.pepathway.org/peo/1.1#F9,F9,,,false,,,http://www.pepathway.org/peo/1.1#gene,,peo:F9,,,,,,,,,http://view.ncbi.nlm.nih.gov/gene/2158,,,,,,,,,,,,,,,,,,,,F9,
